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Currently, when patients are diagnosed with cancer, they often receive a treatment 
based on the type and stage of the tumor. However, different patients may respond to the 
same treatment differently, due to the variation in their genomic alteration profile. Thus, it 
is essential to understand the effect of genomic alterations on cancer drug efficiency and 
engineer devices to monitor these changes for therapeutic response prediction. Nanopore-
based detection technology features devices containing a nanometer-scale pore embedded 
in a thin membrane that can be utilized for DNA sequencing, biosensing, and detection of 
biological or chemical modifications on single molecules. Overall, this project aims to 
evaluate the capability of the biological nanopore, α-hemolysin, as a biosensor for genetic 
and epigenetic biomarkers of cancer. Specifically, we utilized the nanopore to (1) study the 
effect of point mutations on C-kit1 G-quadruplex formation and its response to CX-5461 
cancer drug; (2) evaluate the nanopore’s ability to detect cytosine methylation in label-
dependent and label-independent manners; and (3) detect circulating-tumor DNA collected 
from lung cancer patients’ plasma for disease detection and treatment response monitoring. 
Compared to conventional techniques, nanopore assays offer increased flexibility and 
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1.1 Cancer and Precision Medicine 
Cancer is a group of diseases where abnormal cell growth can potentially spread to 
the surrounding tissues. It arises from the accumulation of score alterations affecting the 
structure and function of the genome. Most cancers belong to one of three groups— 
carcinomas, sarcomas, and leukemias or lymphomas—with carcinomas being accountable 
for approximately 90% of all human cancers.1  
In the United States, there are over one million new cancer cases, and more than 
500,000 cancer deaths, each year. With only 5-10% of all cancer cases coming from 
inherited genetic defects, the majority of cancers are caused by environmental exposures 
and lifestyles, such as viral infection (15%), tobacco use (22%), poor diet (35%), radiation, 
stress, and environmental pollution.2  
 1.1.1 Molecular markers of cancer. The development of a malignant cancerous 
tumor frequently results from a multistep process, rather than just a single genetic change.3 
This multistep process originates from various genetic and epigenetic modifications, which 
exert their pathological effects by causing defects in genes in one of two ways: (1) an 
enhanced expression or activation of oncogenes (gain in function) and (2) repression or 
inactivation of tumor-suppressor genes (loss of function).4 Several methods have been used 
in research for detecting various cancer-causing factors and different techniques are applied 





1.1.1.1 Genetic alterations. In cancer cells, somatic mutations occur and 
accumulate at a significantly higher rate than in normal cells. These mutations cover a wide 
range of structural alterations in the DNA. They consist of large chromosomal alterations 
that encompass millions of base-pairs (e.g. translocation, deletion, or amplification) as well 
as smaller changes in nucleotide sequences (e.g. point mutations). These different types of 
genetic alterations often co-exist within a single tumor.5 Together, they cause defects in 
DNA repair pathways, cell-cycle regulation, apoptosis, or create error-prone DNA 
polymerase.5  The ability to quickly accumulate mutations is critical for cancer cells’ rapid 
growth and development of resistance to cytotoxic cancer treatments.6   
1.1.1.2 Epigenetic alterations. In contrast to genetic alterations, “epigenetic 
alterations” refers to all heritable changes in gene expression and chromatin structure that 
are not encoded in the DNA sequence itself.5 Epigenetic inheritance, such as DNA 
methylation, histone modification and RNA-meditated silencing, are essential mechanisms 
that allow stable propagation of gene activities.7-8 Disruption of these mechanisms causes 
inappropriate gene expression (i.e. activation of oncogenes or inactivation of tumor-
suppressor genes) that can lead to cancer development.9   
A main distinguishing feature of epigenetic alterations compared to genetic changes 
is that they are reversible, and thus, present an exciting opportunity for the development of 
novel strategies for cancer prevention.5 Overall, both genetic and epigenetic alterations are 
involved in the formation of a field for cancerization (i.e. cancers develop at multiple foci 
in a tissue). However, their exact contribution is dependent on the major carcinogens 




1.1.2. Toward precision medicine for cancer treatment. Nowadays, when a 
patient is diagnosed with cancer, they often receive a combination of different treatment 
approaches to combat the disease, including surgery, chemotherapy, radiation therapy, 
immunotherapy, or any combination of the foregoing. The type of treatment and dosage 
are often similar between patients with the same type and stage of cancer. Even so, different 
people may respond differently. This is because a tumor’s genetic changes, which cause 
cancer to grow and spread, can differ significantly among patients with the same cancer. 
On the other hand, different types of cancers can also share the same cancer-causing 
changes.   
Precision medicine is an approach that matches patients to therapies depending on 
their own genomic information, to maximize a patient’s response to treatment.11  Using the 
concept of massively parallel sequencing, the development of high-throughput Next-
generation sequencing (NGS) devices (e.g. Illumina, Complete Genomics, and Roche 
Applied Science 454) have revolutionized personalized genomic medicines. In fact, for the 
first time, several clinical samples of patients were obtained and analyzed with NGS, 
providing an insight into the high complexity of diseases such as cancer.11-19 However, up-
to-date, clinical trials demonstrate that the level of patient benefit from precision medicine 
in cancer treatment is still low.11, 20-23    
A possible explanation for this unexpected result is that most current efforts are 
based on the idea that cancers are just like other rare genetic disorders. Specifically, the 
presence of epigenetic changes, lineage-specific drivers and non-oncogene-driven 
vulnerabilities are often ignored.11 Over 90% of cancer death are caused by metastatic 




decisions are generally based on results of primary tumor specimens from diagnostic 
testing. However, this method neglects a tumor’s genetic and epigenetic evolutionary 
changes, which are shown to present a major challenge for treatment selection.27-30 Thus, 
longitudinal monitoring of a tumor’s genetic and epigenetic variability are essential for 
correct treatment selection and cancer eradication.31 
While it is impractical for patients to undergo serial surgical biopsy along tumor 
progression, liquid biopsy provides a minimally invasive and more sustainable alternative 
to interrogate cancer cells longitudinally. Liquid biopsy is the sampling of non-solid 
biological tissue, to extract tumor-derived materials (e.g. circulating tumor cells, 
circulating tumor DNAs, and exosomes).31 Up-to-date, plasma-derived circulating tumor 
DNA (ctDNAs) are the most commonly used blood-based biomarker in clinical practice, 
and are utilized most frequently to (1) monitor a patient’s response to therapy, (2) detect 
minimal residual disease along treatment, and (3) assess therapy resistance development. 
Currently, the majority of liquid biopsy samples are analyzed with NGS, which can 
be costly and require extensive processing times of up to several weeks, or digital PCR that 
are restricted to a single locus (a fixed position on a chromosome). Furthermore, NGS 
technologies employ several enrichment, amplification, and labeling steps, such as 
polymerase chain reaction (PCR) and bisulfite conversions, which can cause the 
performance to be time and cost intensive, and can also increase the possibility of false 
positive results.32 Due to the need for a label-free, high throughput system, there has been 
a growing interest toward using third- and fourth-generation sequencing, specifically 




1.2 Nanopore Technology 
Since its development and publication in 1996, the nanopore has become an 
emergent and powerful technology for a direct and inexpensive method for DNA 
sequencing, biosensing, and detecting biological or chemical modifications on single 
molecules, as well as the kinetics of DNA and protein folding.33-37 
1.2.1 Definition of nanopore technology. Formal definitions of nanopore 
technology typically feature devices that contain a nanometer-scale pore embedded in a 
thin membrane. Originating from the Coulter counter and ion channels, nanopore-based 
devices can detect various charged biomolecules that are slightly smaller than the diameter 
of the pore. In the nanopore-based analysis, a biological or a solid-state membrane 
separates the experimental chamber into two compartments, referred to as the cis and trans 
sides, to which a cathode and anode are attached, respectively. Negatively charged 
biomolecules, such as DNA, are then introduced into the cis side of the chamber. Under 
the electrophoretic force exerted by the external current, the biomolecule transports 
through the nanopore to the trans chamber. As the molecule moves through the nanopore, 
it interrupts the current signal, causing ionic current blockages. Physical and chemical 
properties of the targeted molecule can be analyzed using the amplitude and duration of 
current blockages through the nanopore.38-39 
1.2.2 Types of nanopore. The two main types of nanopore—biological and solid-
state nanopores—can be obtained or fabricated in numerous ways40-45 and offer a wide 
range of biomolecule detection. Biological nanopores are secreted from different bacteria, 
of which the two most popular types come from α-hemolysin and MspA porin. These 




a phospholipid bilayer, liposomes, or polymer films. Biological membranes are structurally 
well-defined and easily reproducible. Biological nanopores are mostly used for the 
detection of single-stranded DNA (ssDNA), microRNA (miRNA), and disease 
diagnostics.39 Most solid-state nanopores are fabricated in membranes made of silicon 
oxide (SiO), silicon nitride (SiNx), hafnium oxide (HfO2), graphene, aluminum oxide 
(Al2O3) and hybrid materials.46-48 With controllable pore size and membrane thickness, 
solid-state nanopores have been beneficial for use in RNA sequencing, single-stranded and 
double-stranded DNA sequencing, DNA-protein complex detection, and other biomolecule 
detection.  
1.2.3 Experimental setup. Detailed reviews on the experimental setups and uses 
of the nanopore technology have been described in literature before.39-40, 47, 49-51 Figure 1A 
shows a schematic of the biological nanopore experiment setup. Briefly, a Teflon film 
divides the testing chamber into two separate compartments, named cis and trans 
chambers, to which negative and positive electrodes are attached, respectively (as 
described in 2.1 above). When 𝛼-HL protein is introduced to the cis chamber, it can insert 
a mushroom-shaped channel into lipid bilayer, connecting the cis and the trans sides 
(Figure 1B). α – hemolysin (𝛼-HL), a toxin released by the Staphylococcus aureus 
bacterium, is well known for its ability to form a protein channel with a well-defined 
structure as well as dimensions. Specifically, the 𝛼-HL α–hemolysin is a water-filled, 
mushroom-shaped channel consists of a cis-opening (2.6nm), a nano-constriction (1.4nm), 
and a trans opening (2.0nm).52  DNA or any other charged biomolecules are then injected 
to the cis chamber. Under an electrophoretic force, charged molecules (e.g. DNA) can 




characteristic amplitude (%I/Io), dwell time (∆𝑡), and event signature. Depending on the 
specific sequence, ssDNA strands can adopt several common conformations, including 
hairpin, G-quadruplexes and i-motif (among many others).47, 53-55 These secondary 
structures, while different, can coexist at the same time in the solution, causing various 
types of current-blockages as shown in Figure 1C. Depending on the size, conformation, 
and kinetics of each biomolecule species, several types of current blockage can be 
observed. These current blockages are characterized by their specific amplitudes and dwell 





Figure 1. The experimental setup of α-hemolysin nanopore. The experimental setup of the 
𝒂-HL nanopore experiment. (A) The testing chamber contains two compartments, cis and 
trans, separated by a Teflon film. (B)  𝒂-HL, a mushroom shape nanopore which connects 
the cis and trans chambers. (C) When DNA molecules, or other charged biomolecules, are 
inserted into the cis chamber, the applied current forces the biomolecules through the 𝒂-
HL nanopore, causing a current-drop (termed a blockage). Current blockages are analyzed 
and characterized by their amplitudes and dwell times. Each blockage trace is unique to the 
biomolecule species passing through the channel, depending on the size, conformation and 




1.2.4 Nanopore technology for precision medicine. Nanopore technology offers 
many advantages that NGS devices are incapable of: for instance, the nanopore has 
demonstrated the ability to detect CpGs methylation  (one of the earliest epigenetic 
biomarkers in cancer hallmarks) without the need of PCR amplification and bisulfite 
conversion.56-57 Thus, nanopore technology strives to be a potential genomic tool that is 
label-free, has a high throughput, a small sample volume requirement, flexible runtime, 
and minimal footprint.39 However, despite the past twenty years of significant progress in 
single molecular sequencing and analysis, nanopore technologies have not yet been 
translated into even distantly comparable advances in clinical settings. The aim of this 
thesis is to explore the ability of α-hemolysin nanopore to detect genetic and epigenetic 
changes on DNA, specifically ctDNAs. Through studying physical and electrical behavior 
of short DNA fragments, we can enhance the nanopore readout resolution, allowing the 
detection of DNA modifications. We believe that 𝛼-hemolysin nanopore is a good 
candidate, as the pore size stays consistent, yielding replicable results. 
1.3 Thesis Outline 
As described above, despite its significant potential and technological 
advancements in the past decades, applications of nanopore technology in clinical settings 
still come up short. The objective of this research is to explore and enhance the ability of 
α-hemolysin nanopore to study DNA fragments for cancer detection and precision 
medicine. To establish this purpose, we developed protocols to optimize the ability of both 
lab-based and commercially available nanopore assays in detecting DNA genetic and 
epigenetic alterations. A more detailed description of the studies performed in this thesis 




In Chapter 2 we provide an overview of the recent developments and applications 
of nanopore technology in studying cancer biomarkers. The development and progression 
of cancer are influenced by numerous genetic and epigenetic factors (e.g. structural 
variants, transcription factors, G-quadruplexes, methylations, histone modifications and 
expression of microRNAs). While nanopore technology has grown rapidly as a versatile 
DNA sequencer,39-40, 49, 58-61 its potential as a biosensor for cancer markers is still 
significantly underdeveloped.  
DNA is a flexible polymer that can adopt various structures depending on the 
sequence and surrounding environment. It is essential to evaluate the ability of α-hemolysin 
nanopore as a biosensor to detect and distinguish these structural changes. Therefore, in 
Chapter 3, we set out a study of the structural changes of an i-motif sequence with the 
surrounding environment’s pH level. Our results demonstrated that at high ionic 
concentration, C-rich DNA can dynamically fold into an i-motif or compacted structure 
according to the solution pH. These secondary structures, whose sizes were different, 
generated distinct electrical signal events  when captured by the nanopore.  
The most appealing strength of biological nanopores, such as the α-hemolysin, is 
their consistent dimensions and size selectivity. As the α-hemolysin nanopore only allows 
single-stranded DNA to translocate, all secondary structure must first dissociate into a 
linear strand at different rates, depending on its specific structural stability. In Chapter 4, 
we performed a comparative study on the formability and stability of Ckit1 G-quadruplex 
in K+ and Na+ environments. We further evaluated the effect of CX-5461 (a potential 
cancer drug) on stabilizing Ckit1 G-quadruplex structure. Using the event translocation 




we found that cations have a significant impact on the G-quadruplex structural stability and 
volume. Our results demonstrate that combining machine learning classification with 
nanopore results would allow different G-quadruplexes to be distinguished with over 80% 
accuracy and sensitivity.  
While CX-5461 has an amplified effect on unmodified C-kit1 DNA sequence to 
halt cancer cell growth, activating mutations on C-kit1 have been observed in several types 
of malignancy, notably leukemia, melanoma, and gastrointestinal tumors.62-64 Thus, in 
Chapter 5, we set out to evaluate the stability of G-quadruplex structure formed by 
mutated C-kit1 DNA sequences and the altered efficacy of CX-5461 on these structures. 
We designed the sequences containing between zero and six mutated guanines, to partially 
or completely disrupt the G-quadruplex. In this study, we found that while G-quadruplex 
stability depends strongly on the number of mutations present, the position of mutated 
guanine was the main deciding factor for CX-5461 efficacy.   
Another type of epigenetic marker we focused on in this thesis is methylated 
cytosine, which is among the most studied epigenetic markers for cancer diagnosis, 
therapeutics, and prognosis.65-69 Despite the enormous number of studies and papers 
published on promoter methylation as potential cancer biomarkers, currently, there are only 
two FDA-approved, DNA methylation-based biomarker assays available on the market. A 
major challenge in the study of epigenetics is that most commonly used techniques, 
including bisulfite sequencing, cannot directly identify 5-methylated cytosine (5-mC) from 
native DNA. In Chapter 6, our study evaluates the feasibility of label-free detection of 
methylated cytosine using the nanopore. Through employing a salt concentration gradient 




velocity through the pore; thus, increasing the detection resolution. This method allowed 
us to distinguish methylated from unmethylated cytosine in mixtures with different 
composition.  
In Chapter 7, we employed methyl-binding protein (MBD2) as a specific tag, as a 
method to enhance methylation detection with nanopore technology. Label-free detection, 
while attractive for its simplicity, can be affected greatly by the local context of the DNA 
sequence. Conjugation of MBD2 to methylated DNA resulted in a significant increase in 
both event translocation time and current blockage amplitude. Coupling nanopore data 
output with commonly employed machine learning algorithms, we were able to distinguish 
methylated DNA from unmethylated DNA with optimal sensitivity and specificity of 88% 
and 86%, respectively. 
Having determined the sensitivity of nanopore technology, we evaluated the 
feasibility of applying nanopore technology in a clinical setting. Recent studies found that 
circulating-tumor DNA in the bloodstream exhibits the same genetic and epigenetic 
alterations as the solid tumor they originated from,70 and thus ctDNA can reflect such tumor 
type and stage. However, as circulating-tumor DNA are highly fragmented and present in 
low concentrations in blood circulation, it is still challenging for nanopore assay to 
effectively capture them.  In Chapter 8, we developed and evaluated two novel protocols 
that could be integrated: commercially available nanopore assay for sequencing and 
analyzing circulating-tumor DNAs. We employed rolling-circle amplification and blunt-
end ligation methods to create long DNA fragments that could be captured by the nanopore.  
Finally, in Chapter 9 we present a summary of our findings and discuss the 






Piecing Together the Puzzle: Nanopore Technology in Detection and Quantification 
of Cancer Biomarkers 
 
2.1 Abstract 
  Nanopore-based technology has grown rapidly in recent years, which have seen 
the wide application of biosensing research to a number of life sciences. In this chapter, we 
present a comprehensive outline of various genetic and epigenetic causal factors of cancer 
at the molecular level, as well as the use of nanopore technology in the detection and study 
of those specific factors. With the ability to detect both genetic and epigenetic alterations, 
nanopore technology would offer a cost-efficient, labor-free, and highly practical approach 
to diagnosing pre-cancerous stage and early-staged tumors in both clinical and laboratory 
settings. This chapter was adapted from our previously published paper (Vu, Trang, et al. 
“Piecing together the puzzle: nanopore technology in detection and quantification of cancer 
biomarkers.” RSC advances 7.68 (2017): 42653-42666.)2.2 Detection of Cancer 
Biomarkers 
2.2 Current State of the Art 
2.2.1 Structural variants. Structural variants (SVs) are one of the first recognized 
causal factors of cancer. A structural variant is a form of somatic DNA mutation, whereby 
the SV promotes the development and progression of cancer while contributing to all the 
important hallmarks of the instability in cancer genomes.71 The four main types of SVs are 
large deletions, amplifications, inversions and translocations of nucleotides within a DNA 
sequence. They are often responsible for the creation of fusion genes, copy number, and 
other regulatory changes that lead to activation or overexpression of oncogenes, as well as 




simultaneously in a specific pathway that amplifies their genetic effects on cell instability. 
For example, with head and neck cancers, it was found that when the deletion of CDKN2A 
and amplification of CCND1 happen together, there is a higher risk of recurrence, 
metastasis, and death rather than when either genetic alteration occurs alone. 62-63 
SVs are important indicators of human cancers.64-67 Complex SVs have been found 
to cause approximately half of nucleotide deletions in pancreatic ductal adenocarcinoma 
(PDAC).68-70 Furthermore, CDKN2A/p16 and SMAD4/DPaazC4 have been identified as 
two of the most common deleted tumor suppressor genes. The ability to detect these 
mutations is critically important to the healthcare industry, allowing the monitoring of 
cancer patients for early detection of possible relapse.67-71 In mammalian cells with highly 
repetitive genomes, studies of SVs frequently use a resequencing approach, in which the 
read from the target genome is independently aligned from the reference genome to search 
for SVs.72 In general, besides specificity and sensitivity, when detecting SVs, a method’s 
quality is further judged by its ability to accurately predict breakpoint locations, the size of 
variants, and changes in copy count.67, 73 
As shown in Figure 2, Norris et al. demonstrated the value of detecting long SVs 
using Oxford MinIONTM, to detect a series of well-characterized SVs, including large 
deletions, inversions, and translocations that inactivate the CDKN2A/p16 and 
SMAD4/DPC4 tumor suppressor genes in pancreatic cancer.67 Using Oxford Nanopore 
barcodes, the Norris et al. produced libraries for all 12 PCR amplicons in one run, yielding 
reads with PHRED scores of 10.9-11.50. PHRED, invented back in 1998 by Ewing and 
Green, was originally a base-calling program for automated sequencer traces. In later 




accuracy between consensus sequences. The higher the PHRED score, the higher the 
accuracy. For example, a PHRED score of 10 stands for a 90% base call accuracy, and a 
PHRED score of 20 is correlated with 99% base call accuracy.74 For this specific study, 
the readings were averaged at 640 bps long with a PHRED score of 11.50. It was also found 
that these reads are consistent for the entire bp length. The amplicons mapped with an 
overall percentage of 99.6% for regions of hg19, while 79% of aligned reads accurately 
matched to bases. Notably, the representation of amplicons does not change accuracy based 
on the complexity of the sequence. Additionally, the researchers wanted to test their 
method with low frequency SVs. In a 1:100 dilutions, the run produced 4,058 2D reads 
from 270 of 512 channels. The average read length was 650 bps and had a PHRED score 
of 10.9. Overall, the researchers proved their methods can be conducted in a timely manner. 
For the two sequences (CDKN2A/p16 and SMAD4/DPC4) in this study, it took 15 minutes 
and 33 minutes respectively, to generate 450 reads.67 In comparison, 2nd generation 
sequencers can generate millions of reads simultaneously, but it can take hours to days to 
complete. The experiment indicated the ability of nanopores to serve as a reliable and 
efficient method of sequencing, allowing rapid detection of tumor-associated structural 
variants. The two limitations of MinIONTM, as noted by the researchers, were (1) a 







Figure 2. Nanopore Library Prep Workflow. Oxford Nanopore barcodes were incorporated 
into amplicons by PCR- individually for each SV, then resultant reactions were pooled (A). 
After NEB End Repair and dA-tailing modules (B), hairpin and leader adapters were 
ligated on, each containing a motor protein. Only the hairpin protein contained a his-tag, 
which was used to enrich for molecules containing a leader adapter and his-tag (his-tag 
selection step not shown). Tether attachment (C) allowed for direct attachment of the 
molecules to the flow cell membrane. Within the MinION flowcell (D), DNA molecules 
are pulled through a protein pore (blue), with motor protein (orange) affecting speed of 
DNA translocation through the pore. One side of the DNA molecule is read, then the 




Compared to conventional genome-based methods, such as fluorescence in situ 
hybridization (FISH), fiber-FISH, array comparative genomic hybridization (aCGH) and 
paired-end mapping (PEM) (each of which have a read length of approximately 35 ~ 400 
base pairs (bps)),73, 75 nanopore allows for much more flexible read lengths (of a few bps 
to kbps). However, the average PHRED score of reads generated by MinION is still 
relatively low compared to other sequencers (e.g. Illumina, 454, Ion Torrent, PacBio, and 
others). At the moment, Illumina is the most popular DNA sequencer on the market. Still, 




from 3-12 days to complete. Additionally, the current market price of Illumina ranges from 
$50,000 (MiniSeq) to over $6M (Illumina HiSeq X Five), costing significantly more than 
the nanopore-based sequencers. 
2.2.2 Transcription factors. The second most well-known causal factor of cancer 
is aberrant activity of transcription factors (TFs), which are often members of multigene 
families with common structural domains.3 TFs are the main regulators of gene expression 
and signaling pathways in all biological systems and bind to a specific sequence of DNA 
to promote or inhibit gene expression. In cells, a major portion of oncogenes and tumor-
suppressor genes are encoded by TFs.4, 76 Aberrant TF activity can occur due to changes in 
expression, protein stability, protein-protein interactions, post-translational modifications, 
and numerous other mechanisms.77 In a healthy cell, upstream transcriptional regulators 
highly regulate all genes with similar functions. However, changes in TF activity leads to 
deregulation of genes involved in promoting cancer cell proliferation, survival, and 
inducing angiogenesis and metastasis of tumors.4, 76  For example, nuclear TFs, the signal 
transducer and activator of transcription, has been linked to various human cancer cell lines 
and primary tumors, including leukemia and lymphoma, as well as breast, lung, pancreas, 
and prostate cancers.63, 79-87 
Various direct and indirect techniques have been used to characterize TFs, along 
with other sequence-specific DNA binding proteins, including electrophoresis, 
electrophoretic mobility shift assay, nuclear magnetic resonance, X-ray crystallography, 
atomic force microscopy, optical tweezers, and direct fluorescent visualization, among 
others.78, 88-92 However, most of these methods require some combination of chemical 




amplification assays.  Furthermore, due to the complicated requirements, these methods 
would lack the ability to resolve fine details of the TF and DNA complex (i.e. partial versus 
full binding of the TF domains to DNA).78 The specific mechanism of TFs binding to DNA 
sequences is still under intensive study and is a major area of interest in molecular 
biology.78, 93  
Squires et al. used solid-state nanopores as biosensors for the characterization of 
DNA, RNA, and proteins (Figure 3). With the use of an electric field, the researchers  
could guide the polymers through a nanopore and identify individual molecules. The 
current-blockage patterns generated during translocation of charged molecules provides an 
abundance of information about TF local properties, as well as TF-DNA interactions.78 As 
previously noted, the regulation of TFs has not been well investigated, hence the use of 
solid-state nanopores could be a novel technique in describing these molecular interactions. 
As proof of technique, the Squires et al. has shown that their nanopores can distinguish 
between specific and nonspecific binding of TF, by analyzing the ion current of the 
canonical zinc-finger DNA-binding domain of Early Growth Response 1 (zif268). 
Characterization of the zif268 was accomplished using the distinct blockage patterns of the 
current within the nanopore.94 Through analyzing the data, the researchers found that there 
are three main types of blockages, existing mostly in five distinct patterns rather than 
randomly. These patterns have a direct correlation to preexisting data. Hence, the nanopore 
presents great potential in characterizing DNA complexes because of its ability to detect 
complex structures and protein conformations, with the possibility of removing TFs as 




well as distinguish between specific and nonspecific binding. This research technique 






Figure 3. Distinguishing between specific and non-specific binding of TF—DNA with 
solid-state nanopore. Translocation event traces and proposed mechanisms for (A) specific 




2.2.3 Telomeres. On average, telomeres are shortened by 19 bps per year due to 
aging, oxidation, stress, mitotic activity of tissues, and lifestyle.95-98 When shortened to a 
critical length, telomeres lose their ability to protect the DNA chromosomes99 and restrict 
the proliferation of normal somatic cells.98 This leads to chromosomal fusion and 
degradation.100-101 In contrast, approximately 85% of human cancer cells can achieve an 
“immortality” status by maintaining and elongating telomeres via the de novo synthesis of 
telomeric DNA.100 Recently, a study was conducted on 47,102 individuals from the general 




relationship between telomere length and cancer. Although short telomere length is not an 
indication of cancer,98 it was observed that cancer patients with shorter telomere length had 
increased risk of early death. This result was observed in patients with lung and esophagus 
cancer, malignant melanoma, and leukemia.98 
Even though it has been years since the first research, the kinetics of telomeres in 
cancer cells remains elusive. At present, measuring the length of telomeres and observing 
the kinetics of folding are still challenging, as there is no gold-standard technique.102 In 
order to fully understand the role of telomeres in cancer prediction or therapy, it is essential 
to understand the kinetics of telomere folding and other conformational changes as a 
response to different living and environmental conditions. 
Work is currently underway to apply nanopore sensor in tracking the telomeric 
DNA G-quadruplex folding/unfolding (Figure 4). Several research groups have used 
biological nanopore to capture some or all four folded-structures of G-quadruplex, 
including hybrid (hybrid-1 and hybrid-2), basket, and propeller structures.47, 103-105 
Findings from these studies reported that even though the four G-quadruplex structures all 
folded from the same DNA sequence, they produced very different electrical signatures.105 
This was attributed to the overall shape and volume of each secondary structure. It was 
observed that both hybrid-1, -2, and basket forms had a diameter of 2.7 nm and 2.4 nm, 
respectively. Since the cis opening of the α-hemolysin pore has a diameter of 3.0 nm, these 
three folds can enter the large vestibule. However, the propeller fold, with a disk-shaped 
structure and diameter of 4.0 nm, exceeds the diameter of the nanopore cis opening and 







Figure 4. Capturing unfolding process of the four G-quadruplex structures with biological 
nanopore. (A) Schematic of the α-hemolysin nanopore, with the cis opening of 3.0 nm, 
constriction of 1.4 nm, and trans opening of 2.0 nm. (B) Folding structures and dimensions 
of G-quadruplex conformations: hybrid-1, hybrid-2, basket, and propeller. (C) G-
quadruplex fold entered and unfold inside the nanocavity of α-hemolysin nanopore, 
causing two distinct levels of blockage. (D) Except the propeller fold, all other G-
quadruplex can enter the cis opening of  α-hemolysin nanopore  without unfolding, but 
cannot pass through the pore constriction.114 (E) Models of the three conformations with 
the additional 5’-dA25 tail unraveling through α-hemolysin pore. Both hybrid and basket 
folds were able to enter the cis opening of the α-hemolysin pore, thus unraveled inside the 
pore nanocavity. On the other hand, propeller fold, because of its size, could not enter the 
nanopore. This conformation unraveled its structure outside of the pore, using the help of 




Another inventive solution to capture and unravel G-quadruplexes is to employ a 
25-mer poly-2’deoxyadenosine tail (d25A-tail) on the 5’ end of the telomeric DNA. 
Applying this method, the Burrows group reported the analysis of various folding motifs 
of the telomere sequence, with and without the 5’-d25A-tails.105 Among the four loop 
topologies, only the basket fold was able to translocate through the nanopore without the 




nanopore, it needs to unravel to a singular strand which would be able to translocate 
through the narrow β-barrel, and the remaining G-triplex has to roll within the vestibule. 
This is likely a favorable process for the basket fold because of its nearly spherical shape.107 
Even though the volume of the vestibule is large enough to accommodate all four G-
quadruplexes within its cavity, the narrow entrance of the vestibule prevented the propeller 
fold from entering the nanopore. However, with the addition of the 5’ tail, the propeller 
fold was able to circumvent the problem of entering the cavity, and yet still had a very fast 
translocation signature. This is attributed to the fact that the propeller fold was able to roll 
outside of the vestibule while an electric force was applied to the dA25-tail as it threaded 
through the ion channel, without having any molecular interactions or steric hindrance that 
would have been experienced on the interior of the vestibule.105 
In the light of those previous studies, for the first time, the unfolding kinetics of 
human i-motifs were studied using the α-hemolysin nanopore. Under acidic conditions, 
cytosine (C)-rich DNA sequences can adopt i-motif folds, since the hemi-protonation of  
C- rich strands allow C+•C base pairs to form.54 The Ding et al. conducted experiments on 
the human i-motif sequence at a constant ionic strength, but using various pH (5.0 – 7.2). 
Since the dimension of an i-motif (2.0 nm x 2.0 nm) is smaller than the cis opening (~3.0 
nm) of the α-hemolysin pore, it can enter the pore without unfolding and be captured in the 
nanocavity.54 Hence, a d25A tail was attached to the sequence, in order to increase the 
unfolding rate of i-motif. Upon the attachment of d25A, it was observed that at pH 5.0, the 
folded structure entered the α-hemolysin pore, yielding characteristic current patterns. 
However, when the pH were at 6.8 and 7.2 (higher than the transition pH 6.15), the 




applied in this study was analogous to the forces exerted on genomic DNA by RNA 
polymerases II (5-20 pN) and DNA helicase (6-16 pN).54 Hence, these studies strive to 
show the potential of α-hemolysin as part of biosensor development, aiding in our 
knowledge of the lifetimes of i-motifs of telomere sequences, and their biologically 
relevant structures, which can be used as drug delivery targets for cancer treatments.108 
These findings are steps toward a better understanding of the folding and unfolding 
mechanisms of the telomere. When pre-detecting different cancer types, conventional 
methods, such as FISH, Southern blot, and quantitative-PCR, require complicated meta-
analyses, chemical-crosslinking and intensive preparation. This can lead to inconsistent 
results.98, 109-111 Whereas nanopore analysis, lacking all those complications, allows a better 
understanding of the kinetics and mechanisms, aiding in the analysis of how different 
oxidation, stress and factors affect the length of telomeres, as well as the correlation 
between cancer development and telomere immortality.  
2.2.4 DNA methylations. 
 
2.2.4.1 Hyper- and hypomethylation of CpGs. In humans, methylation of DNA is 
an epigenetic modification that transfers a methyl group from S-adenosyl-methionine to 
cytosine residues, forming 5-methylcytosine (5-mC). In mammalian cells, methylation of 
CpGs can directly or indirectly repress gene expression. For example, hypermethylation of 
CpG islands in the promoter region can directly lead to transcriptional silencing of tumor-
suppressor genes. On the other hand, methylated CpGs can indirectly interfere with 
transcription to prevent the binding of basal transcriptional machinery or ubiquitous TFs. 
This process contributes to all of the typical hallmarks of a cancer cell originated from 




accumulation and epigenetic alterations (i.e. aberrant methylation in DNA) the chance to 
build up, causing proliferative advantages and genomic instability. Aberrant DNA 
methylation, including loss of methylation (hypomethylation) and gain of methylation 
(hypermethylation), has been classified as a common causal factor of many cancers.113-117 
For instance, hypermethylation is linked to various types of cancers, including lung, 
prostate, breast and colon cancers,118-121 while hypomethylation of CpGs has been reported 
to be associated with kidney, liver, pancreas, lung, cervix, stomach and uterus cancers.122-
127 Hence, detecting aberrant DNA methylation can have an important role in cancer 
treatment and precancerous detection.37, 56 
The overall level of 5-methylcystosine contained in the cell sample can be 
quantified using high-performance liquid chromatography (HPLC), high-performance 
capillary electrophoresis (HPCE), bisulfite sequencing, methylation-specific PCR, among 
many other methods.128-134 However, these methods have certain drawbacks. For example, 
although HPLC and HPCE can accurately quantify the total amount of methylated CpGs, 
they have incomplete restriction enzyme cutting, offer limited region of study, require 
substantial amounts of high molecular weight DNA, and are labor intensive. Similarly, 
with PCR-based methods, only the methylation status of CpG sites that are complementary 
to the primers can be interrogated. Thus, the predominant methylation patterns in the 
sample may not necessarily reflect the actual results (false positive results). 
With nanopore analysis, current methods used in the detection of aberrant CpGs 
methylation usually employ either a methylation specific labeler, or an electro-optical 
tagging.56-57, 135 The first method, as proposed by Shim et al., employs an engineered 




selective labeler to detect and quantify hypermethylated CpG sites in double-stranded DNA 
(dsDNA) ).56, 135 As the DNA translocated through the nanopore,  the presence of 5-
mC·labeler complexes caused a signature current blockage, allowing the detection and 
coarse quantification of 5-mC sites on a single molecule.135  Indeed, this method set an 
initial application in screening for the presence of hyper- and hypomethylated DNA. 
Moreover, Shim et al. pointed out that with the versatile binding affinity of KZF to various 
methylation patterns, the studied assay can allow various patterns to be screened.56 Since 
nanopore analysis requires low volumes of DNA for testing, the technique will be more 
applicable and practical for clinical use. Without the need of DNA replication and 
amplification, detecting CpG methylation using nanopores requires much less labor in 
comparison to other conventional methods. 
The second method, as previously discussed, uses an electro-optical solid-state 
nanopore to detect and quantify hypomethylation in DNA.57 In this approach, enzyme 
DNA MTases was assisted by small molecular weight synthetic cofactors to catalyze a one-
step enzymatic reaction. This enzyme-cofactor complex was directly conjugated onto 
fluorescent probes and attached to the unmethylated CpG sites. The Meller group was able 
to detect and differentiate between fully methylated, partially methylated and unmethylated 
dsDNA, using ultrasensitive electro-optical nanopore sensing as the tool for single-
fluorophore multicolor quantification. Unlike MBPs, DNA MTase only labeled 
unmethylated CpG sites of the target DNA. This allowed the direct targeting of 
hypomethylated CpG sites in the genome (i.e. promoter regions of oncogenes). 
Furthermore, this electro-optical solid-state nanopore showed a high potential for 




biomarkers, orthogonal labeling/sensing of 5-mC can be achieved in the future.57 Further 
research must be done in order to develop a calibrated scale to count the number of 
unmethylated CpGs in the target sequence. 
2.2.4.2 Other variants of CpGs methylations. The family of Ten-Eleven 
Translocation (TET) proteins have been shown to oxidize methylcytosine (mC) into 
hydroxymethylcytosine (hmC) and further oxidize hmC into formylcytosine (fC) and 
carboxylcytosine (caC) (Figure 5).136-139 5-hmC normally exists at a high level in self-
renewing and pluripotent stem cells.136, 140 Both mc and hmC influence mammalian 
embryonic stem cell maintenance,141-142  angiogenesis,143 and development.144 Thus, hmC 
is a promising molecular biomarker with predictive and prognostic value.145 As for fC and 
caC, there is still very little research being done. Because  the topic has just recently been 
discovered, we currently lack a robust method to distinguish between these five chemical 
modifications of cytosine.  Even distinguishing between mC and hmC is a challenge for 
available methods.142, 146 
The presence of bulk 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-
hmC) on ss- and dsDNA has been successfully detected and distinguished using both solid-
state and biological nanopores.147-149 For instance, the Drndic group proposed a method 
using solid-state nanopore to discriminate two different structures that translocated through 
the pore (5-mC and 5-hmC). Upon the addition of 3kbp dsDNA, a sequence of current 
blockage was generated, in which the magnitude of each spike was related to the excluded 
volume of biopolymer that occupies the pore. From the differences in ΔImax values, Wanunu 
et al. was able to discriminate between 5-mC and 5-hmC. Shorter end-to-end distance of 




and 5-mC. Moreover, it was shown that different proportions of 5-hmC in DNA fragment 
containing cytosine and 5-mC can be quantified using ionic current signal.147 The second 
device used in the detection of CpG methylation variants employed both the wild-type 
phi29 DNA polymerase (phi29 DNAP) and MspA in the same assay.148-149 With this unique 
approach, the Wescoe et al. reported a direction detection of all five cytosine variants (C, 
mC, hmC, fC and caC). In this single-molecule tool, a phi29 DNA polymerase drew 
ssDNA through the pore in single-nucleotide steps and the ion current through the pore 
was recorded.148 Overall, the  single-pass call ranged from approximately 91.6% to 98.3% 
depending on neighboring nucleotides.148-149 Because the knowledge of the five cytosine 
variants, especially fC and caC, is still very limited, the possibility of these variants having 
an impact on genome-wide demethylation or other modifications in cancer cells should not 
be eliminated. 
These studies have shown nanopore analysis potential as a robust and efficient tool 
for the study of DNA methylation. The technique can directly detect CpG methylation 
without the need for DNA amplification or complicated preparation processes. Due to its 
special characteristics, methylation of CpG is usually erased during replication and 
amplification. Hence, nanopore analysis could be a more practical and reliable method to 







Figure 5. Distinguishing variants of cytosine with biological and solid state nanopores. (A) 
Chemical structures of cytosine and its variants. First row: mC (left) and fC (right). Second 
row: cytosine. Third row: hmC (left) and caC (right).123 . (B) Schematic of the Phi 29 
DNAP-MspA complex. MspA pore constriction is shorter and narrower compared to α-
hemolysin(as shown in the top), allowing short subtle structural changes to be 
distinguished. (C) A typical trace of DNA translocation through the  Phi 29 DNAP – MspA 
complex.122 (D) Detection of DNA methylation with methyl binding proteins (MBP) using 
solid state nanopore. MBPs bind to methylated CpGs on DNA, allow the detection and 
differentiation between unmethylated, hypermethylated and locally methylated DNAs. (E) 




2.2.5 Histone-DNA modification. Aberrant DNA-methylations are also linked to 
the presence of aberrant modifications in histones,150-154 which are the gene activity’s 
dynamic regulators. Histones go through several post-translational modifications, such as 
acetylation, methylation, phosphorylation, ubiquitylation and others. Specifically, 




essential role in gene expression and chromatin structure regulation.155 In normal cells, 
histones in DNA sequences are hypoacetylated and hypermethylated. The two key 
regulators of histone modifications are histone deacetylases and histone methyltransferases 
(MTases), which are associated with methyl-binding proteins (MBPs) and MTases.155-157 
Several studies have been conducted on the translocation or unravelling of a 
nucleosome and its subunit structure through nanopore.158-160 Generally, it was found that 
DNA-histone complexes lead to higher applied voltage required and overall longer time 
periods to translocate through the nanopore, most likely due to either: (1) the bulky disk 
shape nucleosome experiencing a higher drag force comparing to a bare dsDNA, (2) the 
positively charged histone core lowering the total net charge density of nucleosomes, 
causing the translocation speed in electrophoresis to reduce, and (3) the unwinding process 
of histone-DNA complex.159, 161 
As previously discussed, epigenetic modifications have been known to affect the 
structural integrity and stability of nucleosomes. Given this fact, it was hypothesized that 
methylation of CpGs on dsDNA would affect the way nucleosomes fold and/or unravel. 
To test this hypothesis, the Langecker et al. investigated the influence of DNA methylation 
on the stability of unlabeled mononucleosomes.160 Similar to the results reported in other 
studies, under the electrophoretic force, the nucleosomal DNA tail entered the pore and 
gradually unraveled under increasing voltage, which was much higher in comparison with 
free DNA capture.162 This experiment was repeated on nucleosomes with and without 
methylated DNA sequences, yielding that methylation of CpGs did not affect the 
nucleosome assembly, stability, or unraveling trajectories. This finding suggested that 




role in nucleosomal maintenance than DNA methylation. The confirmation of methylation-
independent nucleosome stability indicated other possible mechanisms by which DNA 
methylation alters gene expression, for example, modulating the binding of transcription 
activators/repressor.160  
The nanopore-based studies outlined herein lay the groundwork for understanding 
and predicting the influence of different histone core modifications on the nucleosome 
structure,160 about which our knowledge is still quite limited. Unlike conventional methods 
(e.g. single-gene chromatin immunoprecipitation (ChIP), ChIP with a DNA array (ChIP-
on-chip),163-164 HPLC, HPCE, and many others), nanopore devices are more versatile, 
because they do not rely heavily on the quality of the polyclonal antibodies or antibodies 
that are available.154 Although the study here indicated that DNA methylation does not 
affect the nucleosome assemble, further studies need to be done in order to confirm the role 
of DNA methylation in other processes (i.e. regulating transcription activators/repressors 
binding, or gene expressions), as well as the relationship between acetylation and 
phosphorylation on nucleosome assembly and chromatin stability.  
2.2.6 MicroRNA. MiRNAs are small endogenous biomolecules that are in length 
of 18-22 bps. They play an important role in embryonic differentiation, hematopoiesis, 
cardiac hypertrophy and numerous cancer-related processes, including proliferation, 
apoptosis, differentiation, migration and metabolism.165-166 Because a single miRNA can 
target up to hundreds of mRNAs,167 an aberrant miRNA expression may affect several 
transcripts and cancer-related signaling pathways. In cancer cells, because of the genetic 
diversity of tumors and cancer cell lines, an individual miRNA can be up-regulated in one 




their targets within the specific tissue.3 Usually, the up-regulated miRNAs function as 
oncogenes by down-regulating tumor-suppressor genes, while the down-regulated 
miRNAs function as tumor-suppressor genes by down-regulating oncogenes.  
 Detection of miRNAs faces several challenges, mainly due to the short length of 
miRNAs. Some quantitative methods have been applied to miRNA detection with 
enhanced sensitivity and/or selectivity, including quantitative reverse transcription real-
time polymerase chain reaction (qRT-PCR) assays, microarrays, colorimetry, 
bioluminescence, enzyme turnover, electrochemistry, molecular beacons, deep sequencing 
and single-molecule fluorescence.168-171 Unfortunately, these techniques incur DNA 
amplification errors, unavailable internal controls, and cross-hybridization. Also, the short 
sequence of miRNAs makes the designing of probes and primers even more challenging.168, 
170 
MiRNAs have been investigated as potential molecular biomarkers, because their 
expression levels are associated with various diseases.172 For instance, each year, lung 
cancer causes approximately 1.2 million deaths worldwide.173 Since there is no effective 
screening procedure available, more than 70% of lung cancer patients were diagnosed with 
less than a 15% chance of a 5-year survival rate.173 More than 100 types of miRNAs have 
been identified to deregulate lung cancer progression.172 Noticeably, high levels of miR155 
and low levels of let-7a-2 have been associated with a significantly poor prognosis and 
shorter survival times in lung cancer patients.174-175 Many research groups have used 
biological and solid-state nanopores for the detection of miRNAs in different tissues 
(Figure 6). For example, the solid-state nanopore was used for rapid detection of probe-




miRNA duplex per mL solution, the capture rate was 1 molecule per second.  In this study, 
the p19 protein from the Carnation Italian ringspot virus was used to enrich miRNA-122a 
and miRNA-153. Since miRNA concentrations were 1% relative to other cellular RNAs, to 
detect a specific miRNA using a nanopore sequence, an enrichment step was required.176 
p19 binds 21-23bps dsRNA in a size-dependent, but sequence-independent manner. 
Additionally, the highly affinitive and selective viral p19 protein does not bind ssRNA, 
tRNA or rRNA. This eliminates the possibility of false results from mismatched binding.177 
Detection of 250 molecules in 4 minutes was sufficient to determine miRNA concentration 
with 93% confidence.176 
A different approach from using viral proteins for probe-specific miRNAs detection 
is to employ an engineered-probe with a programmable sequence to differentiate single 
nucleotide differences in miRNA family members.172 Wang et al. proposed a system that 
enabled sensitive, selective, and direct quantifications of cancer-associated miRNAs in the 
blood. In this study, the group constructed a robust protein nanopore-based sensor that 
utilized an oligonucleotide probe (P155) to detect aberrant expression of miRNA-155 and 
let-7a-2 from lung cancer patients.172 The generated signature electrical signals provided a 
direct and label-free detection of the target miRNA in a fluctuating background, such as 
plasma RNA extract.172 Probe (P155) has a programmable sequence and can be optimized 
to achieve high sensitivity and selectivity. Additionally, using chemical modifications, 
distinct probes can further be engineered with specific barcodes, allowing multiple 
miRNAs to be simultaneously detected. Furthermore, with the development of miRNA 
markers, manipulatable miRNA profile detection nanopore arrays can be constructed for a 









Figure 6. Detection of a miR-155 using using solid-state and biological α- Hemolysin 
nanopores. (A) Schematic of miRNA detection with viral proteins for probe-specific 
miRNA, using solid-state nanopore.  Protein from Carnation Italian ringspot virus was used 
to enrich miRNA form background fluid. (B) Detection of probe-specific miRNA using 
alpha-hemolysin biological nanopore. MiRNA-155 (shown in red) was attached to a DNA 
P155 probe (shown in green). (C) At 8.0 pH and 100mV, translocation of the miRNA-
155P155 resulted in various current blockage patterns. (C) A typical current blockade with 
three characteristic blocking levels, representing the mechanism of miRNA-155P155 






Compared to qRT-PCR assays, microarrays, colorimetry, bioluminescence, and 
other current methods,168-171 nanopore arrays is a simpler, faster method that can be utilized 
to detect miRNAs in cancer patients. This approach lacks all the complications that 




controls, and cross-hybridization. Early detection is one of the most crucial contributors to 
a higher survival rate, especially lung cancer patients.173 
2.3 Summary and Conclusion 
In this chapter, we have concisely reviewed the main genetic and epigenetic causal 
factors of cancer, as well as summarized how nanopore have been used in the research of 
each factor (Table1). Thanks to several unique features of this emerging technology, the 
nanopore-based analysis offers four main benefits: First, nanopore analysis offers long 
reads of genomic DNA (>10 kB). Therefore, linkages between modified cytosines may be 
revealed that are biologically significant and otherwise difficult to discern. For example, it 
was shown that histone-DNA interaction is not affected by methylation of DNA. Also, for 
the first time, differences between caC, fC, and hmC from mC were successfully 
distinguished. Second, the genomic DNA is read directly as it transports through the 
nanopore. Thus, errors (false-positive results) caused by copying do not occur. Third, with 
biological nanopore membranes, the study of biomolecules’ folding-unfolding kinetics and 
mechanisms are possible to accomplish. Furthermore, the DNA fragment can be retained 
in nanopore indefinitely, allowing rereads of a captured DNA fragment.149 Finally, many 
conventional methods are still impractical for clinical testing, because these methods 
require highly trained experts, intensive labor, a high capital cost, and a large footprint. 
With nanopore technology, there are no such requirements, offering more flexibility and 
practicality for research labs and clinics.  
Although the concepts of nanopore analysis in early cancer detection are 
exceptionally promising, several key technological challenges must be addressed before 




of nanopore-based methods is high mismatch and error rates. Because the nanopore 
membrane thickness, especially with respect to biological nanopores, is relatively large 
compared to a nucleotide, nanopore sensitivity is still low at the single-nucleotide level. 
Furthermore, even though different DNA conformations and foldings yield distinguishing 
characteristic current blockades, information about the molecular structure cannot be 
determined by nanopore membrane alone in order to confirm the exact structure that causes 
a signature blockades. 
In utilizing nanopore technology, researchers need the aid of other equipment, such 
as circular dichroism (CD), FRET, FISH, among many others. This limits the use of 
nanopore membranes as an independent, stand-alone tool for molecular studies in general, 
and early cancer detection, specifically. Moreover, since one single biological molecule 
can quickly adopt multiple, complex conformations under different environments, many 
research groups choose to use short/simplified sequences in their nanopore studies. Hence, 
the complexity of cancer cells has not yet been demonstrated and/or fully investigated with 
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Biophysical Properties of DNA - Investigation of Compacted DNA Structures 
Induced by Na+ and K+ 
 
3.1 Abstract 
 DNA compaction is a highly promising method for gene therapy and delivery. 
Experimental conditions to induce these compacted DNA structures are often limited to 
the use of common compacting agents, such as cationic surfactants, polymers, and 
multivalent cations. In this study, we showed that in highly concentrated buffers of 1M 
monovalent cation solutions at pH 7.2 and 10, biological nanopores allowed real-time 
sensing of individual compacted structures induced by K+ and Na+, the most abundant 
monovalent cations in human bodies. Since the binding affinities of each nucleotide to 
cations is different, the ability of a DNA strand to fold into compacted structure depends 
highly on the type of cations and nucleotides present. Our experimental results were 
favorably comparable to findings from previous molecular dynamics simulations for DNA 
compacting potential of K+ and Na+ monovalent cations. We estimated that the majority of 
single-stranded DNA molecules in our experiment were compacted. From the current 
traces of nanopores, the ratio of compacted DNA to linear DNA molecules was 30:1 and 
15:1, at a pH7.2 and pH10, respectively. Our comparative studies revealed that Na+ 
monovalent cations had a greater potential of compacting the 15C-ssDNA than a K+ cation 
did. This chapter was adapted from our previously published paper (Vu, Trang, Shanna-
Leigh Davidson, and Jiwook Shim. “Investigation of compacted DNA structures induced 






In an aqueous solution, DNA is a long, highly charged polymer, and is usually in 
an elongated conformation due to strong repulsion forces between the negatively charged 
phosphate groups on the DNA backbone.178 Upon the addition of compacting agents, DNA 
can quickly go through a conformational change, mainly due to the neutralization of 
negatively charged DNA through cation binding.178-179 Interaction of cations with the DNA 
phosphate backbone has been known to induce several DNA phase separation processes, 
including DNA compaction, condensation, aggregation, and precipitation, without a clear 
distinction between these processes.180 Previous literatures have intensively studied and 
reviewed several in vivo and in vitro compacting agents, including multivalent cations,181 
polycations,182 neutral polymers,183 cationic nanoparticles,184-185 and surfactants.186-188 In 
addition, the presence of monovalent cations can also promote DNA compaction processes 
in both concentrated and diluted solutions of DNA.180, 189-195 Several previous studies have 
investigated the role and mechanism of cations in the process of binding and compacting 
DNA.184-185 However, the existence of the DNA compacted structure has not been 
discussed in the nanopore analysis setting yet, mainly due to the complex quantum-
chemical mechanism of the DNA compaction process.  
In this chapter, we used 𝛼-hemolysin NPs to capture the cations-induced compacted 
structure of a single-stranded DNA with a specific sequence containing only cytosine 
nucleotides (5’-(CCC)5-3’). In order to investigate the ability of Na+ and K+ monovalent 
cations as compacting agents for ssDNA, studies were conducted with buffers containing 





3.3.1 Chemicals. Chemicals and reagents used in the experiments were purchased 
from the following vendors: 1,2-diphytanoyl-sn-glycero-3-phosphocholine (Avanti Polar 
Lipids); pentane (Sigma-Aldrich); potassium chloride (99.5%, Sigma-Aldrich); sodium 
chloride (Sigma – Aldrich); Tris base (Promega); Ethylenediamine Tetraacetic acid 
(EDTA) disodium salt dehydrate electrophoresis crystalline powder (Fisher BioReagents); 
agarose (Bio-Rad); pentane (Fischer Chemical), hexadecane CH3(Ch2)14CH3 (Avantor); 
and hydrochlodric solution 1M (LabChem). Synthetic oligonucleotides (Integrated 
Technology) with the following sequences were used: 5’-CCC CCC CCC CCC CCC – 3’. 
The control sample is an 18-bases ssDNA with the sequence of 5’-
TAATCATCGCGTACTAAT-3’. Salt solutions were buffered with 10mM Tris and 
titrated with HCl until the required pH of 5.0, 7.2, or 10.0. DNA solutions were suspended 
in a buffer solution containing 10mM Tris, 1mM EDTA, pH 8.0 at room temperature before 
usage.  
3.3.2 Circular dichroism. CD spectra were collected using the Jasco CD 
spectropolarimeter, model J-810. All measurements were measured at 15oC as maintained 
by the temperature-control units affiliated to the spectrometer. All samples used for CD 
measurements contained the same salt (1M) and ssDNA (1 𝜇M) concentrations, as used in 
the single-molecular study. Spectra were captured in the 220-320 nm wavelength, 1.0 nm 
bandwidth, 50 nm/min scanning speed, and a standard sensitivity. 
3.3.3 Experimental setup. The experiments herein were performed following 
previously described protocols.45, 196-198 Briefly, a Teflon film divides the testing chamber 




positive electrodes are attached to, respectively. Artificial lipid bilayer, acting as an electric 
insulation, is formed over a premade orifice of 100𝜇m in diameter in the Teflon film.  𝛼-
hemolysin (𝛼-HL), a toxin released by the Staphylococcus aureus bacterium, is well known 
for its ability to form a mushroom-shaped protein channel with a well-defined structure, as 
well as dimensions. Specifically, the 𝛼-HL consists of a cis-opening (2.6nm), a nano-
constriction (1.4nm), and a trans opening (2.0nm).52 When 𝛼-HL protein is introduced to 
the cis chamber, it can insert a mushroom-shaped channel into lipid bilayer, connecting the 
cis and the trans sides. DNA or any other charged biomolecules are then injected to the cis 
chamber. Under an applied current, DNA molecules are driven through the 𝛼-HL 
nanopore, causing a current-drop (blockage). A lipid bilayer, 1,2-diphytanoyl-sn-
glycerophosphatidylcholine (Avanti Polar Lipids), was formed spanning the hole, creating 
a planar layer of insulation. The cis and trans chambers were both filled with symmetrical 
salt solutions of 1M concentration, containing either NaCl or KCl as per the testing 
conditions. The protein nanopore, α-hemolysin, was injected into the bilayer on the cis side, 
creating a single open channel joining the two chambers. A final concentration of 1 𝜇𝑀 
15C-ssDNA was introduced to the cis chamber. Ag/AgCl electrodes (1.5% Agarose in 3M 
KCl) was attached to each of the cis and trans chambers, with the cis chamber being 
grounded such that a positive voltage would drive the negatively charged DNA molecules 
through the nanopore channel and into the trans chamber. Data acquisition included an 
electrophysiological setup, with picoampere (pA) current traces being recorded as DNA 





3.3.4 Single channel analysis. An Axopatch 200B patch-clamp amplifier was 
employed with Clampex 10.7 software (Molecular Device Inc.) to record and acquire data 
through a Digidata 1550B A/D converter (Molecular Device Inc.) at a sampling rate of 20 
kHZ, and an analogue, eight-pole, low-pass Bessel filter of 5kHz. The data were analyzed 
using Clampfit 10.7 (Molecular Device Inc.), and Excel (Microsoft). Single-channel 
currents were determined using amplitude histograms by fitting the peaks to Gaussian 
functions. Dwell-time histograms fitted to an exponential distribution allowed us to 
determine the duration of short-lived blocks for DNA translocation. Molecular modeling 
and chemical structures were created using Maestro (version 2015-4, Schrödinge Suite). 
All graphical presentations were organized and cleaned up using Illustrator (Adobe). 
3.4 Results and Discussion 
 
We chose single-stranded 15-mer oligonucleotides consisting only of cytosine, 
annotated as 15C-ssDNA, as a proton-sensitive DNA strand to study the compacted DNA 
structure. To emphasize the unique characteristic of 15C-ssDNA to adopt compacted 
structures, control experiments were performed on an 18-bases ssDNA sequence 
(containing all four nucleotides: A, T, C, G). Previous studies have shown that C-rich 
ssDNA has the ability to form i-motif structures under slightly acidic environments (below 
the transitional pH 6.15), and sustain in linear form under neutral or basic environments 
(pH higher than 6.15).199-202 Thus, the cytosine-only sequence chosen for the current study 
makes this DNA molecule highly improbable to form stem-loop intramolecular base 
pairings (i.e. compacted structures) at pH ≥ 6.15. Moreover, a previous study showed that 
using solid-state nanopore, the probability of DNA knots observed in long DNA molecules 




of DNA knots formation in this study. All experiments herein were conducted with 15C-
ssDNA, under constant electrophoretic forces at 100, 120, or 140mV, and symmetrical salt 
concentration of either 1M NaCl or 1M KCl in both cis and trans chambers. Buffers with 
various pH levels at 5.0, 7.2, and 10 were used in the experiments in order to investigate 
the effect and compaction potential of monovalent cations on both folded and unfolded 
single-stranded DNA. All events are characterized by their current blockage amplitude 
(%Ib/Io, where Ib and Io are current amplitudes of the blocked and the empty pore), 
translocation time through the nanopore (𝑡𝑏), and frequency (𝑓). All buffers are prepared 
with 10mM Tris and 1mM EDTA and, hereafter, all buffers are named according to the 
type of cation present (either K+ or Na+) and pH level of the buffer. For example, Na5.0 
indicates 15C-ssDNA sample in 1M NaCl at pH 5.0. Current – voltage (I-V) curves of all 






Figure 7. IV curves of the experimental conditions, containing 1M of either KCl or NaCl, 




3.4.1 Effect of monovalent cations on the folded, i-motif DNA structure. To 
analyze the nanopore ionic current signal for the fully-folded i-motif structure, we first 
examined the translocation properties of 15C-ssDNA at pH 5.0 in both K5.0 and Na5.0 
buffers. At pH 5.0, when the 15C-ssDNA was added to the cis chamber, and 
electrophoretically driven through the 𝛼-hemolysin NP at 100, 120, and 140mV, long-lived 
partial current blockage events were observed in both K5.0 and Na5.0 samples (Figure 8), 
indicating the presence of i-motif inside the nanopore. Capture and analysis of the fully 
folded i-motif structure in K+ environment has been investigated using α-hemolysin 
nanopore before.54 Under slightly acidic conditions, the cytosine-rich DNA sequence 
becomes hemi-protonated, allowing for the formation of the i-motif structure (Figure 8A). 
This i-motif structure is approximately 2.0 x 2.0nm in diameter, 54 thus smaller than the cis 
entrance to the mushroom-head shape nanocavity, but larger than the constriction and β-
barrel of the nanopore. Thus, the folded structure of i-motif can enter the channel and reside 
in the nanocavity. Then the folded i-motif structure can either exit back to the cis opening 
or translocate through the nanopore to the trans side after unfolding in the nanocavity. The 
process can last up to several seconds or minutes, causing event blockades with different 
durations and amplitudes, as shown in Figure 8B (K5.0 and Na5.0), with no real statistical 
difference between dwell times of i-motif structure in K+ and Na+ environments at pH 5.0. 
Our data herein are fully consistent with previous studies, which demonstrated that half-
life, 𝑡𝑓1/2, of the i-motif structure at pH 5.0 can vastly vary from seconds to minutes.204-205 
In these studies, 𝑡𝑓1/2, of a i-motif structure represents the amount of time it takes for half 





Figure 8. Formation of i-motif at pH 5.0. (A) Under slightly acidic conditions, the cytosine-
rich DNA sequence is hemi-protonated, and can adopt an i-motif structure. (B) reflects the 
residence of i-motif structure inside the NP for both samples, containing either 1M KCl 
and 1M NaCl, at pH 5.0. The residence of i-motif structure inside the nanocavity causes 
current blockages that can last up to several seconds or minutes, with %I/Io ~ 50-60%. No 
event with %I/Io < 30% was observed in both samples (K5.0 and Na5.0). (C) Circular 
dichroism measurement confirmed the existence of i-motif at pH 5.0 in both K5.0 and 
Na5.0 samples, which show a typical positive peak at 285nm and a negative peak at 265nm. 
Other samples at higher pH do not exhibit the i-motif characteristic peaks. Overall, the 
main differences in CD spectrum are between samples with a different pH, but not between 
those containing different types of cations (K+ versus Na+) . Samples were labelled per the 
type of cation in the buffer (either K+ or Na+), followed by the solution pH value (i.e, Na5.0 




Circular dichroism (CD) spectroscopy analysis in our laboratories confirmed that 
the DNA molecules K+ and Na+ buffer solutions reveal a typical i-motif conformation only 
at low pH of 5.0 (Na5.0 and K5.0 samples), but a random coil at neutral and high pH 
(Na7.2, K7.2, Na10 and K10 samples). Specifically, the CD spectrum of both Na5.0 and 
K5.0 samples showed a strong positive peak near 285nm, a negative peak near 262nm, and 
a cross over at 275nm, indicating the definite presence of i-motif structure in the 
solutions.206 In contrast, at pH 7.2 and 10.0, all of the samples (Na7.2, Na10, K7.2, and 
K10) exhibited a dramatic decrease in the CD signal and completely lost the characteristic 




a higher pH, thus confirming that differences in CD spectra are due to differences in pH, 
and not due to usage of different cations (K+ versus Na+) in samples.  The results obtained 
from the event data traces of K5.0 and Na5.0 (Figure 8B) and CD spectrum indicate that 
under slightly acid conditions (pH 5.0), there is an absence of compacted DNA structure 
going through the α-HL NP. The binding (or lack thereof) of monovalent cations to ssDNA 
does not induce DNA compaction at pH level of 5.0. Thus, it is hypothesized that the C+-
C base pairing has a significantly higher affinity and can last much longer than cation-DNA 
binding. Currently, it is unclear whether or not the binding of monovalent cations can slow 
down the translocation speed of a fully-folded i-motif structure through the nanopore.  
3.4.2 DNA compaction induced by 𝐊+and 𝐍𝐚+ monovalent cations. In order to 
investigate the effect of monovalent cations on ssDNA compaction, single-channel 
nanopore analysis of the fully unfolded, linear 15C-ssDNA was conducted at pH 7.2 and 
10 (Figure 9 and Figure 10). In an earlier single-channel study of C-rich DNA 
translocation, it was shown that as the pH level was raised to above 6.15, most i-motif 
structures unfolded into linear DNA, resulting in mostly short-lived blockage events.54. 
Indeed, we observe a similar characteristic trend of unfolded, single-stranded DNA 
translocation (%Ib/Io ≥ 80%) in all samples at both pH 7.2 and 10. However, in contrast to 
the previous finding with specific sequencing of i-motif, our experimental data with 
cytosine only sequencing DNA oligos exhibited two types of blockages: Type 1 is the 
translocation events of linear ssDNA (%Ib/Io ≥ 80%), and Type 2 events are caused by the 
encounter of DNA compacted structures with the cis opening of the nanopore (%Ib/Io ~ 
30%), as shown in Figure 9A-B and Figure 10A–B. A transmembrane voltage (+100mV) 






Figure 9. DNA translocation through nanopore at pH 7.2.  Data traces of (A) K7.2 and (B) 
Na7.2 were collected at 120mV applied current. Both samples exhibit two main types of 
events: Type 1 are translocation events of DNA (%I/Io > 70%), and Type 2 are DNA 
compacting events (%I/Io < 70%), caused by the encounter of DNA compacted structure 
with the NP. (C) Correlation between amplitudes of current blockages and their dwell time 
K7.2 (blue) and Na7.2 (red). All DNA compacting events have very short dwell times, 
whereas deeper-current blockages can last several seconds in both type of cations (K+ and 
Na+). The number of events observed in Na7.2 is slightly higher than in K7.2. Similar 
results were obtained through the events frequency analysis for both (D) DNA compacting 












Figure 10. DNA translocation through nanopore at pH 10.  Data traces of (A) K10 and (B) 
Na10 were collected at 120mV applied current. Both samples exhibit two main types of 
events: Type 1 are the translocation events of DNA (%I/Io > 80%), and Type 2 are DNA 
compacting events (%I/Io < 30%). (C) Correlation between amplitudes of current 
blockages and their dwell time K10 (blue) and Na10 (red). All Type 2 events exhibite short 
dwell times, whereas deeper-current blockages can last several seconds. Similar results 
were obtained through the events frequency analysis for both (D) DNA compacting events 




Hereafter, Type 2 events are also referred to as “DNA compacting events.” All 
samples were captured at a sampling rate of 50 μs, and at any given voltage (100, 120, or 
140mV), Type 2 events exhibit a significantly shorter dwell time (tb
c  ~ 100us) and smaller 
current-blockage amplitudes than Type 1 events, forming two distinct clusters of event on 
the amplitudes-dwell time scatterplots (Figure 9C and Figure 10C). Interestingly, as the 
voltage ramped from 100 to 140 mV, a decrease in %Ib/Io is observed for Type 1 events 
(Figure 9F and Figure 10F). For the control experiment, Type 1 events show a significant 
increase in event occurrence, while Type 2 events cannot be observed (Figure 11 and 
Figure 12). This result indicates that the control sample (18-bases ssDNA) cannot adopt 
the compacted structure. Events with %I/Io ~ 50% are suspected to be the stem-loop 





Figure 11. Negative control experiment at pH 7.2. (A) Event data traces of Control K7.2, 
Control Na7.2, K7.2, and Na7.2. The control sample is an 18 bases ssDNA containing all 
four nucleotide base types (A, T, C, G). The absence of shallow blockage event (%I/Io < 
30) indicates the control sample’s inability to form compacted structures. (B) Scatter plot 
represents the correlation between event blockage amplitude and dwell time of the Ctrl-
K7.2 and Ctrl-Na7.2. The two event clusters indicate the presence of hairpin structure 
(%I/Io ~ 50%) and the translocation of a linear ssDNA (%I/I ~ 90%). All events were 







Figure 12. Negative control experiment at pH 10. (A) Event data traces of Control-K10, 
Control-Na10, K10, and Na10. The control sample is an 18 bases ssDNA containing all 
four nucleotide base types (A, T, C, G). The absence of shallow blockage event (%I/Io < 
30) indicates the control sample’s inability to form compacted structures. (B) Scatter plot 
represents the correlation between event blockage amplitude and dwell time of the Ctrl-
K10 and Ctrl-Na10. The two event clusters indicate the presence of hairpin structure (%I/Io 
~ 50%) and the translocation of a linear ssDNA (%I/I ~ 90%). All events were collected at 









3.4.3 Comparing between translocation and DNA compacting events. We 
hypothesize that Type 2 events are produced by secondary structures, with dimensions 
larger than 2.6nm (cis opening of the nanopore), and are the result of the DNA compaction 
induced by monocations (K+ and Na+). Under electrophoretic force, these compacted DNA 
structures are drawn toward the cis opening of the pore, but cannot translocate through due 
to their large size, thus quickly bounce away. This process results in an abundant number 
of short-lived blockages, with (%Ib/Io ~ 30%), and 𝑡𝑏
𝑐 ~ 100𝜇s. At 120mV applied voltage, 
the ratios between the frequency of Type 1 events and Type 2 events are approximately 
1:36 (Na7.2), 1:29 (K7.2), 1:12 (Na10), and 1:14 (K10) (Tables 1 and 2). With increased 
application of applied voltages, frequencies of both Types 1 and 2 also significantly 
increased due to the high electrophoretic force. Most notably, as the voltage ramps from 
100mV to 140mV, frequencies of Type 1 and Type 2 events rise approximately 2-fold, and 
5- to 10-fold, respectively. Thus, single-channel analysis revealed that Type 2 events are 
far more plentiful than Type 1 events in all four samples (Na7.2, K7.2, Na10, and K10), 
implying that the abundancy of 15C-ssDNA was compacted by K+ or Na+ at pH 7.2 and 10 




Table 2  
15mer DNA event summary (pH 7.2) 





 Type 1 events Type 2 events 
 I/Io (%) ∆t (ms) 𝒇(s-1) I/Io (%) ∆t (ms) 𝒇(s-1) 
Na7.2 85.4 ± 1.2 0.42 ± 0.02  0.38 ± 0.03 25.8 ± 6.7 0.1 ± 0.01 13.9 ± 8.48 





15mer DNA event summary (pH 10) 
 




3.4.4 Comparing DNA potential of K+ and Na+. Single-channel recordings of 
the 15C-ssDNA reveal that, at both pH values of 7.2 and 10, most Type 1 events 
(translocation of linear ssDNA) cause a current blockage, %Ib/Io, of ~ 80-86%. At 120mV 
applied voltage, the ratios between Type 2 event frequencies, 𝑓𝑐(s-1), of Na7.2:K7.2 and 
Na10:K10 are 2.188:1 and 1.409:1, respectively (Table 2 and Table 3). Thus, the results 
indicate that between the two types of monovalent cations, Na+ has a higher compacting 
potential for ssDNA. 
Overall, the binding affinity and compacting potential of a monovalent cation to 
DNA strands are characterized by several factors, including but not limited to: (1) its 
hydrated radius, and (2) the chemical structure of the available nucleotides.180, 207 It has 
been shown that a smaller radius corresponds to stronger hydration, because the small size 
of the hydrated cation allows for effective interactions with DNA because of higher 
Coulomb electrostatic potential.180, 208 Subsequently, cations with a smaller hydrated radius 
can bind to DNA stronger than those with a larger hydrated radius.180 In contrast, as a result 
of partial dehydration of monocation in the compact state, higher binding affinity of cations 
correlates to lower DNA compacting potential.180 Thus K+ has higher binding affinity, but 
lower DNA compacting potential than Na+.180  
 Type 1 events Type 2 events 
 I/Io (%) ∆t (ms) 𝒇(s-1) I/Io (%) ∆t (ms) 𝒇(s-1) 
Na10 81.8 ± 0.6 0.55 ± 0.09  0.29 ± 0.01 24.7 ± 5.8 0.09 ± 0.01 3.4 ± 0.65 




Moreover, previous studies have pointed out that due to the differences in their 
molecular structures, the affinity for cations of the five nucleobases (guanine, adenine, 
cytosine, thymine, and uracil) are also varied.209-212 Specifically, it was determined that the  
affinity Na+ has for nucleobases, measured in kcal.mol-1, is 42.1 for guanine, 40.9 
for cytosine, 31.3 for adenine, 33.0 for thymine, and 32.3 for uracil.210-211 With the aid of 
exocyclic amino groups, guanine and cytosine can be involved in cation binding through 
resonance effects; hence, have a much stronger cation binding than other nucleobases.211 
In our present work, the chosen ssDNA sequence contains only cytosine, which is one of 
the two nucleobases with the strongest binding affinity to Na+; thus, the effect of Na+ on 
inducing DNA compaction is significantly enhanced. Thus, the difference in our results in 
comparison to those of the previous group54 mainly arises from the characteristic affinity 
of cations for nucleobases. The differences in event data traces caused by compacted and 
non-compacted DNA can be seen in Figure 11 and Figure 12. 
In the previous study, because the sample DNA strand also contained adenine and 
thymine nucleotides,54 the effect of cation binding and thus, induced DNA compaction, 
became much weaker and could not be observed with 𝛼-hemolysin nanopore (no Type 2 
events). Thus, our findings in the current study fully agree with those from other 
laboratories,180, 207 proving that Na+ monovalent cations have a greater compacting 
potential on the 15C-ssDNA than K+ cation does. 
3.5 Conclusions 
In this chapter we have investigated the interaction of monovalent cations (K+ and 
Na+) with ssDNA using an 𝛼-hemolysin biological nanopore platform. Although many 




rich sequences, the focus of those studies was usually using nanopore technology to capture 
the folding and unfolding of G-quadruplexes or i-motif structures. Thus, current-blockages 
caused by compacted DNA structures in a solution can be easily overlooked or neglected. 
Here, we presented our findings on the compacted structure of ssDNA induced by 
monovalent cations using biological nanopore. The study herein lay the groundwork for 
understanding and predicting the compacting process of ssDNA induced by monovalent 
cations (K+ and Na+) in nanopore-based studies. Moreover, in the recent years, many 
studies have been conducted to develop a nanocarrier for antisense oligonucleotides and 
single-stranded siRNAs in drug delivery, as well as in cancer gene therapy.213-216 We 
believe that the ability of monovalent cations to compact a short oligonucleotide, as 
discussed in this current study, has a promising potential in the development of drug 







Investigation of Ckit1 G-Quadruplex Stability 
 
4.1 Abstract 
In this chapter, we investigated the formation of G-quadruplex on Ckit1 promoter 
sequence, which plays an important role in several human malignancies. Ckit1 is a guanine-
rich sequence that can form stable G-quadruplex structures in the presence of cations, 
causing gene downregulation and leading to suppression of cancer cell proliferation. Our 
study evaluated Ckit1 G-quadruplex structural stability dependence on cations and CX-
5461. Conventional methods often utilize fluorescence spectroscopy and circular 
dichroism to study CX-5461 efficiency on stabilizing G-quadruplex. However, these 
methods cannot provide real-time molecular dynamic sensing of a structure’s 
folding/unfolding behavior. This study utilized the nanocavity of a biological nanopore as 
the main tool for single-molecule analysis of Ckit1 G-quadruplex. Specifically, Ckit1 G-
quadruplex formation and stability with and without CX-5461 presence was analyzed using 
α-hemolysin nanopore, circular dichroism and thermal denaturation. Our results showed 
that Ckit1 G-quadruplex stability is cation-dependent (K+>Na+), resulting in longer 
current-blockage events and significantly decreased event capture rate with K+. Addition 
of CX-5461 drug enhanced Ckit1 G-quadruplex stability resulting in extended current-
blockage events (seconds- to minutes-long) in nanopore study and a significantly increased 
melting temperature. Using machine learning models, we were able to predict the binding 
state of CX-5461 to Ckit1 G-quadruplex in an Na+ environment, with a 92.4% sensitivity, 





G-quadruplexes are nucleic acid higher-order structures, made of one, two or four 
guanine-rich DNA or RNA strands. G-quadruplex consists of stacked G-quartets, which 
are cyclic arrangements of four guanines held together through Hoogsteen hydrogen bonds 
and stabilized by a central cation (e.g. K+). G-quadruplex structures are frequently found in 
the telomeres and gene promoter regions. To date, over 300,000 putative G-quadruplex-
forming sequences have been found in the human genome.217 These structures play a 
functional role in regulating gene expression, controlling chromatin structure, and 
destructing chromosomal stability.218-221 With more than 40% of human protein encoding 
genes containing one or more putative G-quadruplex forming motifs in the promoter 
regions, stabilizing G-quadruplex structures is a promising strategy to control gene 
expression at transcriptional and translational levels.222 
CKIT is a proto-oncogene encoding the Ckit transmembrane tyrosine kinase 
receptor, which participates in the expression of genes, regulates cell differentiation, 
proliferation, migration, and resists cell apoptosis.223-225 Overexpression and mutations of 
the Ckit gene have been found in a number of cancers, including pancreatic, leukemia and 
melanoma.226-228 Promoter region of the Ckit gene contains three guanine-rich regions that 
can fold into stable G-quadruplex structures, known as Ckit1, Ckit2, and kit*. 
For the Ckit proto-oncogene specifically, the presence of G-quadruplex structures 
can prevent cancer cells from replicating. Stabilization of Ckit gene G-quadruplex has been 
linked with inhibition Ckit tyrosine kinase receptor transcription and expression. This leads 
to  cell proliferation and cause DNA damage that would kill cells without nucleic acid 




of Ckit expression through stabilizing kit1 G-quadruplex is an attractive strategy for cancer 
therapy.230-232 Certain molecules, such as CX-5461 (Figure 13), can bind and stabilize 
Ckit1 G-quadruplex structures; thus, effectively blocking the replication of cancerous 
cells.233 Upon binding to Ckit1 G-quadruplexes, CX-5461 reduces the binding affinity of 
SL1 pre-initiation complex and RNA Pol I complex to rDNA promoters, leading to 
apoptosis.234 This molecule was proven to be most efficient in tumorous cells that lack 
DNA repair mechanisms such as the BRCA1 and BRCA2 tumor suppressor genes.235 
In this study, we report the changes in formability and stability of Ckit1 G-
quadruplex in the presence of K+ and Na+ cation. Through electrical current signatures, we 
showed that binding of the CX-5461 molecule has a stronger stabilizing efficiency and 
further alters the volume of Ckit1 G-quadruplex in an Na+ environment as compared to a 
K+ environment. Ultimately, we employed a simple machine learning algorithm to predict 
the CX-5461 bound/unbound G-quadruplex. 
4.3 Methods 
4.3.1 Chemicals and reagents. Chemicals and reagents used in the experiments 
were purchased from the following vendors: 1,2-diphytanoyl-sn-glycero-3-
phosphocholine (Avanti Polar Lipids); pentane (Sigma-Aldrich); potassium chloride 
(Sigma-Aldrich); sodium chloride (Sigma – Aldrich); Tris base (Promega); 
Ethylenediamine Tetraacetic acid (EDTA); pentane (Fischer Chemical); and hexadecane 
CH3(Ch2)14CH3 (Avantor). CX-5461 (Sigma Aldrich) was purchased in powder form, 





4.3.2 DNA samples. Synthetic single-stranded DNA oligos were designed and 
purchased from Integrated DNA Technology (IDT – Coralville, IA). DNA oligos utilized 
in this study had the following sequences: 
Control (linear): 5’ – AGG GAT TTC GCT TTT AGG AGG G-3’ 
Ckit1: 5’ – AGG GAG GGC GCT GGG AGG AGG G-3’ 
Ckit1 2 tails: 5’– dT10 - AGG GAG GGC GCT GGG AGG AGG G - dT10 – 3’ 
Upon delivery, all DNAs were suspended in a standard DNA storage buffer 
containing 10mM Tris, 1mM EDTA and titrated to 8.0pH. All samples were aliquoted into 
small volumes and stored at -80˚C until usage, in order to prevent multiple thaw-freeze 
cycles that can degrade and affect DNA quality. For both nanopore and CD experiments, 
DNA final concentration of 1µM was used. 
4.3.3 Experimental setup. We employed an electrophysiology setup and followed 
a protocol described in previous studies.53, 236 Each experimental chamber was filled with 
electrolyte solutions containing 1M KCl or 1M NaCl,  buffered with 10mM Tris and 1mM 
EDTA titrated to 7.2pH. α-hemolysin protein was inserted into the bilayer from cis side 
forming a single-channel penetrated across the lipid bilayer. DNAs were inserted to the cis 
side. For experiments with CX-5461, electrolyte solutions were titrated to 8.3pH, in order 
to compensate for the acidity of CX-5461 solution. 
4.3.4 Single channel recording. Single-channel recordings were performed using 
Axopatch 200B (Molecular Device Inc.), filtered with a built-in 4-pole low-pass Bessel 
Filter at 5kHz. Data were acquired with Clampex 10.7 (Molecular Device Inc.) and Axon 




data were analyzed using Clampfit 10.7 (Molecular Device Inc.), Excel (Microsoft) and R 
software. 
4.3.5 Data analysis and visualization. Events with %I/Io < 50% were considered 
as brief interaction of DNA and the pore entrance, rather than DNA translocation; thus, 
disregarded from data analysis.237 For every experimental condition, approximately 2000 
DNA translocation events were included for the analysis. Event blockage amplitudes were 
determined from amplitude histograms by fitting the peaks to Gaussian function. The 
duration and occurrence of current-blockage event for DNA translocation were obtained 
by fitting the dwell-time histogram to an exponential distribution. Data were given as the 
mean ± SD, based on at least three separate pores. Plots were  generate using Excel 
(Microsoft) and ggplot2 package (R).  
4.3.6 Circular dichroism and thermal denaturation. Jasco CD 
spectropolarimeter, model J-810, were utilized for both normal absorbance and thermal 
denaturation studies. For all CD measurements, 1µM DNA concentration, CX-5461: DNA 
ratio of 5:1 (when applicable) were used, in consistency with nanopore studies. Spectra 
were capture in the 220-300 nm wavelength, 1.0 nm bandwidth, 50nm/min scanning speed, 
and a standard sensitivity. All experimental solutions contained 1M KCl or NaCl (for 
normal CD) and 0.1M KCl or NaCl (for thermal denaturation studies). The thermal 
denaturation was performed utilizing the same J-810 that was used for the CD portion of 
this study.  In addition, a Jasco PTC-423S temperature attachment was used to increase the 
temperature from 20C to 95C at a rate of 1C/min.  CD was recorded at temperatures below 
100C to prevent the sample from boiling over and affecting the data. All CV results were 




4.4 Results and Discussion 
4.4.1 Formation of Ckit1 G-quadruplex in K+ and Na+. In our experiment, we 
first employed circular dichroism (CD) to confirm the ability of Ckit1 single-stranded DNA 
(ssDNA) to adopt G-quadruplex structure. In CD, as circularly polarized light pass by, 
optically active chiral molecules (e.g. DNA and protein structures) will absorb the light 
differently, allowing them to be measured and quantified. In our study, CD spectra of Ckit1 
DNA in Na+ or K+ solutions both exhibited strong negative and positive peaks at 237 and 
263 nm, respectively (Figure 13D), confirming the formation of G-quadruplexes with 
parallel topology. Unlike telomeric sequence, whose G-quadruplex folding topologies 
depend on different cations,105 the folding topology of Ckit1 G-quadruplex does not depend 





Figure 13. (A) Schematic cross-sectional structures and dimensions of an α-hemolysin 
nanopore embedded in lipid bilayers. (B) Spontaneous folding of a linear single-stranded 
Ckit1 DNA into G-quadruplex structure in the presence of K+. The Ckit1 G-quadruplex 
composes of three G-quartets (each yellow layer) stacking on top of each other, and 
stabilized by K+ cations. (C) Chemical structure of CX-5461 cancer drug, which has been 
shown to promote the formation and stabilize Ckit1 G-quadruplex structure. (D) CD 
spectra of Ckit1 DNA in the presence of K+ or Na+ consisted a positive peak at 263nm and 
a negative peak at 235nm. This result confirmed the presence a G-quarduplex structure 




The transports events of Ctrl ssDNA and Ckit1 ssDNA through nanopores were recorded 
in 1M KCl and 1M NaCl, with and without the presence of CX-5641 molecules (Figure 
14). Ctrl DNA has the same length with Ckit1 DNA with substitution of two opposite 
guanines of every G-tetrad with thymine (Figure 15). This substitution disrupts the 
formation of G-quartet, preventing the Ctrl sequence from folding into the G-quadruplex. 
Instead, Ctrl simply translocates through the α-hemolysin nanopore with a translocation 
time (∆t) of 2.68 ± 0.14 ms and capture rate (𝑓) of 12.24 ± 0.13 s-1. These values are in a 
similar range with those previously reported for linear, single-stranded DNA translocation 
through the nanopore.238 
Compared to Ctrl, Ckit1 DNA yielded current blockage events with significantly 
longer ∆t and reduced 𝑓 (Table 1). Specifically, experiments on Ckit1 DNA yielded two 
major event types, named Type 1 and Type 2. Type 1 consists of independent short-lived 
blocks, whose open pore current blockage (%I/Io) was approximately 69.66 ± 1.81%. 
These spike-like events had similar amplitude and durations with those resulted by the 
linear single-stranded Ctrl DNA translocation through the nanopore. Whereas Type 2 
events featured a deep current-blockage lasting milliseconds before returning to open-
channel current level. The absence of Type 2 events in experiments with Ctrl DNA 
confirmed that these long-lasting events result from the translocation of Ckit1 G-
quadruplex. Strong DNA secondary structure, such as G-quadruplex, require high energy 
to break up the stacked G-quadruplex structure, before it can enter the nanopore 







Figure 14. Data traces from a single α-hemolysin nanopore showing current-blockage 
events of: (A) Control DNA (Ctrl) in Na+, and Ckit1 DNA in (B) K+, (C) K+/ CX-5461, 
(D) Na+ and (E) Na+/CX-5461. The control DNA is incapable of folding into secondary 
structure, causing spike-like events (top panel); whereas Ckit1 DNA spontaneously adopt 
the G-quadruplex structure in the presence of K+ or Na+, leading to long lasting current 
blockages. In all experiments, the concentration of both DNAs was 1 µM. All traces were 
recorded at +160mV in a 1M salt solution buffered with 10mM Tris, 1mM EDTA and 









Figure 15. Stability of G-quadruplexes as determined by thermal denaturation analysis in 
(A) 0.1M KCl and (B) 0.1M NaCl with and without the presence of CX-5461 molecules. 
The secondary structure melting temperature, Tm, is a temperature, where 50% of the DNA 
are folded. (C) Violin plots represent the distribution of current-blockage event dwell time, 
∆t. Plots were arranged in the order of increasing mean ∆t ( Na+ < K+ < Na+ with CX-5461 




As Ckit1 DNA was instantaneously folded into G-quadruplex structure in  the 
presence of monovalent cations (Na+/ K+), the remaining unfolded Ckit1 linear structure 
(Type 1 event) was significantly less than that of Ctrl DNA. Specifically, the occurrence 
rate, 𝑓, of Ckit1 Type 1 in K+ was approximately 5.5 s-1, almost 2.25 times lower than the 
12.24 s-1 for the Ctrl Type 1 event in the same solution. In order to determine the cation 
and stabilizing molecule dependency, we calculated the equilibrium formation constant for 
G-quadruplex in all experimental conditions. As shown in previous studies, equilibrium 
formation constant for G-quadruplex, 𝐾𝑓, is the concentration ratio between folded DNA 




From the correlation between DNA concentration and event capture rate, 𝐾𝑓 can 
also be calculated using the equation: 𝐾𝑓 =
𝑓𝑐𝑡𝑟𝑙
𝑓𝑐𝑘𝑖𝑡1,𝐿 − 1 
.53 In which, 𝑓𝑐𝑡𝑟𝑙 is the capture rate 
of the linear, single-stranded Ctrl DNA and 𝑓𝑐𝑘𝑖𝑡1,𝐿 is the capture rate of linear Ckit1 DNA. 
The calculated 𝐾𝑓 for Ckit1 G-quadruplex was 3.83  in K+, 1.84 in Na+, 4.65 in K+/CX-
5461, and 4.23 in Na+/CX-5461.The equilibrium formation constants suggest the sequence 
of most favored experimental conditions for Ckit1 G-quadruplex formation is: K+/CX-











4.4.2 Stability of Ckit1 G-quadruplex. A thermal denaturation experiment was 
performed to determine the stability of the G-quadruplex structures by comparing its 
melting temperature in Na+ and K+ solutions, as well as investigating stabilization effect of 




must be halted under 100˚C, in order to prevent evaporation of sample. As Tm of Ckit1 G-
quadruplex is approximately 88˚C in 1M NaCl, we decreased the solution ionic strength 
(while keeping DNA concentration at 1µM), which allowed us to record the melting 
temperature of the structures at a range sufficiently far away from the evaporation point as 
to not affect the data (Figure 16).  We decided that 0.1M would be the ideal concentration 
for further testing. The final thermal denaturation study was performed in 10mM Tris-HCl 
buffer (pH 7.2) containing 100mM cation (Na+ or K+). When applicable, CX-5461 
concentration was 5 µM, which corresponds to a 5:1 ratio of ligand to DNA. Reduction of 
ionic strength  resulted in a lowering of Tm of unbound Ckit1 G-quadruplex to 70˚C and 
49˚C in 0.1M KCl and 0.1M NaCl solutions, respectively (Figure 15A – B). Addition of 
CX-5461 increases Tm of Ckit1 G-quadruplex structure, resulting in a ∆Tm of 13˚C and 
11˚C in K+ and Na+ (Figure 15A – B). Higher melting temperature in K+ than in Na+ proves 
that the structure is more stable in K+.  
In order to visualize the distribution of G-quadruplex translocation time through the 
pore, we constructed a violin plot for dwell time of events in each condition (Figure 15C). 
It is important to note that only events lasting longer than 1ms were included in the violin 
plots, as those with shorter dwell time were considered as translocation of unfolded linear 
ssDNA (Type 1 events).  The constructed violin plots for the dwell time, ∆t, of Ckit1 type 
2 events exhibited a bimodal distribution with two populations of events lasting from 
milliseconds to several seconds (Figure 14C). Using paired-wise testing, we found a 
statistically significant difference (95% confidence interval) in dwell time when Type 2 




dwell time in the presence of CX-5461, there was no statistical difference between event 
dwell time in K+ and K+/CX-5461.  
Previous studies showed that the unfolding rate constant (ku) of G-quadruplex is 




.53 Moreover, the kinetic folding rate constant, 𝑘𝑓, is the product of the equilibrium 
formation constant and unfolding rate constant, or: 𝑘𝑓 = 𝐾𝑓𝑘𝑢.53 Using these equations, 
we calculated the folding and unfolding rates for Ckit1 G-quadruplex, as shown in Table 
4. In the absence of CX-5461, Ckit1 G-quadruplex folded much more rapidly in a K+ 
environment than in an Na+ environment (with a 𝑘𝑓 of 1.13 and 0.59, respectively), while 
unfolding more slowly. On the other hand, in the presence of CX-5461,  ku and kf of Ckit1 
G-quadruplex were similar between Na+ and K+ environments. (see Table 4).  
There are multiple factors that contribute to the stabilization of G-quadruplexes and 
their topology, including stacking interactions, hydrogen bonding, solvation, and cation 
bonding.240-241 To stabilize the G-tetrad stacks, the binding cation needs a sufficient ionic 
strength, in order to compensate electrostatic repulsion between the phosphate oxygens of 
four Guanines, instead of two in regular DNA duplexes.241 In general, K+ induced G-
quadruplex is much more stable and has longer lifetime than Na+ induced G-quadruplex, 
owing to the higher ionic strength and lower hydration energy of K+ ions.241-244 
Furthermore, the smaller Na+ cations can be coordinated within the plane of tetrads, 
and occupy a range of positions with lower steric constraints; thus, reducing the 
electrostatic repulsions.241 While Na+ can alternatively occupy coordination sites and 
become closer to the core of the tetrads, Na+ G-quadruplex confers a higher plasticity that 




cavity between two G-tetrads and bridges together eight  Guanines O6 atoms, thereby  
becoming more stable and rigid.241 
Previous studies involving thrombin binding aptamer (TBA) found that ∆Tm 
between K+ and Na+ coordinating TBA decreases from 29˚C (free) to 12˚C (bound).241 This 
can partially explain what we observed in our study: compared to Na+, K+ cation creates a 
much more stable G-quadruplex structure. Presence of CX-5461 in K+ solution produced 
extremely stable structures that could not be included in data analysis, as the event lasted 
several hundred seconds to minutes. Therefore, the enhanced stability induced by CX-5461 
was better observed in Na+ experimental buffers. This was reflected by significant increase 





Figure 16. Thermal denaturation of Ckit G-quadruplex in buffers containing: 1M, 0.2M or 
0.1M NaCl. Melting temperature, ∆Tm, is determined when there are 50% structure 
unfolded. ∆Tm of Ckit1 G-quadruplex reduces approximately 30˚C as salt concentration 







4.4.3 Changes in volume of Ckit1 G-quadruplex. As single-channel data traces 
of Type 2 (i.e. G-quadruplex translocation) exhibited multiple events with well-defined 
step-wise structure that varied in length (Figure 17A–D), we decided to examine  the 
hidden subgroups in Type 2 events of Ckit1 DNA. For this, we utilized an unsupervised 
machine learning technique, which can identify similarities and patterns in datasets, to 
cluster Type 2 events using their amplitude (%I/Io) and dwell time (∆t). Clustering is one 
of the most common data analysis techniques used to explore the structure of the data. 
Specifically, we used the kmeans function in R to classify the Type 2 translocation events 
in each experimental condition. K-means is a randomly-initialized iterative clustering 
method that partitions the dataset into k predefined distinct subgroups and the positions of 
each group’s centroid.  
Traditionally, dwell time is typically used as the main indicator to classify distinct 
translocation events. However, the amplitude of current-blockage events is known to 
reflect the size and interaction of the targeted molecule with the nanopore. Thus, we 
selected both %I/Io and ∆t as features for unsupervised machine learning. The two selected 
features (%I/Io and ∆t) have greatly different measurement scales of 0 – 100% and 1 – 
1000s ms, respectively. To avoid bias introduced by one group being dominant in size, we 
first converted each feature to a 0 to 1 scale. After clustering and calculation of centroids, 
data were converted back to their original values for better visualization and comparison 
between conditions. To determine the optimal parameter k for all data subset, we 
constructed an elbow plot, which suggested that the optimal number of clusters in nanopore 
Type 2 events was k = 2 (Figure 18). Figure 17E–H represents the scatter plots of the ionic 






Figure 17. Clustering analysis for all samples. Examples of Ckit1 G-quadruplex data traces 
in buffers containing: (A) 1M KCl, (B) 1M KCl with CX-5461, (C) 1M NaCl or (D) 1M 
NaCl with CX-5461. Current-blockage events exhibit step-wise changes in amplitude, 
representing different stages of G-quadruplex threading and translocating through the α-
hemolysin pore. (E-H) Clustering analysis of all current-blockage events in all 
experimental conditions using k-mean method. In each solution, there are two main clusters 
of events with shallow (red) or deep current blockage amplitudes (blue), reflecting the step-
wise current blockage amplitude changes. At least 1000 events were included in each 
scatterplot. Events with ∆t ≤ 1ms were excluded in this scatter plotting since those events 











In each plot, there are two event clusters (showed in red and blue), named Type 2a 
and 2b, respectively. Although the event translocation time is largely dispersed (as 
discussed previously), event amplitude seemed to be the main deciding factor in Type 2 
subgroups classification, as shown in Figure 17E–H. These level changes (Type 2a and 2b) 
reflected the two stages of G-quadruplex translocation through the nanopore, which were: 
(a) capturing and (b) unfolding of the DNA secondary structure (Figure 19B). The average 





Figure 19. Ckit1 G-quadruplexes volume. (A) Comparing changes in Ckit1 current-
blockage amplitudes of level 1 and 2 in buffer solutions contains K+ or Na+ (with and 
without CX-5461). The presence of CX-5461 exhibits minimal effect on Level 1 and level 
2 %I/Io in K+, but significantly increases %I/Io of both levels in Na+ solutions. (B) 
Schematic explaining different stages of Ckit1 G-quadruplex translocation through α-




Previous studies involving TBA G-quadruplex and beta-Cyclodextrin (𝛽-CD) 
showed that the amplitude of current-blockage events reflected the change in volume of 
the G-quadruplexes formed by different cations.53, 245 Thus, the current-blockage 
amplitude, %I/Io, of event Type 2a and 2b reflect an overall trend that volume of K+ G-
quadruplex is smaller than Na+ G-quadruplex (Figure 19A). This has been explained in 
previous studies on G-quadruplexes. Briefly, as the Na+ ion is smaller (d = 0.95 Å), it can 
fit in the plane of a quartet; while the larger K+ ion (1.33Å) is coordinated in the center of 
the cavity between two planes. Position of cations within the G-quadruplex, in turn, 
changes the cation-carbonyl distance (d), explaining the reason why volume of K+ G-
quadruplex is smaller than Na+ G-quadruplex, as observed in previous  studies and our 
results herein.53 Specifically, dK-O is shorter than dNa-O, giving rise to stronger attraction 
between cation and the carbonyl, and a more stable G-quadruplex in K+ presence. 
Interestingly, the binding of CX-5461 changed the volume of Ckit1 G-quadruplex 
differently. As shown in Figure 17E–H and Figure 19A, while the volume of K+ G-
quadruplex remains mostly unchanged, volume of Na+ G-quadruplex significantly 
increased when bound by CX-5461, reflecting through a 10 and 5 pA increase in the 
amplitude of event Type2a and 2b, respectively.  
4.4.4 Prediction of CX-5461 binding status. Having determined the changes in 
formability and stability of Ckit1 G-quadruplex in correlation with cations and stabilizing 
molecules, we sought to demonstrate the application of α-hemolysin nanopore as a 
molecular screener for G-quadruplexes. To do this, we used a supervised machine-learning 
to train classifiers for pattern recognition and discriminate Ckit1 G-quadruplex formed in 




we randomly selected 2000 current-blockage events, then divided the datasets into 80% 
and 20% for model training and validation, respectively. Two features, ∆t and average 
%I/Io, collected from the current blockages were used as inputs to a k-nearest neighbor 
(KNN) classifier. We first trained the model using all event captured by the nanopore. This 
first run yielded an average accuracy and sensitivity of 69.6 ± 2%  and 72.2 ± 5%, 
respectively. The model’s prediction ability was quite low, due to the fact that Ckit1 DNA 
could instantaneously fold and unfold into G-quadruplex structure. Thus, the events 
captured by nanopore comprised of both linear and folded DNA (Type 1 and 2 events), as 
previously discussed. Thus, we retrained the model using only events lasted longer than 
1ms, in order to exclude Type 1 events (linear DNA). With the filtered datasets, the model 
performance was enhanced significantly, yielding a new average accuracy and detection 
sensitivity of 81.3 ± 4 % and 92.4 ± 2 %. Table 5 shows the classification accuracy, 




















Condition 1 Condition 2 
K+ Na+ 93.55 77.78 85.66 
CX-5461/K+ KCl 89.66 58.33 73.99 
CX-5461/Na+ Na+ 95.45 70.00 82.73 
CX-5461/Na+ CX-5461/K+ 90.91 75.00 82.95 





Results showed that the model’s ability to distinguish one type of G-quadruplex 
from another is in the order of: (Na+/CX – Na+) > (K+ – Na+) > (Na+/CX – K+/CX > K+/CX 
– K+. As we discussed earlier, the most pronounced changes in the structure’s volume and 
stability occurred when CX-5461 binds to Na+ G-quadruplex; whereas no statistically 
significant changes were found in for Ckit1 G-quadruplex in K+ solution with and without 
CX-5461. Thus, the order of the model’s performance could be explained. A limitation in 
our prediction model comes from having nonhomogeneous control samples. When 
working with dynamic experimental conditions, such as those investigated here, the 
process of ssDNA folding/unfolding and of CX-5461 binding/unbinding to the G-
quadruplex structure constantly occurs. This lowers the model performance, as the training 
dataset are nonhomogeneous.  
4.5 Conclusions 
In summary, we have presented the ability of α-hemolysin nanopore as a real-time 
molecular dynamic sensing for Ckit1 G-quadruplex formation and stability in K+ and Na+ 
environments. While G-quadruplex structures can be extremely stable, their  topology and 
stability depend on many factors, including the length and sequence composition of the 
total G-quadruplex motif, the size of the loops between the guanines, strand stoichiometry 
and alignment, and the nature of the binding cations.240 Our study showed that Ckit1 G-
quadruplex has a parallel folding topology in both environments, with a more tightly 
packed structure in the presence of K+ cations. Binding of CX-5461 molecules significantly 
enhanced the stability and increased the volume of Ckit1 G-quadruplex in Na+, but not in 
K+. In the absence of CX-5461, Na+ G-quadruplex and K+ G-quadruplex featured greatly 




unfolds rapidly, compared to K+ G-quadruplex. On the other hand, presence of CX-5461 
significantly enhanced the folding rate of linear Ckit1 DNA and slows down the unfolding 
rate of G-quadruplex, leading to a similar equilibrium folding kinetic constant in both K+ 
and Na+.  
Apart from determining the structural formation and stability, we further employed 
clustering analysis to determine the hidden pattern of the nanopore current blockage 
amplitudes, which have distinct levels reflecting the two stages of (i) capturing and (ii) G-
quadruplex translocation through the pore. The volume of G-quadruplex is correlated with 
the cation species and presence of CX-5461. These changes in the structure volume and 
stability made it feasible to employ machine learning algorithms to classify G-
quadruplexes formed in different experimental conditions. With the ability to 
computationally predict the binding stage of cation and CX-5641 molecule to G-
quadruplex, we believe α-hemolysin nanopore could be an interesting tool for real-time 








Mutations on Ckit1 G-Quadruplex Reduce CX-5461 Efficacy 
 
5.1 Abstract 
In this article, we employed α-hemolysin biological nanopore to the effect of point 
mutation on Ckit1 G-quadruplex stability and drug efficacy.  Our study employed six DNA 
samples including Ckit1 and its mutated sequences (containing 1-6 mutations). The 
signature blocks in the nanopore revealed that number and position of mutation have an 
impact causing destabilization of the G-quadruplex structure. Specifically, sequences with 
the same number of mutations on the same G-quartet layer exhibited similar stability. 
Furthermore, CX-5461 significantly increases G-quadruplex structural stability only in 
sequences with no mutation on the top G-quartet. Moreover, using a random forest 
classifier on nanopore data, we were able to distinguish mutated from unmutated Ckit1 
sequences with an overall sensitivity and specificity of 81.9% and 83.4%, respectively. 
Understanding the effects of mutation on G-quadruplex stability is beneficial for 
constructing methods to predict treatment response in personalized medicine approaches.  
5.2 Introduction 
In this study, we investigated the efficacy of CX-5461 on mutated C-kit1 promoter 
sequences to elucidate the importance of each component G-tetrad in the overall stability 
of the G-quadruplex structure. Activating mutations on C-kit1 have been observed in 
several types of malignancies, notably leukemia, melanoma, and gastrointestinal 
tumors.246-248 Our study employed a biological nanopore sensor and circular dichroism 
spectroscopy to compare the stability of Ckit1 G-quadruplex and its mutated sequences in 




structural stability is lower in Na+ than K+ environment, the effect of CX-5461 on 
stabilizing the Ckit1 G-quadruplex was more pronounced in Na+ (see Chapter 4). We found 
that CX-5461 affects the stability of the mutated Ckit1 G-quadruplex to varying degrees, 
depending on the mutation position and number. Having more than one mutation on the 
top G-quartet might inhibit binding of CX-5461 to the structure, leading to no significant 
change in G-quadruplex stability. In addition, using nanopore data and machine learning 
algorithms, we were able to distinguish mutated sequences from unmutated Ckit1 with 
81.9% sensitivity and 83.4% specificity.  
5.3 Methods 
5.3.1 Chemicals and reagents. The chemicals and reagents used in this study along 
with the associated vendors are as follows: Sodium chloride (Sigma-Aldrich); 1,2-
diphytanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids); pentane (Sigma-
Aldrich); Tris base (Promega); Ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich); 
pentane (Fischer Chemical); hexadecane CH3(Ch2)14CH3 (Avantor); CX-5461 
lyophilized powder (Sigma-Aldrich); and acetic acid (VWR). The CX-5461 was then 
aliquoted into 1.5 mL microcentrifuge tubes which were wrapped in aluminum foil and 
stored in a freezer at -20˚C. 
5.3.2 DNA samples. All DNA used in this study were designed and purchased from 
Integrated DNA Technology (IDT - Coralville, IA) and had the following sequences: 
Ckit1:  AGG GAG GGC GCT GGG AGG AGG G (0 mutation) 
L1M1: AGG GAT GGC GCT GGG AGG AGG G (1 mutation) 
L1M2: AGG GAT GGC GCT TGG AGG AGG G (2 mutations) 




L2M2: AGG GAG TGC GCT GTG AGG AGG G (2 mutations) 
M2C: AGG GAT TTC GCT TTT AGG AGG G (6 mutations) 
Upon delivery, DNA samples were resuspended in a standard storage buffer 
(containing 10mM Tris, 1mM EDTA and titrated to 8.0 pH).  All samples were then 
aliquoted and stored at -80˚C until experimentation. This was done to prevent the 
degradation of the DNA quality caused by multiple thaw-freeze cycles. In both the 
nanopore and circular dichroism experiments, the final concentration of the DNA was 1 
µM. 
5.3.3 Experimental setup. Detailed protocol and description of the α-hemolysin 
nanopore experimental setup has been discussed in previous studies.47, 50 A 1 µM aliquot 
of DNA sample was inserted into the cis chamber. The cis chamber was grounded, so that 
when applying a positive voltage, the negatively charged DNA would be driven through 
the nanopore to the trans side. Electrolyte solutions in the cis chamber were titrated to pH 
8.15 in experiments using CX-5461, in order to compensate for the acidity of CX-5461 
solution. 
5.3.4 Data analysis and visualization. Event blockage amplitudes were 
determined from amplitude histograms by fitting the peaks to Gaussian functions (single-
sample and mixture models). The duration and occurrence of short-lived blockages for 
DNA translocation were obtained by fitting the dwell-time histogram to an exponential 
distribution. Only current-blockage events with %I/Io ≥ 60 % and ∆t > 1ms were selected 
for data analysis.73 Those with %I/Io < 60% or ∆t < 1ms are considered as brief interaction 




on at least three separate experiments. RStudio was used to run ANOVA and Tukey’s HSD 
tests to determine the significance of dwell-time data.  
5.3.5 Circular dichroism and thermal denaturation. In the studies for both 
absorbance and thermal denaturation, a model J-810 Jasco CD spectropolarimeter was 
utilized. When measuring CD, a CX-5461:DNA (1 µM DNA concentration) ratio of 5:1, 
when applicable, was used, which is consistent with pre-existing nanopore studies. Spectra 
were captured within a 220-300 nm wavelength range, 1.0 nm bandwidth, 50nm/min 
scanning speed, and a standard sensitivity. 1M NaCl experimental solutions were used in 
normal CD studies and 0.1M NaCl experimental solutions were used in thermal 
denaturation studies. J-810 is utilized in both normal CD and thermal denaturation portions 
of this study. In order to increase the temperature from 20˚C to 95˚C, a Jasco PTC-423S 
temperature attachment with a heating rate of 1˚C/min was utilized. To prevent the sample 
from boiling and affecting the data, CD was recorded only at temperatures below 100˚C. 
The results of the CD were exported as .csv files to be analyzed further and plotted in Excel. 
5.4 Results and Discussion 
5.4.1 Experimental design. This study aims to explore the effects of point 
mutations on Ckit1 G-quadruplex formation and stability, as well as the effects of cancer 
drug CX-5461 on mutated C-kit1 G-quadruplexes versus native C-kit1 G-quadruplexes. In 
this study, we employed variations of the Ckit1 DNA, each containing different mutations 
of guanine. Specifically, six DNA samples included: Ckit1 (positive control), L1M1, 
L1M2, L2M1, L2M2, and M2C (negative control). Ckit1 is the unmutated sequence, while 
M2C contains six mutated guanine bases in total, with two at each G-quartet layer. The 




layer (“L”) and number of mutation (“M”), respectively. For example, “L1M2” refers to 
C-kit1 DNA that has two-point mutations on the part of the sequence that would form the 
first layer of the G-quadruplex. In Figure 20, the first column shows schematics of the 
Ckit1 G-quadruplex, with the three layers of G-quartets (yellow layers), its central Na+ 
cations (red dots), and location of the mutated guanine (purple circles). As the G-
quadruplex is symmetrical, we only ran experiments with mutations on the first and second 
G-quartet, assuming CX-5461 effects on G-quadruplex stability if bound to the first or third 
layer would be similar. In order to increase efficiency of the experimental design, we ran 
experiments with C-kit1 DNA with up to two mutations. The G-quadruplex requires four 
guanine bases in order to form. Therefore, two mutations on the C-kit1 G-quadruplex 
sequence would have a sufficient effect on destabilizing of the G-quartet.  
5.4.2 Changes in current-blockage events among conditions. First, we compare 
raw data traces obtained from nanopore experiments of all samples in the same 
experimental conditions (1M NaCl, +160mV, with and without presence of CX-5461). As 
showed in Figure 20, all samples exhibited two types of events, which are spike-like (Type 
1 events) and long-lasting blockages (Type 2 events). In Ckit1 DNA, addition of CX-5461 
significantly increases the dwell time and frequency of Type 2 events (as discussed in 
Chapter 4). However, compared to Ckit1, raw nanopore data traces of mutated sequences 
exhibited a higher amount of spike-like events (Type 1), indicating that the mutated 
sequences were less likely to form stable G-quadruplexes. Moreover, increased incidence 
of Type 1 events also reflects higher amounts of linear DNA being captured. This result is 
much more pronounced in the L2M2 and M2C samples, compared to other mutated 




other samples. Similar to Ckit1 and L1M1, L1M2 and L2M1 data traces contain both Type 
1 and 2 events; however, the increased frequency of Type 1 events indicated less G-
quadruplex formation.113 Interestingly, addition of CX-5461 to L2M2 has shown slight 
increases in the signal event length when compared to L2M2 without the addition of CX-





Figure 20. Nanopore raw data traces. (Left) Schematics represent six variations of the 
Ckit1 sequence, containing 0 – 6 mutation points (purple circles) and their location on the 
G-quadruplex structure. Experiments were conducted in duplicate with and without CX-
5461 for all DNA sequences, including: positive control DNA (Ckit1), mutated sequences 
(L1M1, L1M2, L2M1, L2M2 and M2C) (top to bottom). (Middle) The  positive control 
(C-kit1) DNA spontaneously adopts the G-quadruplex, leading to long lasting current 
blockages (top panel); whereas M2C (containing 6 point mutations) is incapable of folding 
into a unimolecular G-quadruplex, causing a significant increase in frequency of spike-like 
events (bottom panel). (Right) Addition of CX-5461 did not show a clear visible effect on 
mutated sequences. In all experiments, the concentration of both DNAs was 1 µM. All 
traces were recorded at +160mV in a 1M salt solution buffered with 10mM Tris, 1mM 






Using circular dichroism (CD), we measured the optical absorbance of all the 
sequences investigated in this study (Figure 21). Both Ckit1 and Ckit1_CX formed a 
parallel G-quadruplex structure that was characterized by a strong positive peak at 263nm 
and a negative peak at 237nm (Figure 21A). Compared to Ckit1, the CD absorbance spectra 
of mutated sequences exhibited both positive and negative peaks between 220 – 300nm, as 





Figure 21. Circular Dichroism spectra of all tested sequences were measured between 220 
– 320nm, at room temperature. Samples were measured without (black line) and with the 
presence of CX415461 drug (dotted orange line). CD spectra of C-kit1 DNA had a positive 
peak at 263nm and a negative peak at 235nm, reflecting the presence a G-quadruplex 
structure with parallel folding topology. For all other sequences, these two peaks (at 235nm 








L1M1 and L1M1_CX spectra were similar to that of Ckit1 and Ckit1_CX, 
respectively (Figure 21C). However, the peaks were significantly broadened and/or shifted 
in L1M2, L2M1, L2M2 and M2C samples. Diminishing of 263nm and 235nm peaks in 
mutated sequences indicate a reduction in parallel G-quadruplex formation and an increase 
in topological changes. This effect varies with the number and position of mutations. In the 
following sections, we will take a closer look at the structural volume and stability of these 
structures.  
5.4.3 Structural volume of Ckit1 and mutated sequences. We would like to 
understand if the volume of Ckit1 G-quadruplex is affected by presences of mutations and 
CX-5461. Previous work has shown that the potential volume of the secondary structure 
of the DNA could be determined by the current blockage amplitudes.104 For each sample, 
we selected at least 1000 current-blockage events that lasted longer than 1 ms for the 
analysis, as those with shorter dwell time were considered as translocation of unfolded 
linear ssDNA (Type 1 events). In accordance with the nanopore conductance with (I) and 
without (Io) sample translocation, we calculated the current-blockage amplitude (%I/Io). 
Without CX-5461, all samples folded into structures with a similar volume (for summary 
statistics, see Table 6). Specifically, the mean current blockage amplitude of all samples 
was approximately 69.7 ± 2.3% (Figure 22). Addition of CX-5461 greatly increased the 
current-blockage amplitude of Ckit1 (similarly observed in Chapter 4) and M2C by over 








Figure 22. Average current blockage amplitude at +160mV of all samples, including: 
Ckit1, L1M1, L1M2, L2M1, L2M2 and M2C without treatment (green) and with the 
addition of CX-5461 (orange). All samples exhibited a similar average current-blockage 
amplitude of 69 ± 2%. Addition of CX-5461 showed minimal effect on L1M1, L1M2, 
L2M1 and L2M2, but increased %I/Io of both Ckit1 and M2C by approximately 5%. The 
average %I/Io of each sample was found by selecting at least 1000 events to construct a 
























71.85 101.87 50.15 71.21 10.94 
Ckit1 x 72.89 100.76 50.08 74.27 10.08 
L1M1 
 
68.68 86.26 51.22 67.64 9.34 
L1M1 x 67.35 101.63 50.14 66.20 8.34 
L1M2 
 
70.78 98.71 50.48 69.77 8.58 
L1M2 x 71.87 101.13 51.02 69.93 9.81 
L2M1 
 
72.03 101.61 50.41 69.13 9.05 
L2M1 x 72.78 99.04 50.76 70.89 8.14 
L2M2 
 
72.75 99.04 50.76 70.88 8.14 
L2M2 x 73.79 94.00 51.84 71.07 8.09 
M2C 
 
68.81 98.34 53.75 67.47 5.42 





5.4.4 Effect of CX-5461 on mutated Ckit1 G-quadruplex stability. Stability of 
the G-quadruplex structure is measured in relation to length of the current blockage. First, 
we constructed a box-and-whiskers plot for all the experimental conditions (Figure 23A). 
Upon calculating the summary statistics of these samples, we found that the majority of 
the event dwell times were between 1-100ms (with the exception of Ckit1_CX), with 
median ∆t decreasing in the sequence of: Ckit1 > L2M1 > L1M1 > M2C > L2M2 > L1M2.  
Addition of CX-5461 increased the samples’ ∆t to varying degrees, except for L2M1 and 
M2C, whose ∆t significantly decreased (Table 7). Specifically, the median ∆t of all samples 
in the presence of CX-5461 can be listed in decreasing order as follows: Ckit1 >> L1M1 > 
L2M2 > L1M2 > M2C > L2M1 (Table 7). In all experimental samples, there were multiple 
outliers, which were events with extremely long ∆t (several seconds to minutes). This was 
a result of metastable state of DNA—a phenomenon that was well described in previous 
studies.249-251 Thermal denaturation experiments were performed to assess the stability of 
the Ckit1 G-quadruplex and its mutated structures in each experimental condition (Figure 
22B – E). The melting curves were collected at 263 nm (which was the positive peak in the 
circular dichroism experiments), with temperatures ranging from 20 - 95oC. The melting 
temperature is determined when 50% of the DNA is unfolded. As discussed in Chapter 4, 
while the nanopore experiments were conducted in buffer containing 1M NaCl, thermal 
denaturation experiments were carried out in 0.1M NaCl environment, in order to keep the 









Figure 23. Stability of mutated Ckit1 G-quadruplex. (A) Grouped boxplot representations 
of the distribution of event dwell times for all samples, including: Ckit1, L1M1, L1M2, 
L2M1, L2M2 and M2C. All experiments were conducted in duplicate with (orange, right 
side) and without (green, left side) the addition of CX-5461. Ckit1 DNA is relatively more 
stable than its mutated sequences, as indicated by a higher median dwell time. Presence of 
CX-5461 increases stability of most sequences to varying degrees, except for L2M1, whose 
stability decreases. (B) Thermal denaturation studies were performed to determine the 
stability of G-quadruplex structures formed by mutated sequences with (orange dotted line) 
and without (solid green line) the presence of CX-5461. The secondary structure melting 
temperature, Tm, is the temperature, where 50% of the DNA are folded. Circular dichroism 




Among the samples, The L1M1 condition exhibited a melting curve that was 
remarkably similar to the positive control Ckit1 DNA, with the addition of CX-5461 
slightly shifting the melting curve to the right. Specifically, the observed melting 
temperature of L1M1 and L1M1_CX were approximately 65˚C and 70˚C, respectively 
(Figure 23B). This indicates excellent stability of the G-quadruplex both with and without 
CX-5461. Notably, Tm of L1M1 was slightly higher than that of Ckit1 in the same 




increase in nanopore event dwell time of L1M1 sequence in comparison to Ckit1 DNA. 
However, this increase in dwell times was not statistically significant. On the other hand, 
L2M1 exhibited a straight down trending line and no inflection point in the melting curve 
(Figure 23D). The addition of CX-5461 to L2M1 somewhat rescued the sigmoidal shape 
that was characteristic of the melting curve of the positive control, but offbeat degrees of 
ellipticity persisted, indicating poor stability of the G-quadruplex. In other samples (e.g. 
L1M2, L2M2, and M2C), the behavior bore little to no resemblance to the positive control 
Ckit1 DNA with relatively low G-quadruplex stability at its peak degree of ellipticity. 










5.4.4.1 Having more than one mutation destabilizes Ckit1 G-quadruplex. All 
three of the examined sequences with at least two mutations within the same level had 












Ckit1  4432.63 114411.35 1.05 5.75 13919.90 
Ckit1 x 11587.29 152850.00 1.02 47.36 26625.04 
L1M1  4283.26 51802.34 1.02 4.94 10577.08 
L1M1 X 1887.54 39545.14 1.04 11.73 6195.79 
L1M2  9.43 296.95 1.02 3.00 24.21 
L1M2 X 629.38 39771.09 1.02 5.04 3552.46 
L2M1  2153.12 65396.62 1.02 5.53 7404.17 
L2M1 x 31.49 1447.89 1.03 3.50 135.46 
L2M2  31.42 1447.89 1.03 3.51 135.28 
L2M2 X 6175.41 119939.50 1.02 8.54 16886.62 
M2C  15.27 3449.96 1.02 4.17 123.22 





L1M2, L2M2, and M2C), with all exhibiting decreased dwell times (as shown in Table 8). 
This indicates that having multiple mutations within the same level of Ckit1 compromises 
the overall stability of the G-quadruplex, while having just one mutation did not. 
Furthermore, there were no significant differences between the dwell times of L1M1 and 
L2M1 or L1M2 and L2M2, but there were significant differences between L1M2 - L1M1 
and L2M2-L2M1, suggesting that the number of mutations has a much more relevant 
impact on G-quadruplex stability than the position (G-quartet level) of the mutation (Table 
9). 
5.4.4.2 The outer G-quartet layer is crucial to the binding of CX-5461. Addition 
of CX-5461 created significant changes in the stability of  Ckit1, L2M1 and L2M2  with 
opposite effects, suggesting different interactions of CX-5461 to the mutated Ckit1 
structures (Table 10). As expected, the addition of CX-5461 to the positive control Ckit1 
DNA proved to significantly increase Ckit1 G-quadruplex stability, as discussed in Chapter 
4. This was also the case with L2M2 (p < 0.001), which makes sense given that addition 
of CX-5461 somewhat rescued the shape of the denaturation curve. CX-5461 did not 
appear to have significant effects on L1M1, L1M2, or M2C (p = 0.091 , p = 0.976 , p = 
0.967 , respectively), although L1M1 did exhibit a notable, but not significant, increase in 
dwell time with the addition of Cx-5461. Because CX-5461 stabilizes G-quadruplex by 
binding to the DNA sequence,252 this may implicate the outer G-quartet (L1) is critical for 
an efficiency binding of CX-5461), because its mutation results in abrogation of the 
stabilizing effect. Having more than one mutated guanine on the first layer inhibits the 
formation of layer 1 G-quartet, thus interfering with CX-5461 binding to the structure. This 




Ckit1 and L2M2 conditions, both of which lacked mutations in the first layer of G-quartet 
(L1). However, addition of CX-5461 to L2M1 produced a significant difference that 
resulted in a decrease in dwell time, and thus a decrease in structural stability. This is 
indicative of a destabilizing interaction of unknown cause that L2M1 has with CX-5461. 
This follows the trend that was illustrated in the thermal denaturation curve produced by 
L2M1, where the addition of CX-5461 resulted in a drastically offbeat degrees of ellipticity 












Statistical comparison between dwell times of mutated sequences. 
 
Groups Adj. p-value  
L1M1-Ckit1 1.0000 ns 
L1M2-Ckit1 0.0000 *** 
L2M1-Ckit1 0.0003 *** 
L2M2-Ckit1 0.0000 *** 
M2C-Ckit1 0.0000 *** 
*Note: adjusted p-values was obtained from using Anova on all samples, followed by Tukey’s 
post-hoc test.  
 
Groups Adj. p-value  
L1M2-L1M1 0.0000 *** 
L2M2-L2M1 0.0003 *** 
L2M1-L1M1 0.0950 ns 
L2M2-L1M2 1.0000  ns 
L2M2 - M2C 1.0000  ns 
L1M2 - M2C 1.0000  ns 
L1M1 - M2C 0.0000 *** 
L2M1- M2C 0.0000 *** 
*Note: adjusted p-values was obtained from using Anova on all samples, followed by Tukey’s 












5.4.5 Distinguishing unmutated Ckit1 sequences from mutated ones. We 
explored the feasibility of detecting mutated Ckit1 sequences by employing machine 
learning classification models on data obtained from nanopore single–molecular analysis. 
In particular, there were five models, including: K-nearest neighbor (KNN), Random 
Forest (RF), Logistic Regression (LG), Linear Discriminant Analysis (LDA), and 
Quadratic Discriminant Analysis (QDA), employed for the binary classification of mutated 
and unmutated Ckit1 DNA.  
To minimize the potential issue of overfitting one group, we sampled a balanced 
dataset, in which the number of mutated and unmutated sequences are represented 
eqrrrrrually (i.e. approximately 1000 events each). The dataset was comprised of two 
distinct groups. The first group, called “Ckit1”, was comprised of the current-blockage 
events of Ckit1 DNA. The second group, called “Mut”, consisted of an equal mixture of 
all the mutated sequences (e.g. L1M1, L1M2, L2M1, L2M2, and M2C). The dataset was 
then split into 80% and 20% portions for model training and validation purposes, 
respectively. Current – blockage amplitude (%I/Io) and dwell time (∆t) were selected as 
input features for the model. To evaluate the model’s performance, we compared their 
Groups Adj. p-value  
Ckit1_CX-Ckit1 0.0000 *** 
L1M1_CX-L1M1 0.0907 ns 
L1M2_CX-L1M2 0.9761 ns  
L2M1_CX-L2M1 0.0003 *** 
L2M2_CX-L2M2 0.0000 *** 
M2C_CX-M2C 0.9666  ns 
*Note: adjusted p-values was obtained from using Anova on all samples, followed by Tukey’s 




AUROC values. We ran the same five algorithms in duplicate on a dataset containing (1) 
all current-blockage events and (2) only those with %I/Io > 75%. The first one (1) yielded 
extremely poor results, with all algorithms returning an AUROC value of approximately 
0.5 (data not shown). Results obtained from the latter dataset (2) were similar, except for 






Figure 24. Machine learning models for classification of mutated C-kit1 sequence from 
unmutated one. (A) Evaluation of model performance based on the distribution of their 
AUROC value: models were ranked based on the median AUROC score and arranged from 
best to worst performance (top to bottom). (B) Confusion matrix shows results of random 
forest classification for mutated sequence from unmutated one using nanopore events. 
Unmutated sequences contained Ckit1 DNA and mutated group consists of all other 
sequences (i.e. L1M1, L1M2, L2M1 and L2M2). The random Forest classifier model 





To visualize the true positive and false positive rates, we constructed a confusion 
matrix for the RF model (Figure 24B). This matrix shows the true positive and true negative 




hand, the false negative and false positive predictions are placed in the lower left and upper 
right corners (orange boxes). Thus, for mutated and unmutated Ckit1 sequences, the RF 
classifier yielded an 82.7% accuracy, 81.9% sensitivity and 83.4% specificity. As 
determined before, point mutations have varying effects on the secondary structural 
volume and stability. It was surprising to see that most classifiers yielded a poor 
performance since point mutations can increase or decrease the mutated structure’s volume 
and stability concurrently (depending on the number and position of mutation). This 
hindered the model performance. Applying the same classifiers on datasets containing 
Ckit1 and only one mutated sequence will enhance the accuracy of classifiers. However, 
this would not be practical in a real-world scenario, where the number and position of point 
mutation is unknown. 
5.5 Conclusions 
Through this nanopore single-molecule study, we determined the effect of point 
mutations on stability of Ckit1 G-quadruplex and CX-5461 stabilizing efficiency using the 
event dwell time. With a maximum width of approximately 2.1 nm,253 the G-quadruplex is 
able to fit within the 2.6 nm wide nanocavity entrance. However, the β-barrel entrance 
(constriction site) of the nanopore is just 1.4 nm wide, making it impossible for the G-
quadruplex structure to translocate without unfolding. Therefore, electrophoretic force 
drives the analyte into the nanocavity where it becomes trapped and either (1) unravels and 
translocates through the β-barrel and into the trans side of the test chamber, or (2) 
regurgitates backward into the cis solution.47 Previous studies have demonstrated that 
translocation events with G-quadruplex have significantly longer dwell times on the order 




trapped in the nanocavity.47, 105 By contrast, simple linear DNA produces very short, 
transient current blockages.47 Taken together, this indicates that dwell time provides a 
valuable assessment of the structural stability of the G-quadruplex, with higher dwell times 
indicating a more stable structure. 
Results obtained from our study suggest that the number and position of mutations 
have an impact on G-quadruplex structural stability. Furthermore, addition of CX-5461 to 
samples does not have a significant effect on the stability of samples with a mutation on 
the top G-quartet (layer 1), implicating it as a crucial factor in the binding of CX-5461 to 
the DNA structure. Lastly, addition of CX-5461 to conditions with an intact level 1 (Ckit1 
positive control, L2M1, and L2M2) resulted in an increase in G-quadruplex stability, with 
the exception of L2M1 which oddly exhibited a decrease in stability. Using Random Forest 
algorithm on nanopore data, we were able to distinguish mutated Ckit1 sequences from 
unmutated ones with an overall sensitivity of 81.9%, specificity of 83.4% and balanced 
accuracy of 82.7%. Excessive activation of the C-kit1 gene is implicated in several human 
malignancies and its expression is downregulated by the stabilization of its G-quadruplex 
structure.254 Knowing the effect of mutation on drug efficiency can have implications in 
the implementation of cancer therapies, particularly the drug CX-5461. As mutations on 
G-quadruplex sequences have been observed in several cancers, this research may be 









Employing LiCl Salt Gradient to Slow Down DNA Translocation for Label-Free 
Detection of Cytosine Methylation 
 
6.1 Abstract 
In this chapter, we demonstrate a label-free detection, biological nanopore-based 
method to distinguish methylated cytosine (mC) from naked cytosine (C) in sample 
mixtures containing both C and mC at prolonged translocation duration. Using 15-fold 
increase in LiCl salt concentration going from cis to trans chamber, we increased the 
translocation dwell time of ssDNA by over 5-fold and the event capture rate by 6-fold in 
comparison with symmetric concentration of 1.0M KCl (control). Moreover, salt gradients 
can create a large electric field that will funnel ions and polymers towards the pore, 
increasing the capture rate and translocation dwell time of DNA. As a result, in 0.2M – 
3.0M LiCl solution, ssDNA achieved a prolonged dwell time of 52 𝜇s/nucleotide and a 
capture rate of 60 ssDNA per second. Importantly, lowering the translocation speed of 
ssDNA enhances the resulting resolution, allowing 5’-mC to be distinguished from C 
without using methyl-specific labels. We successfully distinguished 5’-mC from C when 
mixed together at ratios at 1:1, 3:7 and 7:3. Distribution of current blockade amplitudes of 
all mixtures adopted bimodal shapes, with peak-to-peak ratios coarsely corresponding to 
the mixture composition (e.g. the density and distribution of events shifted in 
correspondence with changes in 18b-0mC and 18-2mC concentration ratios in the 
mixture).This chapter was adopted from our published article (Vu, Trang, et al. 
"Employing LiCl salt gradient in the wild-type α-hemolysin nanopore to slow down DNA 





Cytosine methylation is the most well-established and understood epigenetic 
modification on DNA, affecting the activity and stability of genomic regions.118, 255-256 
Specifically, methylation of cytosine is the gain or loss of a methyl group on cytosine in 
the 5-position,56, 257-258 which is frequently found at CpG dinucleotides.256 These CpG 
nucleotides often occur in bunches widely known as “islands” which are linked to promoter 
regions of genes. Aberrant methylations of these regions can lead to gene inactivation or 
loss-of-function mutations.259 Beside DNA promoter regions, cytosine methylation of 
various types of RNA (e.g. tRNA, mRNA, and non-coding RNAs) has gained increasing 
attention in recent years.260-263 For instance, it was shown that specific signature 
methylation pattern of microRNAs (miRNA1, miRNA9, miRNA124 and miRNA137)  
could be used to identify ulcerative colitis patients with elevated risk for colorectal 
neoplasia.264 Unlike genetic mutations, which can occur anywhere in a gene, cancer-
specific cytosine methylation mostly locates at defined regions (e.g. the promoter of genes 
or on specific sequences), making it easier to devise targeted probes for molecular 
alterations. 
Currently, bisulfite-conversion is the “gold-standard” to detect and profile DNA 
methylated cytosine.265 However, bisulfite-conversion cannot directly identify 5-
methylated cytosine (5-mC) from native DNA. Unmethylated cytosine must first be 
converted to uracil, consequently, increasing the complexity of library preparation and the 
potentials for artifacts and biases. Due to extensive fragmentations in the bisulfite-
conversion process, any breaks at inserts can prevent downstream amplification of DNA.265 




demonstrated different ways to detect and quantify the presence of 5’-mC on both ss- and 
dsDNA by long-read sequencing,266-267 employing methyl-CpG-binding domain protein 
(MBD),56, 268 Kaiso-Zinc Finger (KZF),56 optical-tagging,57 among many others.145-148, 275 
Comparing to PacBio and bisulfate conversion, methylation detection with nanopore 
technology has yet to match the performance, but shows advantages on maintaining the 
DNA sequence complexity and imprinting.267   
In this chapter, we investigated the ability of wild-type α-hemolysin nanopore in 
label-free detection of methylation on cytosine, with a focus on slowing down translocation 
velocity to enhance the result readout and accuracy. Through research and analytics, 
several methods have been proposed to impede translocation velocity via decreasing 
experimental temperature, altering bulk density, changing applied potential, or using an 
alternating electric field.269 However, compared to those physical conditions, the effect of 
cation nature, electrophoretic, electroosmotic, and diffusioosmotic flows are far more 
significant on the translocation of DNA.269-271 In our study, electrophoretic, electroosmotic, 
and diffusioosmotic flows have been adopted to slow down the translocation velocity of 
ssDNA through biological nanopores, enabling label-free detection of 5-mC from C in 
ssDNA mixtures. 
6.3 Methods 
6.3.1 DNA samples. Synthetic 18-mer, single-stranded DNA purchased from 
Integrated DNA Technology (Coralville, IA) have the following sequences:  
Sample 1 (18b-0mC): 5’-TAA TCA TCG CGT ACT AAT-3’ 




DNAs were suspended in a buffer solution containing Tris (10mM) and EDTA (1.0mM), 
titrated to 8.0 pH, then aliquoted and stored at -80oC until usage. For all experiments, DNA 
final concentration of 1 μM in the cis chamber was used. 
6.3.2 Experimental setup. Each chamber was filled with electrolyte solutions with 
either LiCl or KCl solution, with a salt concentration of 0.2M, 1.0M or 3.0M, buffered with 
10mM Tris and titrated to pH 7.2. The salt concentrations in each chamber varied based on 
the experimental conditions being tested. 
6.3.3 Single-channel recording. Single-channel recordings were performed using 
Axopatch 200B (Molecular Device Inc.), filtered with a built-in 4-pole low-pass Bessel 
Filter at 5kHz. Data were acquired with Clampex 10.7 (Molecular Device Inc.) and Axon 
Digidata 1550B A/D converter (Molecular Device Inc.), at a sampling rate of 20 kHz. The 
data were analyzed using Clampfit 10.7 (Molecular Device Inc.), Excel (MicroSoft) and 
MatLab (2017a) software. Event blockage amplitudes were determined from amplitude 
histograms by fitting the peaks to Gaussian functions (single-sample and mixture models). 
The duration and occurrence of short-lived blocks for DNA translocation were obtained by 
fitting the dwell-time histogram to an exponential distribution. Only current-blockage 
events with %I/Io ≥ 70% were selected for data analysis.35 Those with %I/Io < 70% are 
considered as brief interaction of DNA and the pore entrance (e.g. interaction of hairpin 
structure with vestibule), rather than DNA translocation, thus, were disregarded.237 Data 









6.3.4 Mixture analysis. Current blockage events were calculated as the percent 
blockage of the open pore current (%I/Io). To predict the distribution of the two samples in 
mixture solutions, %I/Io was first calculated, then fitted with Gaussian Mixture Model (two 
components) in MatLab (2017a). 
6.4 Results and Discussions 
We employed the α-hemolysin nanopore as a single channel sensing element to 
detect ssDNA at single-molecule level. Experiments were performed on two single-
stranded DNA samples with identical sequences, containing either cytosine, or 5-
methylcytosines at the center, hereafter, called C-DNA and mC-DNA. C-DNA has a 
sequence of 5’-TAA TCA TCG CGT ACT AAT-3’, and mC-DNA has a sequence of: 5’-
TAA TCA TMG MGT ACT AAT-3’ (with M standing for 5’-mC). Most of the studies 
have largely investigated long nucleotide sequences (hundreds to thousands bases), thus, 
in this study, we selected 18-mer sequences to investigate the effect of electrophoretic, 
electroosmotic and methylation hydrophobicity on shorter strands, such as tRNA and 
miRNA. All experiments were reproduced multiple times, yielding comparable results. 
The open pore conductance varies upon the change of solute ionic concentration and 
gradient. Let Ctrans/Ccis be the ionic concentration ratio between the trans and cis chambers. 
With Ctrans/Ccis > 1 (higher  salt concentration in the trans side), there is a constant diffusion 
of cation from the trans to cis chamber, creating a negative current even if there is no 
external voltage applied.  
The α-hemolysin nanopore is water-filled, thus, the charge distribution inside the 




hemolysin nanopore (Figure 25). The 5kHz low-pass Bessel filter in Axopatch 200B and 










6.4.1 Li+ and salt gradient increase translocation time. Cations, depending on 
their ionic radii and concentration, can affect the electrophoretic mobility of DNA 
differently.272-274 To examine this, we conducted two sets of experiments on both samples, 
18b-0mC and 18b-2mC DNAs, at various conditions of: (1) symmetric and (2) asymmetric 
salt concentration in the cis and trans chambers. For symmetric 1.0M – 1.0M solutions, we 
found that the ratio for the translocation time, ∆t, of ssDNA is KCl : LiCl ~ 1 : 2.3 (Figure 
26A – B). When comparing within the same type of sample (either 18b-0mC or 18b-2mC) 
translocated through the pore at +120mV, as the ionic concentration in the trans side 
increases from 1.0M LiCl to 3.0M LiCl, the translocation time, ∆t, increased approximately 




intensify the magnitude of ssDNA translocation time through the nanopore. With a 15-fold 
increase in ionic concentrations going from the cis to the trans chambers (0.2M – 3.0M 
LiCl), the average translocation times of 18b-0mC and 18b-2mC DNA are 0.945 ms and 
0.765 ms, respectively, at biased voltage of 120 mV. In other words, the addition of a salt 
gradient (0.2M – 3.0M LiCl in cis/trans) increases the translocation times of both samples 
by 2-fold and 5-fold, when compared to the results obtained from 1.0M – 1.0M LiCl and 
1.0M – 1.0M KCl solutions of the same sample type (either 18b-0mC or 18b-2mC, as 
shown in Figure 26A – D). Note that the open pore current depends on the electrolyte’s 
conductivity and ionic concentration. Thus, amplitudes of open pore current decreases with 
decreasing ionic concentration in the cis side, reflected by current blockages with various 
amplitudes (Figure 26E – F).  
Overall, an increase in salt concentration gradient going from the cis to the trans 
chamber results in a proportional elongation of individual DNA translocation time. 
Notably, in any given experimented solutes and applied voltages, mC-DNA translocate 
through the nanopore faster than C-DNA does. This result agrees with findings from a 
previous study, showing that addition of a methyl group on Cytosine (mC) increases the 
local hydrophobicity and rigidity of G-mC bps, thus leading to a smoother and faster 
translocation of mC-DNA through the nanopores.275 
To understand the changes in ∆𝑡 observed in this experiment, we scrutinize the 
effect of Li+ ions on ssDNA and its surrounding environment. Li+ ions can effectively 
reduce the mobility of ssDNA through the α-hemolysin nanopore, because of its counter-
ion effect and physical-chemistry properties. In theory, electrolyte solution containing 




including changing water’s bulk properties,276 modifying DNA conformation, and 
affecting the preferential binding of counter-ions to DNA.272, 277-279 More specifically, 
binding of counter-ions partially neutralizes the negatively charged phosphate backbone; 







Figure 26. Comparison of cation effects on DNA translocation time. (A – D) 18b-0mC and 
18b-2mC DNA translocation time, ∆t, in: (A) 1.0M – 1.0M KCl (control), (B) 1.0M – 1.0M 
LiCl, (C) 1.0M – 3.0M LiCl, (D) 0.2M – 3.0M LiCl (optimal condition). The recorded ∆𝒕 
were plotted as a function of applied voltage at 100mV, 120mV, and 140mV. All points 
are the value of the fit with standard error. Each data is overlaid with over n = 2000 
separated translocation events recorded per data point. The 18b-2mC DNA, with an 
increased in hydrophobicity due to the addition of methyl groups, can translocate through 
the nanopore faster than 18b-0mC DNA does at any given experimental condition. At 0.2M 
– 3.0M LiCl (cis/trans), event translocation times were prolonged approximated by 6-fold 
for both DNA samples, when compared to 1.0M KCl (control). (E-F) Characteristic current 
blockade signatures representing the 18b-0mC DNA (left) and 18b-2mC DNA (right) 
through the α-hemolysin nanopore are shown. 18b-2mC DNA generates shallower current 
blockages than 18b-0mC does for all applied voltages. Overall, the current blockage 







Previous studies showed that binding affinities of cations to DNA are inversely 
proportional to the radius of the specific binding ion. Thus, binding affinity of cations to 
DNA increases with decreasing ion radius, explaining the increased bond strength of 
binding Li+ as opposed to K+. The measured radii of Li+, Na+ and K+ has been reported as 
follows: 0.69, 1.02 and 1.38 Å, respectively.276, 281 Lithium shows the strongest binding 
affinity, as well as the longest binding time, resulting in increased translocation times of 
ssDNA in solid-state,271 and in biological nanopores, as shown here. 
However, the physical-chemistry properties of Li+ in fact are a greater contributor 
in decreasing the mobility of DNA. Studies show that the effects of these binding counter-
ions are due to changes in viscosity of the electrolyte solution, and perturbed hydrogen, 
leading to a decrease in the mobility of both ss- and dsDNA.282 Specifically, lithium is 
considered a water making ion, since it has a greater number of hydrogen bonds in solution 
compared to neat water (∆NHB). In lithium, the ∆NHB is 0.28, whereas potassium, a water 
breaking ion, has a ∆NHB of -0.58.272 A positive ∆NHB indicates an increase in the friction 
between water molecules due to its effect on hydrogen bonding.272 The rotational 
correlation times of water molecules may indicate DNA mobility since they are related to 
the number of hydrogen bonds between the water molecules.279 Overall, the viscosity 
coefficient of lithium is higher than the viscosity coefficient of potassium, further 
indicating that DNA is less mobile in lithium ion solution than potassium ion solution.272 







6.4.2 High ionic concentration decreases DNA mobility. Increase in solute bulk 
conductivity at high ionic concentration can prolong the translocation time of DNA.284 An 
approximate 2-fold increase in ∆t is observed as the ionic concentration switches from 
symmetric 1.0M to 3.0M of KCl or LiCl (Table 11 and Table 12). This can be explained 
by the interionic effects at high concentration, which as a result, increases the resistivity of 
the ionic solution.284 Interionic effects occur when ions are submerged in an ionic space 
with a net charge opposite that of the ion’s.284-286 Thus, this ionic solution diminishes the 
mobility of the ions within through a drag force. This interionic effect is related to the 
concentration of the ionic solution in that a weak electrolyte solution promotes weak effects 
whereas a strong electrolyte solution promotes strong effects. Furthermore, in highly 
concentrated solute (e.g. 3.0M LiCl), DNA molecules are saturated with counter-ions that 
can decrease effective charges on the DNA and therefore, prolong the translocation time. 
Notably, lowering the ionic concentration in the cis chamber, while keeping the trans 
chamber with the same concentration (1.0M – 3.0M LiCl and 0.2M– 3.0M LiCl) can 
further increase the translocation time of ssDNA (Table 13). This phenomena were 
explained in a previous study.287 Briefly, longer translocation time of DNA under 
asymmetric salt concentration is an effect of increasing electroosmotic flow of counter-
ions along the DNA. With the salt concentration lowers in the cis than in the trans chamber, 
cations move from trans to cis, down the direction of both electrical and chemical potential 
gradients. Thus, electroosmotic flow of cation is significantly increased.287 This further 
provides a drag force opposed to DNA motion in the pore, hence, hindering the 




solution in the cis side, while keeping trans side constant, we achieved the highest 





Summary of event analysis for 18b-0mC sample in KCl solutions 
 
 Amplitude (pA) Dwell time (ms) Frequency (s-1) 
 Mu Sigma Tau S.E. Tau S.E 
1M-3M KCl -179.05 3.82 0.32 0.04 10.08 0.38 
1M-1M KCl -101.79 6.67 0.17 0.003 6.72 0.43 
3M-3M KCl -282.99 4.84 0.47 0.015 1.30 0.06 
3M-1M KCl -169.38 4.56 0.13 0.011 0.98 0.08 
3M-0.2M KCl -109.72 2.34 0.14 0.067 0.24 0.04 
 
Note: All data were collected at 120mV, pH 7.2. Experiments with asymmetric 






Summary of event analysis for 18b-0mC sample in LiCl solutions 
 
 
Note: All data were collected at 120mV, pH 7.2. Experiments with asymmetric 




 Conc. Amplitude (pA) Dwell time (ms) Frequency (s-1) 
Condition Trans/ 
Cis 
Mu Sigma Tau S.E. Tau S.E. 
0.2M-3M LiCl 15 -79.63 2.49 0.945 0.08 55.62 3.32 
0.3M-3M LiCl 10 -88.35 0.47 0.88 0.05 52.03 4.70 
0.5M-3M LiCl 6 -87.14 0.21 0.81 0.06 47.62 2.08 
1M-3M LiCl 3 -137.4 4.39 0.67 0.02 34.53 1.72 
2M-3M LiCl 1.5 -152.3 3.65 0.57 0.07 2.44 0.16 
3M-3M LiCl 1 -166.4 3.39 0.52 0.02 0.68 0.09 
3M-1M LiCl 0.33 -168.1 4.31 0.19 0.02 1.47 0.13 
3M-0.2M LiCl 0.067 -149.2 0.61 0.18 0.01 0.94 0.13 
1M-1M LiCl 1 -79.27 3.54 0.38 0.02 4.8 0.31 





Effect of salt concentration on the translocation events 
 
 18b-0mC 18b-2mC 
 I (pA) ∆t (ms) 𝒇 (s-1) I (pA) ∆t (ms) 𝒇 (s-1) 

















































(Note: All data were collected at 120mV, pH 7.2. Experiments with asymmetric 




6.4.3 Effect of salt gradient on the event occurrence. Salt concentration 
asymmetry (0.2M – 3.0M LiCl) results in a significant increase in the event capture rate. 
A series of experiments were conducted by varying the ionic concentration between the cis 
and the trans sides revealing significant changes in the amplitudes, as well as dwell time, 
and occurrence of current blockage events. Both of the latter properties are inversely 
proportional to Ctrans/Ccis (the ionic concentration ratio going from trans to cis chamber). 
In other words, ∆t and  𝑓s significantly increases when Ctrans/Ccis > 1 and decreases rapidly 
with Ctrans/Ccis < 1 (event data traces are shown in Figure 27 and Figure 28). Interestingly, 
although the event capture rate is controlled by multiple factors (e.g., ionic concentration, 
voltage amplitude, and cation’s nature), ionic concentration gradient between the cis and 
trans sides exhibits the most abundant effect. Figure 29A–D shows sample traces for 
typical events of 18bp ss-DNA translocations in 1.0M – 1.0M KCl, 1.0M – 1.0M LiCl, 
1.0M – 3.0M LiCl, and 0.2M – 3.0M LiCl salt solutions (from top to bottom). We found 




occurrence, 𝑓s) of ssDNA are KCl/LiCl ~ 1.40 and 1.46 for C-DNA and mC-DNA samples, 
respectively. Upon changing the salt concentration between cis and trans chambers from 
1.0M – 1.0M LiCl to 1.0M –3.0M LiCl and 0.2M – 3.0M LiCl, occurrence increase 
significantly. As shown in Figure 29E – F, while the translocation times are found to 
gradually increase, the event occurrences, 𝑓s, quickly reached maximum value as the 
trans/cis concentration ratio exceed 2-fold. Specifically, C-DNA sample increase 
approximately 12 and 82 times upon changing the solute from symmetric 1.0M – 1.0M 
LiCl to 0.2M – 3.0M LiCl, and from symmetric 3.0M – 3.0M LiCl to 0.2M– 3.0M LiCl, 
respectively (Table 13). Interesting, both of the plots obtained from Figure 29E – F have a 
logarithmic trendline (R2 ≥ 0.92), different from a linear one obtained previously in solid-





Figure 27. Sample data traces and current blockage events of 18b-0mC in KCl electrolyte 
buffers with varied concentrations. Different ionic concentrations between the cis- and the 
trans side lead to significant changes in events dwell time and occurrence. All data were 







Figure 28. Sample data traces and current blockage events of 18b-0mC in LiCl electrolyte 
buffers with varied concentrations. Different ionic concentrations between the cis- and the 
trans side lead to significant changes in events dwell time and occurrence. All data were 






Figure 29. Effect of salt concentration on event occurrence. (A – D) Raw data traces of 
18b-0mC and 18b-2mC DNA translocate through the nanopore at: (A) symmetric 1.0M 
KCl, (B) symmetric 1.0M LiCl, (C) asymmetric 1.0M – 3.0M LiCl, (D) asymmetric 0.2M 
– 3.0M LiCl. (E) Correlation between trans/cis concentration ratio and event occurrence of 
both samples, and (F) Correlation between trans/cis concentration ratio and dwell time  of 
both samples. For all experiments, ionic concentration of the trans side was fixed at 3.0M 
LiCl, while cis concentration decreases from 3.0M to 0.2M LiCl. At any given 
experimental condition, the event occurrence of both samples was comparable, while the 
translocation time of 18b2mC were shorter than 18b0mC DNA. All data presented were 




In the presence of salt concentration asymmetry, the drastic increase in attraction 
of ssDNA toward the nanopore is a consequential result of two main factors: 
electrophoretic effects and diffusioosmotic flow.288 Specifically, as the constant current of 
ions flowing through the nanopore, it creates a long range electric field funneling ions and 
DNA toward the pore,287-291 increasing the DNA electrophoretic motion.288 Moreover, 
because of the asymmetric salt concentration between the cis  and the trans sides, there is 
a constant diffusion of ions between the two chambers, creating an additional electric field. 
For concentrations lower on the cis than the trans side of the pore, the created electric field 
is larger than if the concentrations were reversed.292 The stronger the electric field, the 
better the pore is able to pull cations through the membrane.292 Since the asymmetric salt 
concentration is increasing the electric field within the pore, it is also increasing the 
effective voltage in the cis side without reducing translocation times.287 This effect is 
mostly due to the conductance of the pore which is dependent on both the polarity and 
magnitude of the voltage applied.281  Thus, using asymmetrical salt concentration can 
greatly enhanced capture rate, proven in previous studies by successful detection of 
extremely low concentration samples  (at pico- and nanomolar range).293-294 
6.4.4 Label-free detection of cytosine methylation. Following the analysis of Li+ 
and salt concentration asymmetry effect on ssDNA, we further investigate the ability of the 
α-hemolysin nanopore to detect and discriminate methylated cytosine in both pure and 
mixed samples with unmethylated cytosine. Using various methods, previous works have 
shown that both solid-state and biological nanopores can be used to distinguish 5’-mC from 




hemolysin nanopore can discern subtle structural changes on a single molecule through 






Figure 30. Detect and distinguishing methylated cytosine. (A) Peak values of gaussian 
fitting for current blockage, ∆𝐼 (pA), of pure samples containing only 18b-0mC DNA 
(orange) or 18b-2mC (yellow) at: 1.0M – 1.0M KCl (control), 1.0M – 1.0M LiCl, 1.0M 
– 3.0M LiCl, and 0.2M– 3.0M LiCl (optimal condition). Peak-to-peak distance increases 
as a function of the difference in salt concentrations between the cis and trans chambers, 
with the highest peak discrepancy achieved at 0.2M – 3.0M LiCl (cis/trans). (B) Gaussian-
fittings for the distribution of current blockage amplitude for both samples at 0.2M – 3.0M 
LiCl.  (C) Raw data trace of the 1C – 1MC mixture contains current blockage events with 
two different levels, denoted as ImC for mC-DNA events and IC for C-DNA events, 
respectively. (D-F) Distribution of current blockages of 18b-0mC and 18b-2mC mixtures 
of different ratios: (D) 1:1, (E) 3:7, and (F) 7:3. The distribution of event blockages exhibits 










Figure 31. Gaussian fittings of 18b-0mC and 18b-2mC samples’ event blockages at: 1M-
1M KCl, 1M-1M LiCl, 1M-3M LiCl, and 0.2M-3M LiCl. As the concentration gradient 
between cis- and trans chamber increases, the peak-to-peak distance between two samples 




The two samples employed in this study, C- and mC-DNAs, have an identical 
sequence, but differ in 5’-mC content. Gaussian-fittings of their current blockade 
information were then overlaid, revealing the changes in current blockages with regards to 
the electrolyte (see Figure 30A). Under symmetrical salt concentration of 1.0M KCl on 
both cis and trans sides, 5’-mC and C show the least discrepancy between one another 
(Figure 30A and Figure 31). Whereas in LiCl electrolyte solutions, the two Gaussian peaks 
are clearly separated from one another, with a peak-to-peak distance increase in direct 
relationship with the asymmetric concentration difference of LiCl between the cis and trans 




conducted at 0.2M – 3.0M LiCl (Figure 30A – B). This finding agrees with our hypothesis 
that reduced translocation speeds of DNA through the nanopore can increase the resolution 
of readout results, allowing 5’-mC to be distinguished from C. Notably, C-DNA causes a 
slightly deeper current blockade than mC-DNA does, at any experimental conditions. 
To further examine the ability of α-hemolysin nanopore in distinguishing 5’-mC 
from C within the same solution, we performed experiments on the mixtures of C- and mC-
DNA samples at different ratios (C : mC): 1:1, 3:7, and 7:3 (see Figure 30D – F). As 
discussed in previous sections of this study, the 0.2M – 3.0M LiCl experimental condition 
has the most pronouncing effects on the event occurrence and dwell time of ssDNA; thus, 
was chosen for this second set of experiments. A sample current trace of the C-DNA : mC-
DNA mixture (1:1 ratio), with two level event blockades, is depicted in Figure 30C. Herein, 
we developed a MatLab code employing a Gaussian-fitting for a mixture with n 
components (n = 2). Histograms of current blockades of all mixtures adopted a bimodal 
shape, contributing to the presence of 5’-mC and C. The predicted Gaussian-fittings yield 
peak-to-peak ratios that are coarsely corresponded to the mixture composition, specifically, 
with the density and distribution of events shifted in correspondence with changes in 18b-
0mC and 18-2mC concentration ratios in the mixture (Figure 30E – F). 
Different methods to detect and quantify 5’-mC on both ss- and dsDNA using 
nanopores have been demonstrated in previous studies.56-57, 135, 295-296 In theory, the current 
blockade amplitude is directly corresponded to the size of the molecule translocating 
through the pore. Although the addition of a methyl group slightly increases the size of the 
5’-mC base, whether 5’-mC DNA cause a smaller or larger current blockage than C DNA 




blockade produced by mC, compared to C, translocating through the α-hemolysin nanopore 
is found to be varied between ours and previous studies,295-296 this inconsistency in current 
blockage amplitude indicates that the size of a methylated DNA strand is sequence-
dependent. It is well-known that cytosine methylation can alter the local DNA structure.297-
299 Cytosine methylation has influence on DNA curvature and can induce local distortion 
in the structure of DNA.297-298 Moreover, the presence of methyl groups can exert an effect 
on A-tracts position up to three base pairs away from the site of methylation.299 
Furthermore, the presence of hydrophobic methyl group can subtly widen the major 
groove, and in turn, narrow the minor grove, leading to steric hindrance.300 
Moreover, presence of a cytosine methylation can increase the angle of DNA roll 
by 6º or decrease its propeller twist by 5˚, depending on the local sequence.301 Thus, we 
suggest that in order to achieve successful label-free detection and profiling methylated 
cytosine using α-hemolysin nanopore, the interaction between epigenetic modification and 
neighboring nucleotides should be carefully considered. Recently, the Rohs group 
developed a high-throughput method, named methyl-DNAshape,301 which could be used 
to predict the effect of cytosine methylation on DNA. This should be a promising tool to 
couple with nanopore assay for cytosine methylation detection. 
6.5 Conclusions 
In this study, we have investigated the effect of salt gradients and the nature of 
monovalent cations (Li+ and K+) on ssDNA translocation dwell time through the 𝛼-HL 
nanopore. Firstly, the attraction of cations to DNA is shown to be an important factor in 
affecting translocation speeds. Cations reduce the overall charge of DNA molecules and 




properties of DNA.292 The counter-ions binding to DNA effectively lower the overall 
charge on DNA, lessening the electrophoretic drive of the system, and lowering 
translocation speeds. Ion binding to DNA is independent of the ion type, however, bond 
strengths are not equal; Li+ bonds last longer on average in comparison to Na+, which last 
longer than K+ bonds. The difference in bond strengths lead to different net forces acting 
on the DNA, and thus velocity differs depending on the type of electrolyte solution.302 
Notably, the stronger electroosmotic flow in the presence of LiCl than KCl can further aid 
in the prolonged translocation time of ssDNA through the α-hemolysin nanopore.  
Secondly, previous experiments show that DNA is saturated with counter-ions, 
thus, increasing the salt gradient will decrease the charge on the DNA.269 Additionally, the 
continuum flow theory based on the Navier-Stokes equations assumes the state variables 
(such as density) do not significantly change over intermolecular distances. However, 
observations showed fluctuations in fluid density close to the surface in molecular 
dynamics simulations and experiments, hence, shear viscosity near the nanopore wall 
dramatically increases, leading to slower translocation times.284 Salt gradients can create a 
large electric field that will funnel ions and polymers towards the pore,309 increasing the 
capture rate and mean translocation time of DNA.288 For concentrations lower on the cis 
than the trans side of the pore, the created electric field is larger than if the concentrations 
were reversed.287 The stronger the electric field, the better the pore is able to pull cations 
through.292 
Through a series of comparative studies between C-DNA and mC-DNA, we found 
that in a pure sample (containing only either 18b0mC or 18b2mC) with any of the salt 




(2) a smaller current blockage amplitude than C-DNA does. In the presence of cytosine 
methylation, the local structure of DNA strands is altered in a sequence-specific manner, 
thus, increasing or decreasing the current blockage amplitude of methylated DNA 
comparing to an unmethylated strand. Interestingly, in mixtures containing both cytosine 
and methylated cytosine, mC-DNA exhibits a lower pore selectivity than C-DNA does. 
Using the LiCl salt concentration asymmetry, we were able to detect and distinguish mC-







Enhancing Cytosine Methylation Detection with MBD2 Protein 
 
7.1 Abstract 
In this chapter, we explored the feasibility of enhancing the nanopore signal for 
methylated cytosine using engineered methyl-binding domain 2 (MBD2). Dissociation and 
translocation of double-stranded DNA through a biological nanopore causes a current 
blockage event with distinct levels. Our results showed that cytosine methylation increases 
DNA duplex stability, thus, significantly increasing the event translocation time. 
Moreover, our results showed that the presence of MBD2 protein significantly increased 
the event amplitude and strand dissociation time. Finally, we explored the feasibility of 
distinguishing unmethylated from methylated DNA using supervised machine learning 
models. Addition of MBD2 protein significantly increased the models’ performance, 
yielding the optimal classification model with 88% sensitivity and 86% specificity. 
7.2 Introduction 
In Chapter 6, we investigated the possibility of label-free detection of DNA 
methylation using the 𝛼-hemolysin nanopore. With the aid of an ionic gradient between 
the cis and the trans chambers, we were able to distinguish between ssDNA containing 
methylated and unmethylated cytosine in mixtures with various composition. In theory, the 
current blockade amplitude directly corresponds to the size of the molecule translocating 
through the pore. However, label-free detection of 5-methyl-cytosine (5mC) using the 𝛼-
hemolysin nanopore remains challenging because current blockade amplitude of 5mC is 
dependent on its interaction with the neighboring nucleotides, which can induce possible 




Methyl-CpG-binding proteins (MBPs) are proteins that are able to identify 
methylated cytosine paired with guanine dinucleotides (CpGs), to recruit co-repressor 
molecules and modify the surrounding chromatin to block transcription.303 MBPs play an 
important role in mediating the silencing of gene expression, and are of particular interest 
because they serve as great identifiers for DNA methylation.  
In this chapter, we explore the feasibility of using MBP, specifically methyl-
binding domain 2 (MBD2 protein) as a tag for detection of methylated DNA. Specifically, 
we designed synthetic dsDNA fragments containing the GREM_1 promoter region 
sequence, with single-stranded overhangs. MBD2 and methylated DNA conjugate to form 
MBD2-DNA complexes, which can amplify the signals of current-blockages caused by 
methylated cytosine on the dsDNA.304-306 Additionally, the single-stranded overhangs can 
translocate through the constriction part of the pore and reside in the long 𝛽-barrel stem, 
allowing DNA duplex to unzip with a voltage pulling force.  Using ionic spectroscopy, we 
showed that binding of MBD2 significantly enhanced the current amplitude difference in 
methylated and unmethylated DNA fragments. We also evaluated the effect of adding 
MBD2 protein on the overall performance of five supervised machine learning algorithms, 
to classify unmethylated from methylated DNA. 
7.3 Methods 
7.3.1 DNA samples. Synthetic double-stranded DNA with single-stranded 
overhangs were designed and purchased from Integrated DNA Technology (IDT – 
Coralville, IA). DNA oligonucleotides utilized in this study had the following sequences 
(underlined = single-stranded region, bolded  = GREM_1 promoter region, M  = 




u100 DNA (unmethylated DNA):  
Forward strand: 5’ – CTT CTG ACT GGG GAG AGG CGC GGC CCC GGG 
CCG CGC TCT GCC GCCGC ATT TAA ACG GGA GAC GGC GCG ATG CCT 
GGC ACT CGG TGC GCC TAT CTA TGT G– 3’ 
Reverse strand: 5’- GCG CAC CGA GTG CCA GGC ATC GCG CCG TCT 
CCC GTT TAA ATG CC GCG GCA GAG CGC GGC CCG GGG CCG CGC CTC 
TCC -3’ 
m100 DNA (Methylated DNA):  
Forward strand: 5’ – CTT CTG ACT GGG GAG AGG CGC GGC CCC GGG 
CCG CGC TCT GCC GCMGC ATT TAA ACG GGA GAC GGC GCG ATG CCT 
GGC ACT CGG TGC GCC TAT CTA TGT G– 3’ 
Reverse strand: 5’- GCG CAC CGA GTG CCA GGC ATC GCG CCG TCT 
CCC GTT TAA ATG CM GCG GCA GAG CGC GGC CCG GGG CCG CGC CTC 
TCC -3’ 
m100•MBD2: methylated DNA (m100) sequence conjugated with MBD2 protein.  
Forward strand: 5’ – CTT CTG ACT GGG GAG AGG CGC GGC CCC GGG 
CCG CGC TCT GCC GCMGC ATT TAA ACG GGA GAC GGC GCG ATG CCT 
GGC ACT CGG TGC GCC TAT CTA TGT G– 3’ 
Reverse strand: 5’- GCG CAC CGA GTG CCA GGC ATC GCG CCG TCT 
CCC GTT TAA ATG CM GCG GCA GAG CGC GGC CCG GGG CCG CGC CTC 
TCC -3’ 
Upon delivery, all DNAs were suspended in a standard DNA storage buffer 




into small volumes and stored at -80˚C until usage, in order to prevent multiple thaw-freeze 
cycles that can degrade and affect DNA quality. For both nanopore and circular dichroism 
(CD) experiments, a final DNA concentration of 100 nM was used. 
7.3.2 Methyl-binding domain 2 (MBD2) protein. Recombinant binding-domain 
of MBD2 protein was kindly provided by LumiMac Inc. (South Korea). The purified 
MBD2 protein monomer (MW = 10.7kDa) was stored at 1.3mg/ml of buffer containing 
25mM Tris (pH7.5), 500mM NaCl, 0.1% Tween 20, 0.1mM EDTA, 0.5 mM DTT and 50% 
glycerol. The MBD2 protein samples were shipped in dry ice and immediately stored at -
20˚C upon arrival. Prior to experimentation, MDB2 protein was reactivated in a solution 
containing 10mM Tris (pH7.2), 1mM MgCl2, 1mM DTT, 5% glycerol for 15 minutes at 
room temperature. This step was critical for assuring optimal MBD2 binding activity. 
Then, the reactivated MBD2 protein was incubated with methylated DNA at a 2:1 
concentration ratio for 15 minutes at room temperature, before being added to the 
experimental buffer.  
7.3.3 Single-channel recording. Single-channel recordings were performed using 
Axopatch 200B (Molecular Device Inc.), filtered with a built-in 4-pole low-pass Bessel 
Filter at 5kHz. Data were acquired at 180mV with Clampex 10.7 (Molecular Device Inc.) 
and Axon Digidata 1550B A/D converter (Molecular Device Inc.), at a sampling rate of 20 
kHz. We used Clampfit 10.7 (Molecular Device Inc.), Excel (Microsoft) and R software 
for data analysis and processing. 
7.3.4 Data analysis and visualization. Events with translocation time < 2ms or 
%I/Io < 50% were considered as either translocation of single-stranded DNA or  brief 




analysis.237 We used ggplot2 package (R) to generate boxplots for the overall event dwell 
time and histogram of current blockage amplitude. 
7.4 Results and Discussion 
In this study, we employed three DNA samples with identical sequences but 
differences in methylation status: (1) unmethylated DNA (u100), (2) methylated DNA 
(m100), and (3) MBD2 bound methylated DNA (m100•MBD2). All DNA samples contain 
a double-stranded section (78 bps) and two overhang single-stranded ends (11 bps each). 
The specific length of the overhangs was designed to ensure that a sufficient number of 
nucleotides resided within the pore 𝛽-barrel at all times, to initiate the unzipping of DNA 
duplex upon electrical pulling force.307-311 
7.4.1 Mechanism of DNA unzipping through the nanopore. As shown in Figure 
32A, when dsDNA unzips in a nanopore it undergoes two distinct steps. The first step is 
when the ssDNA tail is caught in the nanopore and begins to translocate,319 while the 
ssDNA tail is simultaneously pulled through the bulk solution to the nanopore because of 
the DNA’s negative charge.307 As the ssDNA tail gets caught in the nanocavity, the 
dsDNA region cannot translocate through the nanopore constriction section without 
melting into single-stranded DNAs (e.g. strand dissociation).60  After the dsDNA region 
is unzipped, the two strands are physically separated (Step 2).60 
Translocation of MBD2-dsDNA complex through the nanopore is similar to that of 
unbound dsDNA, with an extra step of protein dissociation (Figure 32B). As the distance 
between base pairs of DNA is approximately 0.34nm, the total length of the DNA 







Figure 32. Mechanism of DNA translocation through the nanopore. (A) Translocation of 
and unbinding dsDNA occurs in two steps: (1) single-stranded tail gets captured by the 
pore and (2) complimentary strand dissociates under constantly pulling force of the 
electrophoretic field.  (B) Mechanism of m100•MBD2 DNA translocation through the 
nanopore is similar to that of u100 and m100; however, MBD2 must detach prior to duplex 
full dissociation. (C) Typical step-wise function of a translocation event, reflecting the two 
stages: (1) DNA capture and (2) strand dissociation. (D) Box-plot of the event amplitude 




Since the methylated CpG is located at the 44th base from the 5’ end, the double-
stranded DNA dissociation (Step 1) must happen prior to MBD2 protein dissociation (Step 
1). Specifically, as the MBD2-methDNA complex threads through the 𝛼-hemolysin 
nanopore, the MBD2 protein gets stuck at the pore entrance for a short period, then 
transiently dissociates from the DNA strand, causing a prolonged current blockage event.  
This initial ssDNA blockage results in a Level 1 current blockage (i.e. event capture), 
which characterizes the beginning of an event.  When the first strand that has the initial 
ssDNA strand is translocated, the second strand coils in the vestibule of the nanopore.307 




blockage.6 The current drops again as the second strand begins to translocate.314 If the 
second strand exits the nanopore, then the signal will continue to return to the baseline after 
the initial spike (Figure 32C).307  
Overall, the mechanism of dsDNA strand dissociation is governed by the DNA 
sequence (i.e. length, GC content) and by the environment that the DNA experiences (i.e. 
voltage, ionic strength, temperature).309 Since the dsDNA region cannot enter the neck, 
interactions between the dsDNA and the nanopore contribute to the unzipping.307  The 
length of the dsDNA region also affects the ease at which a strand will unzip.312 Longer 
dsDNA region associates with a more stable the DNA complex.312 This increase in stability 
changes the energy interactions of the energy field and the pore.312 The force of the energy 
field causes the dsDNA region to experience an upward shear force.313 As the dsDNA 
region unzips, the complex also experiences a traction force as the strands are pulled 
apart.313 
7.4.2 Binding of MBD2 does not change event amplitude. We examined the 
overall average current-blockage event amplitude (%I/Io) of u100, m100, and 
m100•MBD2 DNAs (as shown in Figure 33). As mentioned previously, the samples 
employed in this study had an identical sequence, but differ in 5’-mC content. Gaussian-
fitting of their current blockage information exhibited a prominent peak of %I/Io ~ 86.5 ± 
1% (Figure 33),  which were slightly shallower than that of single-stranded DNA 
translocation through the nanopore (as concluded in Chapter 6).238 
Comparing between three samples, the mean current-blockage event amplitude 
(%I/Io) increased in the order of u100 < m100 < m100•MBD2 (Table 14). Specifically, the 




m100•MBD2 DNAs, respectively. Moreover, we performed an unpaired t-test and %I/Io 
of all samples was statistically significant from each other at 99% confident interval 
(adjusted p << 0.01), as shown in Figure 33. The slight difference in %I/Io of u100 and 
m100 DNAs observed herein was resulted from interaction of methylated cytosine with 
adjacent bases, as previously discussed (see Chapter 6; Conclusions).238 Addition of MBD2 
protein resulted in a 0.9% increase in the event average %I/Io (from 86.5% in m100 DNA 
to 86.5% in m100•MBD2 DNA). This change was visible during the strand dissociation 
step but not during event capture (Figure 32D). In other words, after the  m100•MBD2 
complex was captured and started unzipping, the MBD2 protein got pulled toward the pore 






Figure 33. Changes in current blockage amplitude. Distribution of the overall current 
blockage amplitude (%I/Io) of three DNA samples, including: u100 (pink), m100 (green) 
and m100•MBD2 (blue). All samples exhibited a normal distribution curve, with a 
prominent peak at approximately 85 – 87%. Student’s [STUDENTS’?] test showed 


















While each current blockage event was a step-wise function, the duration of each 
amplitude level was greatly different. In the majority of the dsDNA that successfully 
melted and translocated through the pore, strand dissociation was the rate-determining step; 
thus, consequently dominates the final value of the average event amplitude. We suspect 
that the slight decrease in value of event current blockage of dsDNA observed herein, in 
comparison to that of ssDNA, most likely  was due to technical limitations. Specifically, 
translocation of dsDNA through the nanopore occurs in two steps of capture and 
dissociation, leading to a step-wise function in current blockage event amplitude. As shown 
in Figure 32D, capture of ssDNA overhang caused a shallow blockage amplitude of 73 ± 
0.5%, while the strand dissociation step was characterized by a prominent long block at 
87.5 ± 1% (similar to ssDNA translocation). When detected by Clampfit software, the 
current blockage amplitude was automatically calculated as an average of the whole event 
amplitude, thus leading to a slight decrease in %I/Io of dsDNA translocation. 
7.4.3 Increased strand-dissociation time in methylated DNA and MBD2-bound 
DNA. Event translocation time reflects the structural stability and interaction with the pore. 
In Figure 34, we plotted the distribution of event dwell time for u100, m100 and 
m100•MBD2 DNAs in the same experimental condition. Under  a +180mV applied voltage 
and an ionic concentration of 1M – 1M NaCl (in the cis and trans chambers), the average 
Condition Mean (%) Max (%) Min (%) Median (%) Std. 
u100 84.06 92.37 75.29 84.33 3.25 
m100 84.71 94.95 75.17 85.60 3.55 





translocation time, ∆t, increased in the order of u100 < m100 < m100•MBD2 DNA (∆t = 
1.2, 1.7, and 2s, respectively (Table 15)). In other words, ∆t of m100 and m100•MBD2 
DNA increased approximately 1.4 and 1.6 times for m100 and m100•MBD2, respectively, 






Figure 34. Changes in translocation time. (A) Boxplot of event dwell time distribution for 
unmethylated DNA, methylated DNA and MBD2-methylated DNA complex. Students’ 
test determined a statistically significant change in dwell time of m100•MBD2, in 
comparison to u100 DNA> (B) Bubble plot of event dwell time, associated with two stages 
in dsDNA translocation through the nanopore: (1) capture of single-stranded overhangs 
and (2) dissociation of complimentary base-pairs in double-stranded section. The majority 
of change in dwell time exhibited in the strand dissociation time, reflecting an increase in 





Summary of current blockage event dwell time (ms) 
 
 
Condition Mean Max Min Median Std. 
u100 1262.17 23077.65 1.25 153.55 3041.21 
m100 1719.08 34113.85 1.05 267.45 3678.56 





Notably, ∆t of identical DNA sequences from the same group of samples was 
greatly varied (from ms to tens of seconds), due to the random thermal activation required 
for separation.256 The melting process of dsDNA occurs in two steps: the first is the initial 
separation to overcome the energy barrier, and the second is the unzipping of the rest of 
the strand.316 The energy barrier refers to the amount of energy required to break the 
hydrogen bonds of the dsDNA region.309 The energy that breaks the hydrogen bonds is 
fueled by the energy field within the nanopore.321 The electrons in the energy field within 
the nanopore causes the dsDNA to denature and begin to unwind.314 Sometimes, trouble 
arises during the transition from the initial metastable state to a final stable (lower-free-
energy) state. When this happens, the dsDNA can get stuck inside the nanocavity, causing 
current blockage events lasting minutes or indefinitely.315 
On the other hand, the overall increase in ∆t among different samples, as observed 
from Figure 34A, was a consequential result of increased DNA duplex stability. As 
mentioned previously, each translocation event of dsDNA consists of two steps: event 
capture and strand dissociation. Through manual analysis of the data, we found the time of 
strand capture was similar among the three samples (~250 ±70ms), while strand 
dissociation times significantly increase in m100 and m100•MBD2 DNA (as shown in 
Figure 34B). As the methylated cytosine is at the 44th base of the DNA sequence, distance 
between MBD2 protein and the 5’- or 3’- end of the DNA was sufficiently long (~ 15nm) 
to prevent the binding of MBD2 from affecting the capture of ssDNA overhangs.  
 This explains the reason why capture time remained similar between three samples, 
while increases in ∆t of the strand dissociation step indicated enhanced stability of dsDNA 




m100 and m100•MBD2 were 0.87, 1.36 and 1.75s, respectively. In other words, compared 
to u100 DNA, there were 1.6 and 2 times increase in strand dissociation time in m100 and 
m100•MBD2, respectively. Using an unpaired t-test, we determined that there was 
statistically significant change in ∆t of m100•MBD2 in comparison with u100 DNA 
(adjusted p value = 0.018). The main contributing factor to enhanced duplex stability was 
the presence of methylated cytosine on the 44th base. Previous studies showed that DNA 
templates with different content of cytosine methylation have different melting 
temperatures.18 DNA methylation increases the DNA duplex stability, reflecting through 
both its thermal and mechanical properties. In the context of nanopore experiments, 
dsDNA translocating through the pore went through a force-induced strand separation, 
which is greatly affected by the strand mechanical stability. 
In m100•MBD2 sample, both the presence of methylated cytosine and MBD2 
contributed to the prolonged strand dissociation time. As mentioned earlier, in order for 
the m100•MBD2 complex to translocate through the pore, MBD2 protein must first 
dissociate from dsDNA. A previous study reported MBD2 to have a dissociation constant 
(KD) of 2.1 𝝻M.316 The structure of MBD2 consists of a long finger-like projection that is 
composed of three strands of 𝛃 sheets.316 When binding to DNA, MBD2 interacts with 
approximately 10-11 nucleotide base pairs.316-317 Its finger-like projection extends into 
major grooves of the DNA where it contacts the CpG sequence. In particular, the region 
contacting the DNA is well structured and thus creates a stable connection.316 This stable 
bond is created by interactions between specific amino acids that make up the MBD and 
bases of the CpG sequence. Specifically, Arginine (R), Tyrosine (Y), and Aspartic Acid 




orientation.316-318 The Arginine forms hydrogen bonds with symmetrically opposed 
Guanine bases. This allows its side chains to pack against neighboring methylated cytosine 
groups. This dense packing causes the Arginine side chains to form van der Waals contacts 
with the DNA, which further stabilizes the bond.316-317 Finally, the Tyrosine and Aspartic 
Acid also form hydrogen bonds with the surrounding complex, which further strengthens 
the connection and locks MBD2 into place.316-317 As dsDNA is pulled through the 
nanopore, MBD2 protein is anchored at the pore entrance until there is sufficient energy to 
break its connection to the DNA; thus, prolonging the event dwell time.   
7.4.4 MBD2 enhance methylation detection accuracy. Having determined the 
changes in amplitude and stability of the three samples (u100, m100, and m100•MBD2), 
we tested the efficiency of using machine learning algorithms to distinguish methylated 
from unmethylated DNAs. Specifically, we performed comparative analysis using the 
same set of five different algorithms in duplicate on: (1) u100 and m100 DNA and (2) u100 
and m100•MBD2 DNA. The final goal was to determine whether employing MBD2 
protein enhanced the nanopore’s ability to detect methylated cytosine on dsDNA.  
The five algorithms we used included: K-Nearest Neighbor (KNN), Logistic 
Regression (LR), Linear Discrimination Analysis (LDA), Quadratic Discrimination 
Analysis (QDA), and Random Forest (RF). In each DNA sample group, we randomly 
selected 500 current-blockage events, then used 80% of the dataset for model training and 
the remaining 20% for validation purposes. Two features of the current-blockage event, ∆t 
and %I/Io, were used as input for the models.  
To evaluate the overall performance of the models on classifying u100 from m100 




shown in Figure 35A – B, respectively. In this plot, the box and whiskers show the median 
of ARUOC as a dot, and the interquartile range of each distribution as a box around the 
median. The x-axis represents the area under the Receiver Operating Characteristics curve 
(AUROC). The closer the AUROC value is to 1, the better the model at is correct 
classification. Generally, a better model would have higher median AUROC and smaller 
range between minimum and maximum AUROC. For a binary system, the threshold is 





Figure 35. Machine learning classification of methylated and unmethylated DNA.  Five 
machine learning models were employed to classify u100 from m100 or m100•MBD2. The 
models include: K-nearest neighbor (KNN), Random forest (RF), Logistic regression (LG), 
Linear discrimination analysis (LDA), and Quadratic discrimination analysis (QDA). Box-
and-whisker plots represent distribution of area under the receiver operating characteristic 
curve (AUROC). Model’s performance was ranked based on increasing median AUROC 




Classification models for u100 and m100 DNA yielded relatively poor results, with 
the majority of the models having a median ARUOC ≤ 0.65. The QDA classifier had the 
best performance with a median AUROC of 0.76. The classifier’s optimal sensitivity and 




classifying models on u100 and m100•MBD2 dataset, all classifiers returned a median 
AUROC value ≥ 0.75 (comparing to 0.65 for the u100 – m100 dataset).  
KNN model had the highest median AUROC of 0.83, with the optimal sensitivity 
and specificity of 88% and 86%, respectively.  It is worth noting that according to the 
decision tree (Figure 36 and Figure 37), the current-blockage event amplitude outweighed 
dwell time and played the most important role in classification of u100 from m100 and 
m100•MBD2 DNA.  
Altogether, our study showed that the addition of MBD2 protein significantly 
improved the probability of correctly distinguishing unmethylated DNA from methylated 
DNA. A limitation in our prediction model comes from having nonhomogeneous control 
samples, specifically m100•MBD2 population. When working with dynamic experimental 
conditions, such as those investigated here, the process of MBD2 protein 
binding/unbinding to dsDNA happens constantly; thus, there is always a mixture of both 
bound and unbound dsDNA in the m100•MBD2 sample. This creates bias in the training 















In this work, we showed that the α-hemolysin nanopore can be used as a biosensor 
for detecting the methylation status of dsDNA. Since a level amount of methylation directly 
affects the DNA’s stability and its corresponding translocation time, it is possible to build 
a panel of dsDNA translocation times in correlation with the sequence length, GC content, 
and methylation level. Previous studies have shown that methylation of a certain level (i.e. 
40% CpG is methylated in CDKN2B gene) can result in complete gene silencing, regardless 
of the CpG methylation pattern.22 While it will remain challenging to understand the exact 
number of methylation sites on a random DNA fragment, it is feasible to determine whether 
the sequence is hypermethylated or under methylated (compared to a threshold methylation 







Gone Fragments: Capturing Circulating-Tumor DNA 
 
8.1 Abstract 
Compared to traditional tissue biopsy methods, the use of plasma or urine samples 
(the so-called “liquid biopsy”) is less invasive, improves the patient’s quality of life, while 
offering a more reliable and frequent detection of cancer signal over time with longitudinal 
sampling. Unfortunately, current methods to analyze liquid biopsy samples are time-
consuming, expensive and biased towards a specific fraction of the genome or mutations. 
In this chapter, we describe two novel sample-preparation strategies that enable sequencing 
of long cfDNA fragments, which are often missed by the current Next-generation 
sequencing (NGS) platforms (i.e. Short-read Illumina sequencers). These techniques, 
which employed rolling-circle amplification (RCA) or blunt-end ligation, transform 
cfDNA fragments into long strands that are easily captured by the nanopore sequencer. The 
proposed techniques can reduce the time required to process and analyze liquid biopsy 
samples (from weeks currently to less than 2 days). This study was carried out under the 
supervision of Dr. Florent Mouliere (Amsterdam UMC) and in collaboration with the group 
from Dr. Jeroen de Ridder (Utrecht UMC). 
8.2 Introduction 
Liquid biopsy is the study of tumor material collected in a minimally invasive 
manner through sampling of blood, urine and other bodily fluids.319  Presence of cell-free 
DNA (cfDNA) in human blood was first described by Mandel and Metais in 1948. 
Abnormally high concentration of cfDNA in cancer patients was first observed in 1977.320 




originated from tumor cells, giving rise to the term ‘circulating tumor DNA’ (ctDNA).321-
322  
 Among the potential signals of cancer in the bloodstream,323-325 ctDNA has 
strongly emerged as a major tool and biomarker for precision medicine in the past 
decade.326-328 ctDNA is tumor-derived, fragmented DNA found in bodily fluids. Though 
the existence of ctDNA is now widely accepted, the mechanisms by which ctDNA enter 
the bloodstream are still unclear.329 There are  two main proposed mechanisms for cfDNA 
release: (1) apoptosis/necrosis, or (2) active secretion.330-332 CfDNA, which was first found 
in the circulation, has been detected in various bodily fluids, including urine, saliva, pleural 
fluid, and cerebrospinal fluid.333-338 Epigenetic and methylation analysis revealed that in 
healthy individuals and cancer patients, the majority of cfDNA originates from 
hematopoietic cells.339-340 These cells have a modal size of approximately 166bps, which 
corresponds to the length of DNA wrapped around a nucleosome (~147bp) plus linker 
DNA.319 Demonstration by PCR and sequencing revealed that ctDNA molecules are 
normally shorter than non-mutant cfDNA, with an average size of 134bp – 144bp.341 
However, the cause of shortening in ctDNA fragment is unclear.319 
As ctDNA exhibits both the genetic and epigenetic alterations from their cancer 
cell origin,339, 342-343 and can reflect tumor type and stage, it has therefore been hypothesized 
as a prognostic and predictive marker in cancer treatment selection326, 344 and detection.345 
Specifically, various types of genomic and epigenomic DNA alterations have been 
observed in cfDNA, including for example mutation, DNA hypermethylation, copy 
number variation, microsatellites instability, rearrangements and losses of 




treat. However, the potential use of ctDNA for detecting early-stage cancer still presents 
great challenges. For example, ctDNA amount in total cfDNA is usually very low; thus, 
demanding techniques with sensitivity for detecting low tumor fraction and high technical 
and biological background signal. In healthy individuals, cfDNA concentration tends to 
range between 1 and 10 ng per ml in plasma (Figure 38).347-348 In cancer patients, the 
concentration of cfDNA in plasma or serum can increase over 10-fold (compared to healthy 
individuals), with an average of 180 ng per ml.349 The exact amount of ctDNA released 
into the blood stream varies depending on the stage and type of cancer.350-351 While the 
concentration of ctDNA content can be much higher in late-stage cancer patients,350, 352-353 
they usually make up less than 10% of total cfDNA.354-356 Thus, it is still challenging to 
detect and diagnose tumor-related cancers with a good specificity and sensitivity, reducing 





Figure 38. Changes in cfDNA concentration in plasma collected from three non-small cell 
lung cancer patients. Samples were collected multiple times for up to three months 
(longitudinal sampling).  (A) Concentration of cfDNA ranges between 0 – 10ng/µL 
(Qubit). (B) Changes in cfDNA overtime and treatment, as normalized by the starting 
cfDNA concentration at the first collection time (t = 0). A high cfDNA concentration could 
be an indication for high ctDNA in the sample, though more tests are usually followed to 




Currently, monitoring disease burden is performed using imaging or molecular 
methods, which are associated with radiation exposure or logistical burden.319, 357 
Conventional methods for sampling solid tumor, such as needle biopsies, are subjected to 
high procedure complication rate (1 out of 6 cases in some cancer types),358 and sampling 
biases that arise from tumor genetic heterogeneity.359-361  Compared to the traditional 
surgical biopsy, liquid biopsy is less invasive, improving the patient’s quality of life, while 
offering a more reliable detection of tumors and mutations over time with longitudinal 
sampling. Since the half-life of cfDNA is between 16 minutes to 2.5 hours in circulation,362-
364 analysis of ctDNA can be considered as ‘real-time’ dynamic snapshot of disease 
burden.319 
Currently, the majority of liquid biopsy samples are analyzed with PCR methods 
or Next Generation Sequencing systems (e.g. Illumina, Roche, or Ion Torrent), whose 
optimal DNA  read length range between 75-500bp (i.e. short-read sequencing). As these 
systems sequence through enzymatic reaction, their efficiency significantly reduces when 
the DNA fragment is longer than 500bp.365  While Next-generation sequencing can be 
highly accurate, this platform may not practical in clinic, due to extensive processing time 
and the restriction imposed by the gene panel used. Another common method for cfDNA 
analysis is digital droplet PCR, which has been proven to be a fast and efficient tool for 
studying a single locus (a fixed position on a chromosome). However, when the targeted 
gene does not have a hotspot (i.e. TP53), it is challenging to design and employ the correct 
set of probes, even more if the location of point mutation is unknown.  
However, there is a population of cfDNA fragments that is currently missing from 




percentage agarose gel showed a variation in size of cfDNA, ranging between 0.18 – 21 
kbs.349, 366 Recently, long cfDNA fragments (>1000bp) have also been identified in healthy 
individuals using long-read sequencing techniques.367 These fragments might be released 
to the circulation in association with exosomes,368-369 or by tumor cells via necrosis.370 A 
portion of long cfDNA fragment could come from fusion genes or oncogene-carrying 
extrachromosomal DNA (ecDNA, 1-3Mbs long),371 which is a potent mechanism leading 
up very high copy number of oncogenes.372 Unfortunately, these long cfDNA fragments 
are usually poorly recovered due to bias in DNA extraction methods,373-374 sequencing 
library preparation,375 and limitation in the enzymatic reaction of the current short-read 
Illumina sequencing platforms.319   
Nanopore sequencing offers a shorter processing time, lower capital cost, and high 
flexibility. At the moment, MinION (Oxford Nanopore) is the most well-known nanopore 
sequencer that is commercially available and has been successfully employed in multiple 
fields, including oncology research, agriculture, and outbreak surveillance (i.e.CoVid19, 
Ebola, Zika virus outbreaks). Unlike other sequencing platforms, nanopore uses electrical 
signal disruption (as explained in previous chapters), instead of synthesis. Thus, it does not 
suffer from enzymatic reaction exhaustion when sequencing DNA fragments > 500bp (e.g. 
long-read sequencing). While nanopore can effectively capture long DNA fragments, it 
still suffers from (1) low base-calling accuracy fragments shorter than 1kbp,304and  (2) high 
amount of DNA input required.  
Compared to short-read sequencing platform like Illumina chemistry, read-length 
of nanopore is the same as the length of the native DNA fragment in cell nucleus. This 




range, fragmentation, and also gene fusion. While the Oxford Nanopore is attractive with 
its ability to directly sequence DNA without PCR amplification, this is not yet an option 
when working with cfDNA. Specifically, most of nanopore library preparation kit requires 
at least 500ng - 1 µg gDNA input (or 100fmol of shorter DNA), which is approximately 
100 times higher than the normal input for other NGS library preparation. As the average 
concentration of cfDNA is 1 – 10ng/ ml in plasma, whole genome amplification is a 





Figure 39. Presence of long cfDNA fragments. Bioanalyzer results of cfDNA extracted 
from (A-D) cancer cell cultures media, (E) urine sample, and (F) plasma sample of cancer 
patients. Preliminary results showed that the size distribution and concentration of cfDNA 
greatly varied among samples and sample types. Besides the characteristic peaks of cfDNA 
(~166bp), multiple samples exhibited a presence of long cfDNA fragments (1-3kbs), which 




Thus, it is essential to develop a new protocol for nanopore sequencing that could 
effectively capture both short and long fragments of cfDNA. As long cfDNA fragments 
(e.g. fusions, extrachromosomal DNA) are currently missed by standard Illumina 
sequencing, the nanopore could have here a conceptual advantage for analyzing them.  
To tackle this issue, we developed two new protocols to perform the preprocessing 
cfDNA for nanopore sequencing, using: (1) rolling-circle amplification to create long 
fragments with tandem repeats, and (2) blunt-end ligation to create DNA concatemers. 
Specifically, we will discuss technology development and evaluate preliminary results of 
using these two techniques on plasma samples from non-small cell lung cancer patients.  
8.3 Materials and Methods 
8.3.1 Cell culture and sampling. 143B Human metastatic osteosarcoma cells were 
cultured in IMDM +/+ (+10% FBS + 1% penicillin/streptomycin). Cells were plated at 
30% confluency and allowed to attached for 4hr. Once attached, media was changed to 
4mL serum free media. Cells were serum starved for 24hr to synchronize. First collection 
was done (0h) at the end of serum starvation, and processed. After that, media was changed 
to 4mL regular growth media and media was collected in duplicate at 4h, 24h, 48h and 72h 
from the same flask. At 72h, all cells were dead due to lack of space and nutrient and we 
excluded this timepoint from the study. 
8.3.2 Cell sample processing. Upon media collection, duplicated sample was 
divided into two groups (A and B), then immediately processed to remove supernatant. 
Specifically, samples in group A were centrifugated at 500 g for 5 minutes (removal of 




were processed similar to group A, but had a third centrifugation step at 10,000g for 10 
minutes (removal of micro-vesicles). All samples were then stored at -20˚C.  
8.3.3 Extraction of cfDNA from cell culture. Samples were thawed at room 
temperature for 1 hour, then quickly vortexed and spinned down. For each sample, cfDNA 
was extracted from 500 µL cell media using QIAamp Blood MiniKit (following 
manufacturer’s instruction). Sample was eluted in 200 µL nuclease-free water, and 
concentrated to 50µL using SpeedVac at 37˚C. Finally, all samples stored at -20˚C until 
quantification. 
8.3.4 Extraction of cfDNA from plasma. Blood samples of non-small cell lung 
cancer patients were collected aseptically and processed using the standard operating 
procedure validated by the Liquid Biopsy Center, Cancer Center Amsterdam (the 
Netherlands). For each sample, cfDNA was extracted from 3 mL plasma using 
QIASymphony automatic extraction system and magnetic beads chemistry, followed by 
elution in 90 µL nuclease-free water and stored at -20˚C. Concentration of cfDNA 
extracted checked with Qubit according to the manufacturer’s instructions.  
8.3.5 Agilent Bioanalyzer 2100. Size distribution analysis of cfDNA were 
performed by capillary electrophoresis using Agilent 2100 Bioanalyzer (Santa Clara, CA), 
in combination with a High-sensitivity DNA Chip (Agilent Technologies). Agilent 2100 
Bioanalyzer is a microfluidic-based platform for sizing and quantification of DNA and 
RNA, using fluorescent dye molecules. The assay was performed according to 
manufacturer’s specific instruction for High-sensitivity DNA chip. After separated 




which are then represented graphically as a virtual band. Size and concentration of each 
band are automatically calculated by 2100 Expert Software (B.02.08.SI648, Agilent).  
8.3.6 Gel electrophoresis. 2% agarose gel (w/v) was prepared by dissolving 1g 
agarose in 50mL 1X Tris-Borate-EDTA (TBE) buffer, and 2.5 uL Ethidium Bromine. Gel 
was casted and settled at room temperature for at least 30 minutes prior to experiment. 
FastRuler Low Range DNA ladder (Thermo Scientific) and O’GeneRuler 1kb Plus DNA 
ladder (Thermo Scientific) were used as references. All electrophoresis experiments were 
performed at 100mV for 15-45 minutes. 
8.4 Methods Development 
8.4.1 Detection of long cfDNA in cell culture. Release of cfDNA was 
characterized over time (Figure 40). We divided the collected cell culture media into two 
group of samples— group A and group B (see Materials and Methods for detailed 
information on the difference in sample processing). Comparing between the two groups, 
there was no significant change in peaks positions at any given time point. Specifically, at 
the end of serum starvation, there was a minimal amount of long cfDNA fragments (~1-
3kbps) observed (collection time t = 0, Figure 40A and E).  After growth medium renewal, 
the amount of cfDNA increased incrementally, notably peaked after 24h and continued to 
increase at 48h. This could be explained by the increasing number of cells in the culture 
over time. In addition, previous reports reported that more cfDNA was released also per 
cell.376-378 
At t = 24h and 48h, we observed an expected peak at 166bp and ladder pattern, 
which could indicates an apoptotic origin.379-380 The pattern was reminiscent to that 




However, besides a peak at ~160 bps, there was a much more prominent peak near ~2kbps 
that consistently appeared in all samples, except for at 4h. Previous studies on the same 
cell line (143B) showed that these long cfDNA fragments were neither from apoptotic or 






Figure 40. Short and long cfDNA fragments in cell culture overtime. Bioanalyzer results 
of cfDNA extracted from 143B osteosarcoma cells culture media, collected at 0h, 4h, 24h, 
and 72h. (A-D) samples in groups A was centrifuged at 0.5g x 5min and 2g x 5min. (E-H) 
samples in group B was centrifuged at 0.5g x 5min, 2g x 5min, and 10g x 10min. Presence 
of long cfDNA fragments (1-3kbs) from both groups indicated that they may not come 




Samples in both groups were collected at the same time, but processed slightly 
differently (Materials and Methods). Because of the difference in centrifugations, samples 
in group A contained intermediate-size extracellular vesicles (e.g. microvesicles, 100-
1000nm), while those in group B only contained smaller extracellular vesicles (e.g. 
exosomes, 30-100 nm). Thus, it was interesting that concentrations of long fragments 
(~2kbps) at 24h and 48h are higher in group B than in group A. We suspected that these 
long fragments might be DNA bound to surfaces of extracellular vesicles that were released 
with centrifugation.381 Currently, it is still challenging to access these long fragments using 
short-read sequencing platforms.  
8.4.2 Methods to capture both short and long cfDNA fragments. Herein, we 
describe two sample-preparation strategies that convert cfDNA into long fragments that 
can be sequenced on the nanopore systems. The main goal of both protocols was to produce 
> 500ng of long cfDNA fragments (>1000bps), through two main steps: (a) whole-genome 
amplification and (b) long-fragment synthesis.   
8.4.2.1 Method 1: Rolling-circle amplification. The first sample-preparation 
strategy enables capturing and sequencing of both short and long cfDNA fragments 
through circularization, followed by whole-genome amplification of cfDNA using rolling-
circle amplification technique. Rolling-circle amplification is an isothermal enzymatic 
process where short, circularized DNA or RNA is quickly amplified to form a long single-
stranded fragment with multiple tandem repeats.382 As the RCA products can be tailor-
designed through manipulation of the original circular template, this technology has been 
widely utilized for biotechnology, drug delivery, diagnosis, and many other techniques.382 




patients were first end-repaired to create blunt end fragments, then cleaned up with a 
commercial reaction cleanup kit. After that, the blunt-end fragments were a phosphorylated 
at the 5’ end. This population will be referred to as the insert (I). At the end of each step, 
the sample was cleaned up using a column-based reaction clean-up kit in order to remove 
excess enzymes and waste products. After the second clean up, we used Qubit to quantify 
the concentration of end-repaired DNA samples. The Qubit results indicated that there were 
approximately 4.5ng of end-repaired DNA product, reflecting approximatively a 90% loss 
of DNA input.  
As nanopore sequencing requires at least 500ng -1µg of input DNA (or 50-100 fmol 
of shorter DNA fragments), it was essential to perform a whole genome amplification. In 
this protocol, the circular template for amplification consisted of two components: the 
cfDNA insert (I) and the barcoded backbone sequence (BB). The BB sequence (a 250bp 
blunt-end, synthetic DNA fragment) was designed to contain a phi29 DNA polymerase 
binding domain, a restriction enzyme cutting site, DNA barcode, and a CRISPR cutting 
domain. Phi29 DNA polymerase was chosen for its  exceptional processivity and strand 
displacement ability.383   
Note that in order for ligation to happen, at least one fragment (either I or BB) needs 
to be phosphorylated. Backbone and insert cfDNA were mixed and incubated together for 
5.6 hr, allowing ligation and circularization. The BB was unphosphorylated, in order to 
minimize the amount of backbone-backbone ligation (e.g. containing no cfDNA). After 
ligation, there were four possible products: circularized BB:I, circularized BB:BB, 
circularized I:I, and linear fragments. As the circularized BB:BB population contained no 




sequencing. In order to do so, backbone DNA was designed so that when two BB:BB 
ligated, they would form a sequence recognized and cut by CRISPR. This step prevented 






Figure 41. Flow chart of sequencing using a guided system. (A) Each cfDNA fragment is 
end-repaired and attached to a backbone, then amplified with rolling circle amplification. 
This procedure takes approximately two days, yielding an end product containing long 
DNA fragments,  each of which contains tandem repeats of the backbone and one insert 
cfDNA. After that, the sample is ready for nanopore library preparation and sequencing 
(24-48hrs). (B) Gel image of DNA after RCA reaction. (C) Preliminary results of all 
sequencing reads (Patient 1) from a Flongle flow cell after 48 hours. There were 






The results from the gel electrophoresis (Figure 41B) indicated that for both 
samples (Patient 1 and 2), RCA reaction creates DNA fragments of over 20kbps 
(undigested). Upon digestion with restricted enzyme, digested samples exhibited three 
distinct bands at 250, 400, and 20kbps+. The first two bands corresponded to BB:BB and 
BB:I fragments, respectively. Long fragments that remained after restriction enzyme 
digestion could result from inefficient digestion, or simply because they did not contain a 
backbone sequence (e.g. multiple insert cfDNA ligated together).  
Next, RCA primers were annealed to the circular template. RCA reaction was 
carried out with 12h incubation (overnight) at 30˚C, then heat inactivated at 60˚C for 10 
minutes. RCA reaction yielded > 100µg final product, providing a sufficient amount of 
DNA for quality control and multiple sequencing runs. After a final clean up with 
Dynabeads, the RCA products were ready for library preparation using 1D Ligation Kit 
(Oxford Nanopore Technology) and sequencing.  
To evaluate the efficiency of the technique, we performed whole-genome 
sequencing on an Oxford Flongle using the RCA product from Patient 1. Compared to the 
MinION’s traditional flowcell, a Flongle only has 126 channels, instead of 512; thus, the 
output yield is also significantly reduced. However, as the cost per sample is low 
(approximately $200), it is suitable for smaller experiments, such as preliminary testing 
and quality check. Thus, we first sequenced the RCA product from Patient 1 sample on a 
Flongle flow cell. A 48 hr run yielded approximately 70,000 reads, each of which contained 
information from a unique fragment post-RCA. Figure 41C shows that about 10% of the 
sequenced fragments had no insert (B:B). Only one third of all the reads (blue) had the 




no backbone (I:I). The rest of the reads (gray) contained extremely short inserts (BB:I, with 
I < 50bps) and were discarded from analysis. The number of repeats indicated how many 
tandem repeats a fragment had. As RCA is an enzymatic reaction, the number of tandem 
repeats could not be precisely controlled.  
We selected reads with more than five tandem repeats (approximately 10,000 of the 
70,000 total reads) to examine the distribution of cfDNA fragment length (Figure 41D).  
As can be seen, the histogram is left-skewed, with a prominent peak near 166 bps, similar 
to read length distribution obtained from Illumina sequencing (data not shown). However, 
there is a long right tail representing cfDNA fragments of up to 500bps. Also, it is important 
to note that Figure 41D only reflects 10% of the total sequencing data. 
At the moment, we are working on our bioinformatic pipeline to include RCA 
fragments that only contained inserts (I:I). Since the backbone sequence was 250bp, the 
optimal length of insert DNA ranged between 90 – 160 bp. While the system could capture 
insert fragments outside of the optimal range (as shown in Figure 41D), its efficiency had 
not been determined. Thus, we expected the fragment size distribution of fragments 
without BB would be quite different from the one shown in Figure 41D. As preliminary 
data obtained from Flongle flow cell showed promising results of capturing long cfDNA 
fragments, we multiplexed and sequenced RCA products of both patients 1 and 2 using a 
PromethION flow cell. While the cost of running a PromethION flow cell is about 10 times 
higher than a Flongle, the actual cost per Gb of data is much lower, due to higher output 
and ability of multiplexing. 
8.4.2.2 Method 2: DNA Concatenation. The second method of sample-preparation 




genome amplification followed by ligation (Figure 42A). First, we used a commercially 
available NGS library preparation kit to perform whole-genome amplification of extracted 
cfDNA (Plasma-Seq, Takara). For this reaction, up to 10 µL of isolated cfDNA (e.g. 1-
10ng total) were used for reaction input. Briefly, isolated cfDNA was first end-repaired, 
then blunt-end ligated to NGS sequencing adaptors (i.e. library synthesis). Sequencing 
indexes were then added through high-fidelity amplification using PCR (i.e. library 
amplification). After the addition of sequencing adaptors and indexes to the two ends, 
length of cfDNA fragments increased by 150bps (length of adapters + indexes).  Finally, 
we used magnetic beads to clean up the post PCR product. This process of NGS library 
preparation took approximately 3 hours, yielding 100-400ng DNA output.  
Then, we performed phosphorylated the NGS library for 30 minutes at room 
temperature, allowing blunt-end ligation in the next step. Long DNA concatemers were 
created by adding NEB Blunt-end ligation mixture to the sample and incubated at room 
temperature for four hours, to maximize the amount and length of DNA concatemers. 
Finally, we cleaned up the reaction and eluted final product in nuclease-free water. To 
check for concatemers quantity and size distribution after the reaction, we used Qubit and 
a DNA high sensitivity chip with Bioanalyzer Agilent 2100, respectively. 
The final clean up step was necessary to remove T4 ligase enzyme and any reaction 
chemicals that could potentially interfere with sequencing. During the development of this 
protocol, we tested both column-based and gel-based purification methods.  The latter one 
was quickly ruled out due to low recovery (only up to 80%) and long processing time (over 
20 minutes). As our target was whole-genome sequencing, rather than a size-specific 




recovery. It is important to note that the DNA size selection range of the selected column 
should be carefully considered, in order to maximize recovery of long fragments while 
efficiently removing T4 ligase enzymes. In this protocol, we used NucleoSpin Gel and PCR 
Clean up kit (Takara Bio), which allowed recovery of fragments between 50 – 20,000bps 





Figure 42. Sample-preparation method: Concatenation. (A) Flow chart of sequencing using 
DNA concatenation. Sample containing extract cfDNA undergoes the standard Next-
generation sequencing library preparation, followed by end-repair and blunt-end ligation 
to create long DNA fragments. The procedure takes approximately one day. (B-E) 
Bioanalyzer traces of Patients 1 and 2 samples after step 1 (NGS library preparation) and 
step 2 (blunt-end ligation / concatenation). Disappearance of the prominent peaks, and 





Overall, this second strategy of sample-preparation takes approximately 8 hours 
and yield between 100-400ng of DNA that can be directly used for ONT 1D ligation library 
preparation and nanopore sequencing. The final amount of concatemer obtained strongly 
depends on the output of whole-genome amplification with PCR.  
We applied this protocol to prepare samples from lung cancer Patient 1 and 2 for 
nanopore sequencing. Comparing the bioanalyzer trace at each step (isolated cfDNA – after 
library amplification – after DNA concatenation), we observed a clear shift in fragment 
size distribution (Figure 42B – G).  After DNA concatenation (Figure 42D and G), the 
prominent peaks that previously showed Figure 42B-C and E-F disappeared, replaced by 
multiple smaller peaks that stretched passed the end marker (10380 bp). 
These results indicated successful ligation and formation of DNA concatemers with 
random length. Since ONT 1D ligation library preparation kit requires at least 500ng – 1µg 
DNA input per sequencing run, we plan to pool these two samples (from Patient 1 and 2) 
together in  one nanopore flow cell. As these two samples contained two different NGS 
index combinations, it is possible to sequence them as is, without a second step of 
multiplexing using ONT barcode. Currently, a new bioinformatic pipeline is under 
development to analyze the sequencing results of DNA concatemers prepared using this 
second strategy. As each DNA concatemers consist of several individual cfDNA fragments 
that are separated to each other by a duplicate pair of adaptor and index, we need this 
bioinformatic tool to: (1) divide one concatenated strand into its component fragments, (2) 
trim the adaptor and index at 3’ and 5’ end of each fragment, (3) align the fragments to a 
reference human genome, and (4) perform downstream analysis (i.e. copy number 






Comparison between sequencing methods   
 
 
* Note:  
1 About 90% of cfDNA input was lost before ligation of cfDNA and backbone, 
due to reaction cleanups and fragment blunting.   
2 Amount of DNA output after whole-genome amplification. 




8.5 Results and Discussion 
So far, we have shown evidences of long cfDNA fragments, and described in 
detailed two recently developed strategies for sample-preparation before nanopore 
sequencing. These protocols enabled capture of both short and long cfDNA fragments. In 
Table 16, we give a brief comparison between the two strategies and Illumina sequencing. 
These two protocols, while having the same end goal, had different wet lab approaches that 
brought in unique advantages and disadvantages. Specifically:   
8.5.1 Method 1: Rolling-circle amplification. Summary:  
(1) High accuracy: End product consisted of long fragments with tandem repeats, 
allowing a highly accurate sequencing result that could be used for SNP detection 
(i.e. mutation).  
 Reference:  
Illumina (NGS) 




Amount cfDNA input < 10 ng 40 ng1 < 10 ng 
Amount DNA output2 100 – 500 ng  > 100 µg 100 – 500 ng 
Sample preparation time 3 – 5 hours ~ 24 hours 8 – 10 hours 
Sequencing time 24 – 80 hours3 24 – 48 hours 24 – 48 hours 
Wait time ~ 3 weeks -  -  





(2) High amount of output: RCA reaction yielded over 100 µg DNA, which exceeds 
the input requirement of nanopore sequencing; thus,  allowing quality controls and 
multiple testing.  
(3) Fragment length: ability to capture long-fragments that previously missed by short-
read platforms, as indicated by preliminary sequencing with the Flongle flow cell.  
(4) Long processing time: Sample preparation time took 24 hr total. However, there 
was a  long waiting period between steps, and the process actually took 2-3 working 
days, which is not practical in clinics.  
(5) High amount of isolated cfDNA input: depending on the concentration of cfDNA, 
4 – 40mL of plasma is needed, in order to obtain 40-50ng cfDNA input per sample. 
Moreover, as 90% of the DNA input was lost before RCA reaction, the diversity of 
the RCA product was significantly reduced. 
8.5.2 Method 2: DNA concatenation. Summary:  
(1) Simpler and shorter processing time: sample preparation plus ONT library 
preparation takes approximately 8 hours. Thus, DNA sequencing can be started 
within the same day.    
(2) Adaptable procedure from short-read technology: since the first half of this protocol 
used a common NGS library preparation method, this protocol is highly convenient 
for laboratories that currently rely on short-read platforms, but would like to try out 
long-read sequencing. Specifically,  the sample can be divided for sequencing with 




(3) Low DNA output: as nanopore sequencing requires at least 50-100fmol (or 500ng 
– 1µg) of DNA input, at least two or more samples will have to be multiplexed for 
a sequencing run.  
(4) Unavailable bioinformatic pipeline: This protocol is a combination of both NGS 
and nanopore sequencing, thus it requires a new, adapted pipeline. We estimate that 
it will take approximately 1-3 months to develop and employ this new 
bioinformatic pipeline.  
8.6 Conclusions 
Up-to-date, long fragments of cfDNA are still missing from the analysis, due to 
bias in sample preparation and sequencing limitations.326 Nanopore technology can be a 
potential tool to retrieve these missing fragments, thanks to its ability to perform long-read 
sequencing. However, sequencing ctDNA with nanopore sequencer is still challenging, due 
to the high input requirements and low base-calling accuracy with fragments shorter than 
1kbps. In this study, we showed two novel sample-preparation methods that can capture 
both short and long cfDNA fragments for sequencing with high accuracy using nanopore 
technology. At the moment, these methods are still under development and optimization to 
lower the cost and maximize sequencing output. We have sent samples from patients 1 and 
2 to sequence with both Illumina and nanopore sequencers. In the future, it is our goal to 
conduct a full-scale comparison of the advantages and disadvantages of WGS using three 
techniques: Next-generation sequencing (Illumina), Nanopore sequencing (using RCA and 








Summary and Conclusion 
 
This thesis focuses on exploring the α-hemolysin nanopore’s capability to detect 
and study molecular markers of cancer for precision medicine. The studies described 
herein, and summarized below, showcase different techniques to improve nanopore 
sensitivity in molecular detection and demonstrate how to bring the application of this 
technique from the lab-bench to the clinic.   
In Chapter 2, current work on applying nanopore technology in studying cancer 
biomarkers is summarized. We provided an overview of the essential genetic and 
epigenetic modifications in cancerous tissue and the progression of cancer cells. With the 
complexity of the human body and more specifically cancer tissues, many of the 
mechanisms for cancer proliferation remain unknown. Nanopore membranes have shown 
their ability to detect various biomolecules’ chemical and structural modifications, as well 
as genetic and epigenetic modifications. There is a growing opportunity for more 
significant research in this field to be conducted in the next few decades.   
Unlike solid-state nanopores, whose size can vary, α-hemolysin is a bacterial toxin 
that forms a nanopore with well-defined structure and consistent dimensions. This feature 
allows a reproducible sensing of molecular structure. Taking advantage of the α-hemolysin 
nanopore’s size selection, in Chapter 3, we evaluated the pore’s ability to sense DNA 
secondary structures that were different in size. The employed C-rich single-stranded DNA 
were able to adopt an i-motif structure in solutions with pH less than 6.15 and a linear 
strand when pH is higher than 6.15. However, we found that in highly concentrated buffers 




DNA, as the exocyclic amino group of cytosine allows strong cation-nucleotide binding 
because of resonance effects. This process created secondary structures larger than 2.6nm 
(nanopore cis opening), resulting in shallow current blockage events (%I/Io < 30%) that 
could be sensed by the pore. In either type of solution (1M NaCl or 1M KCl), both DNA 
compacting and translocating events were observed, hinting that the 15C-ssDNA adopted 
both elongated and compacted forms and could spontaneously shift from one conformation 
to the other.  
Formation of G-quadruplexes in the promoter region of Ckit1 proto-oncogene 
suppresses gene expression and prevents cancer cell replication. Excessive activation of 
the C-kit1 DNA sequence is implicated in several human malignancies and its expression 
is downregulated by the stabilization of its G-quadruplex structure. In Chapter 4, we 
studied the formability, stability and responsiveness to CX-5461 cancer drug of Ckit1 G-
quadruplex in K+ and Na+ environment. Using circular dichroism, we determined that Ckit1 
G-quadruplex adopted a parallel folding topology in both environments, with a more tightly 
packed structure in the presence of K+. While formation of a stable G-quadruplex was 
observed in both environments, Na+ G-quadruplex folded much slower and unfolded more 
rapidly than K+ G-quadruplex. Binding of CX-5461 effectively increased the structural 
stability and structural volume of G-quadruplex in both Na+ and K+ environments. 
Subsequent validation by thermal denaturation with circular dichroism revealed a 13˚C and 
11˚C increase in melting temperature of (CX-5461 bound versus unbound) K+ and Na+ G-
quadruplex, respectively. Moreover, through exploratory analysis using clustering, we 
identified two distinct populations of current blockage events, representing  the two stages 




pore (%I/Io = 85.1±2.9%). The volume of G-quadruplex is correlated with the cation 
species and presence of CX-5461. As the stability and volume of Ckit1 G-quadruplex were 
dependent on cations and ligand-binding status, it was feasible to distinguish different 
structures of Ckit1 G-quadruplex using nanopore data alone (e.g. predicting the binding 
state of CX-5461 to Ckit1 G-quadruplex in Na+ environment: 92.4% sensitivity, 70.3% 
specificity, and 81.3% average accuracy). 
In addition to binding of ligands (e.g. CX5461), other factors, such as point 
mutation, can also strongly affect the stability of G-quadruplex. Activating mutation on 
Ckit1 has been observed in several types of malignancy; however, their direct effect on 
cancer drug efficacy (i.e. CX5461) remains unclear. Therefore, in Chapter 5, we evaluated 
the ability of mutated Ckit1 sequences to form G-quadruplex, as well as their stability with 
respect to ligand binding. We employed six samples that were variations of the Ckit1 
sequence, including one wild-type (control) and five sequences containing 1-6 guanine 
mutations. Nanopore dwell time analysis of these mutated structures revealed a general 
decrease in G-quadruplex structural stability, with the most significant changes present 
when there was more than one mutation of the same G-quartet. Thermal denaturation study 
with circular dichroism showed that sequences with more than one mutation on the same 
G-quartet lost their characteristic positive peak (at 263nm), hinting a partial or uncomplete 
formation of G-quadruplex. While addition of CX5461 to mutated Ckit1 DNA sequences 
increased the overall stability of G-quadruplex structure formed by most samples, 
sequences with mutations on the outer G-quartet did not exhibit statistically significant 
changes. This result indicated the important role of the outer G-quartet for ligand-binding 




nanopore sensing data to distinguish mutated from unmutated Ckit1 DNA ( AUC = 0.89, 
sensitivity = 81.9%, specificity = 83.4% and balanced accuracy = 82.7%). Understanding 
the potential effect of mutation on drug efficiency can have implications in the 
implementation of cancer therapies. Our results indicate the potential of using a nanopore 
biosensor to study DNA molecular stability and their interaction with cancer drugs for 
constructing methods to predict therapeutic response, as well as personalizing cancer 
treatment.  
In addition to DNA secondary structure, other types of DNA modifications, such 
as methylation of DNA, are important markers for cancer diagnosis and therapeutic 
response prediction. While conventional methods can detect cytosine methylation with 
high accuracy, they still require a high amount of input and extensive sample processing. 
In Chapter 6, we  performed, for the first time, label-free detection of cytosine methylation 
on single-stranded DNA, using an α-hemolysin nanopore sensor. One of the main 
challenges with nanopore sensing is low accuracy due to fast translocation speed of 
biomolecules through the pore. To tackle this issue, we employed a concentration gradient 
of salt across the experimental chambers. As the cations move down the concentration 
gradient, they move against DNA translocation direction, thus, significantly lowering the 
electrophoretic drive of the system and DNA translocation speed. With a 15-fold increase 
of LiCl concentration going from the cis to the trans chamber, DNA translocation speed 
was effectively decreased by 5 times, allowing a clear distinction between methylated and 
unmethylated DNA. Distribution of current blockage amplitude for methylated – 
unmethylated DNA mixtures exhibited bimodule distributions, with peaks’ height 




Results of this study indicate the potential of simplifying label-free cytosine methylation 
detection with nanopore, using LiCl salt concentration asymmetry.  
While label-free detection of cytosine methylation is feasible, current blockage 
amplitude of methylated DNA varies based on the local-sequence context, thus, 
complicating the computational aspect. Therefore, in Chapter 7, we employed methyl-
binding protein (MBD2) to enhance the signal of methylated cytosine going through the 
nanopore. Binding of MBD2 to duplex DNA increased the structural stability and 
significantly prolonged the event translocation time through the pore. Applying machine 
learning classification models on nanopore results revealed that utilizing MBD2 protein 
provided a good discriminatory power for cytosine methylation detection with an optimal 
AUC of 0.83, 88% sensitivity and 86% specificity (using KNN algorithm).  
Finally, we explored the potential of applying nanopore technology to capture 
cancer biomarkers in a clinical setting. Liquid biopsy—a technique to study cancer through 
circulating-tumor DNA—offers a minimally invasive and reliable detection of tumors’ 
genomic evolution through longitudinal sampling. Current work with cell-free DNA 
obtained from cancer cell culture media reflected the existence of long cfDNA fragment 
(>1kbps). However, current sequencing techniques, which depend on enzymatic reaction, 
are limited by the read-length (<500bps). Compared to conventional methods, the nanopore 
offers a shorter sample processing time and the ability to capture long cfDNA fragments. 
However, because of their rapid translocation speed, short DNA fragments (<1kbps) are 
often missed by the nanopore. In Chapter 8, we developed two methods to capture both 
short and long fragments of cell-free DNA using commercially-available nanopore assay. 




circle amplification to amplify and convert them into long fragments with tandem repeats. 
In the second method, we used standard sequencing library preparation (NGS library) to 
perform whole-genome amplification, after which, long fragments were generated through 
blunt-end ligation (Gibson assembly). We tested the two methods using  plasma samples 
obtained from the same lung cancer patients. Sequencing results with Flongle showed 
successful capture of both short and long cfDNA fragments (50bps to over 600bps). While 
further validations and optimization are needed, our study demonstrated the potential 
benefits and applications of nanopore in sequencing cfDNA for monitoring treating 
progression. 
Overall, in this thesis, we aimed to validate and improve α-hemolysin nanopore 
assays toward precision medicine in oncology. Specifically, we investigated the potential 
of lab-based and commercially available nanopore assays for molecular sensing and 
ctDNA sequencing. While lab-based assay offers the flexibility for controlling and fine-
tuning of parameters, commercial assay provides higher sensing resolution and throughput. 
Each method certainly has its own potential area in precision medicine. Thanks to its low 
capital cost and small footprint, nanopore technology offers a higher mobility and more 
flexibility than conventional techniques. Our study demonstrated the nanopore’s ability for 
rapid molecular sensing and sequencing (within a few days, compared to the standard three 
weeks’ waiting period for NGS sequencing). The biggest challenge remaining for both 
types of assays is their high input requirement, compared to clinical standards. Therefore, 
there is a need for future advancements in both wet lab and technological development for 
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Example of R Code for Dwell Time Boxplots 
 
################ Dwell time distribution - Grouped Boxplot ################## 
dwelltime <-read.csv("Amplitude_Dwelltime_allconditions_mut_4columns_new.csv", sep = ",", 
header = TRUE) 
dwelltime.f <- dwelltime %>%filter(dwelltime$Amplitude > 60 & dwelltime$Dwell.Time > 1) 
head(dwelltime.f) 
##   Amplitude Dwell.Time Condition Treatment 
## 1    86.263       1.80      L1M1     No CX 
## 2    86.226       7.92      L1M1     No CX 
## 3    85.990       1.84      L1M1     No CX 
## 4    85.956     818.26      L1M1     No CX 
## 5    85.549   27910.62      L1M1     No CX 
## 6    85.416       2.54      L1M1     No CX 
# annotation table with adjusted pvals and y-position of the labels 
anno_df = compare_means(Dwell.Time ~ Treatment, group.by = "Condition", data = dwelltime.
f) %>% 
  mutate(y_pos = 40) 
## Warning: `cols` is now required. 
## Please use `cols = c(p)` 
p <- ggplot(dwelltime.f, aes(x=Condition, y=Dwell.Time)) +  
  geom_boxplot(aes(fill = Treatment)) +  
  scale_fill_brewer(palette = "Dark2")+ 
  scale_y_continuous(trans = 'log10') 
 
p <- p + stat_compare_means(comparisons = list(c("No CX", "With CX")), size = 4)+  
  theme(legend.position="none")+ # Remove legend 
  # set transparency 
  theme( 
    panel.grid.major = element_blank(),  
    panel.grid.minor = element_blank(), 
    panel.background = element_rect(fill = "transparent",colour = NA), 
    plot.background = element_rect(fill = "transparent",colour = NA) 






ggsave(p, filename = "Ckit_Mut_Dwelltime_GroupedBoxplot.png",  bg = "transparent") 








Example of R Code for Summary Statistic and Pairwise Comparison  
 
##########Summary of the dwell time table: mean, max, min, median## ######### 
dwelltime <-read.csv("Amplitude_Dwelltime_allconditions_mut_new.csv", sep = ",", header = T
RUE) 
dwelltime.f <- dwelltime %>%filter(dwelltime$Amplitude > 50 & dwelltime$Dwell.Time > 1) 
stat.sum <- as.data.frame(dwelltime.f %>%  
                            group_by(Condition)%>% 
                            summarise(Mean = mean(Dwell.Time), Max = max(Dwell.Time), Min =min(
Dwell.Time), Median = median(Dwell.Time), Std = sd(Dwell.Time) )) 
 
stat.sum 
##    Condition         Mean        Max    Min  Median        Std 
## 1      Ckit1  3677.865950 114411.352 1.0500  5.5500 12755.3138 
## 2   Ckit1_CX 10245.271661 152850.000 1.0200 31.1900 25301.9010 
## 3       L1M1  3455.983506  51802.340 1.0200  3.5500  9639.9690 
## 4    L1M1_CX  1664.956641  39545.141 1.0230  8.8000  5819.8137 
## 5       L1M2     8.650711    296.945 1.0160  2.7190    22.9824 
## 6    L1M2_CX   563.404257  39771.090 1.0200  4.4885  3364.7391 
## 7       L2M1  2055.286784  65396.621 1.0200  5.2800  7247.3926 
## 8    L2M1_CX    30.167402   1447.891 1.0310  3.2660   132.3704 
## 9       L2M2    30.100872   1447.891 1.0310  3.2830   132.2039 
## 10   L2M2_CX  6388.554461 119939.500 1.0200  8.9800 16950.6187 
## 11       M2C    14.967050   3449.960 1.0200  4.0800   121.7973 
## 12    M2C_CX   312.115897  29303.414 1.0155  4.8599  1863.5142 
# Compute the analysis of variance 
res.aov <- aov(Dwell.Time ~ Condition, data = dwelltime.f) 
# Summary of the analysis 
summary(res.aov) 
##               Df    Sum Sq   Mean Sq F value Pr(>F)     
## Condition     11 4.461e+10 4.056e+09   78.04 <2e-16 *** 
## Residuals   9294 4.830e+11 5.197e+07                    
## --- 
## Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
#Multiple pairwise comparison 
TukeyHSD(res.aov) 
##   Tukey multiple comparisons of means 
##     95% family-wise confidence level 
##  
## Fit: aov(formula = Dwell.Time ~ Condition, data = dwelltime.f) 
##  
## $Condition 




## Ckit1_CX-Ckit1    6.567406e+03   4934.7940  8200.017464 0.0000000 
## L1M1-Ckit1       -2.218824e+02  -2252.6909  1808.925998 0.9999999 
## L1M1_CX-Ckit1    -2.012909e+03  -3553.2472  -472.571381 0.0011828 
## L1M2-Ckit1       -3.669215e+03  -4968.2458 -2370.184726 0.0000000 
## L1M2_CX-Ckit1    -3.114462e+03  -4391.5832 -1837.340205 0.0000000 
## L2M1-Ckit1       -1.622579e+03  -2778.6092  -466.549135 0.0002834 
## L2M1_CX-Ckit1    -3.647699e+03  -5097.9737 -2197.423364 0.0000000 
## L2M2-Ckit1       -3.647765e+03  -5096.7379 -2198.792281 0.0000000 
## L2M2_CX-Ckit1     2.710689e+03   1130.0860  4291.291062 0.0000014 
## M2C-Ckit1        -3.662899e+03  -4600.9346 -2724.863192 0.0000000 
## M2C_CX-Ckit1     -3.365750e+03  -4313.9376 -2417.562523 0.0000000 
## L1M1-Ckit1_CX    -6.789288e+03  -9130.8543 -4447.721959 0.0000000 
## L1M1_CX-Ckit1_CX -8.580315e+03 -10511.9957 -6648.634339 0.0000000 
## L1M2-Ckit1_CX    -1.023662e+04 -11981.9661 -8491.275828 0.0000000 
## L1M2_CX-Ckit1_CX -9.681867e+03 -11410.9679 -7952.766882 0.0000000 
## L2M1-Ckit1_CX    -8.189985e+03  -9831.6775 -6548.292229 0.0000000 
## L2M1_CX-Ckit1_CX -1.021510e+04 -12075.7621 -8354.446464 0.0000000 
## L2M2-Ckit1_CX    -1.021517e+04 -12074.8136 -8355.527950 0.0000000 
## L2M2_CX-Ckit1_CX -3.856717e+03  -5820.6555 -1892.778875 0.0000000 
## M2C-Ckit1_CX     -1.023030e+04 -11726.5199 -8734.089282 0.0000000 
## M2C_CX-Ckit1_CX  -9.933156e+03 -11435.7565 -8430.555048 0.0000000 
## L1M1_CX-L1M1     -1.791027e+03  -4069.2174   487.163654 0.2970685 
## L1M2-L1M1        -3.447333e+03  -5569.8293 -1324.836297 0.0000073 
## L1M2_CX-L1M1     -2.892579e+03  -5001.7379  -783.420553 0.0004611 
## L2M1-L1M1        -1.400697e+03  -3438.8127   637.419207 0.5154649 
## L2M1_CX-L1M1     -3.425816e+03  -5644.1058 -1207.526398 0.0000293 
## L2M2-L1M1        -3.425883e+03  -5643.3211 -1208.444185 0.0000289 
## L2M2_CX-L1M1      2.932571e+03    626.9657  5238.176197 0.0019255 
## M2C-L1M1         -3.441016e+03  -5363.8847 -1518.148260 0.0000003 
## M2C_CX-L1M1      -3.143868e+03  -5071.7086 -1216.026666 0.0000065 
## L1M2-L1M1_CX     -1.656306e+03  -3315.6580     3.046169 0.0509311 
## L1M2_CX-L1M1_CX  -1.101552e+03  -2743.8095   540.704725 0.5550697 
## L2M1-L1M1_CX      3.903301e+02  -1159.6294  1940.289674 0.9996296 
## L2M1_CX-L1M1_CX  -1.634789e+03  -3415.0328   145.454347 0.1080353 
## L2M2-L1M1_CX     -1.634856e+03  -3414.0385   144.326988 0.1074817 
## L2M2_CX-L1M1_CX   4.723598e+03   2835.6694  6611.526193 0.0000000 
## M2C-L1M1_CX      -1.649990e+03  -3044.9377  -255.041525 0.0062430 
## M2C_CX-L1M1_CX   -1.352841e+03  -2754.6356    48.954072 0.0703972 
## L1M2_CX-L1M2      5.547535e+02   -863.6426  1973.149735 0.9818354 
## L2M1-L1M2         2.046636e+03    736.2110  3357.061151 0.0000217 
## L2M1_CX-L1M2      2.151669e+01  -1554.5882  1597.621562 1.0000000 
## L2M2-L1M2         2.145016e+01  -1553.4564  1596.356705 1.0000000 
## L2M2_CX-L1M2      6.379904e+03   4683.1089  8076.698634 0.0000000 
## M2C-L1M2          6.316339e+00  -1116.5013  1129.133975 1.0000000 
## M2C_CX-L1M2       3.034652e+02   -827.8473  1434.777718 0.9993243 
## L2M1-L1M2_CX      1.491883e+03    203.1727  2780.592311 0.0085447 
## L2M1_CX-L1M2_CX  -5.332369e+02  -2091.3336  1024.859929 0.9939262 
## L2M2-L1M2_CX     -5.333034e+02  -2090.1880  1023.581211 0.9938793 
## L2M2_CX-L1M2_CX   5.825150e+03   4145.0693  7505.231125 0.0000000 
## M2C-L1M2_CX      -5.484372e+02  -1645.8334   548.959014 0.8968496 




## L2M1_CX-L2M1     -2.025119e+03  -3485.6096  -564.629147 0.0003670 
## L2M2-L2M1        -2.025186e+03  -3484.3829  -565.988946 0.0003600 
## L2M2_CX-L2M1      4.333268e+03   2743.2872  5923.248193 0.0000000 
## M2C-L2M1         -2.040320e+03  -2994.0726 -1086.566828 0.0000000 
## M2C_CX-L2M1      -1.743171e+03  -2706.9101  -779.431707 0.0000002 
## L2M2-L2M1_CX     -6.652969e-02  -1701.8739  1701.740880 1.0000000 
## L2M2_CX-L2M1_CX   6.358387e+03   4543.1927  8173.581461 0.0000000 
## M2C-L2M1_CX      -1.520035e+01  -1310.0120  1279.611326 1.0000000 
## M2C_CX-L2M1_CX    2.819485e+02  -1020.2365  1584.133537 0.9999157 
## L2M2_CX-L2M2      6.358454e+03   4544.2996  8172.607599 0.0000000 
## M2C-L2M2         -1.513382e+01  -1308.4866  1278.218929 1.0000000 
## M2C_CX-L2M2       2.820150e+02  -1018.7194  1582.749409 0.9999145 
## M2C-L2M2_CX      -6.373587e+03  -7812.8732 -4934.301617 0.0000000 
## M2C_CX-L2M2_CX   -6.076439e+03  -7522.3612 -4630.515953 0.0000000 







Example of R Code for Machine Learning Classification Models  
 
####Machine learning: predicting methylated from unmethylated DNA ##### 
## With MBD2  
bothend.ml <-read.csv("bothend_nome_MBD2_ml.csv", sep = ",", header = TRUE) 
head(bothend.ml) 
##   Amplitude Dwell.Time Condition 
## 1  82.35037   20704.35      nome 
## 2  86.29356     802.45      nome 
## 3  89.52220     206.75      nome 
## 4  55.81189      14.75      nome 
## 5  79.11031       6.35      nome 
## 6  60.56889       3.95      nome 
dim(bothend.ml) 
## [1] 1151    3 
dwelltime$Condition <- as.factor(dwelltime$Condition) 
 
df_ML <- bothend.ml 
df_ML <- na.omit(df_ML) 
 
 
df_ML.f <- df_ML%>%filter( df_ML$Amplitude > 75 & df_ML$Dwell.Time > 100 & df_ML
$Dwell.Time <10000) #Filtering data: only choose data with dwell time > 50ms.  
dim(df_ML.f) 





train_indx <- createDataPartition(df_ML.f$Condition, p = 0.80, list = FALSE) 
 
train_set <- df_ML.f[train_indx,] 
test_set <- df_ML.f[-train_indx,] 
 
nrow(train_set) 
## [1] 289 
dim(train_set) 





## [1] 71 
##################### Train the algorithm ############################ 
fitControl <- trainControl(method="boot", 
                           number = 10, 
                           preProcOptions = list(thresh = 0.99), # threshold for pca preprocess 
                           classProbs = TRUE, 
                           savePredictions = TRUE, 
                           summaryFunction = twoClassSummary) 
 
#################### Random Forest ################################# 
 
model_rf <- train(Condition~ Amplitude_scaled+Dwell.Time_scaled,data = train_set, method="r
f", metric="ROC", 
                  preProcess = c('center', 'scale'), trControl=fitControl) 
## note: only 1 unique complexity parameters in default grid. Truncating the grid to 1 . 
pred_rf <- predict(model_rf, test_set) 
cm_rf <- confusionMatrix(pred_rf, test_set$Condition, positive = "nome") 
cm_rf 
## Confusion Matrix and Statistics 
##  
##           Reference 
## Prediction me_MBD2 nome 
##    me_MBD2      28    7 
##    nome          7   29 
##                                            
##                Accuracy : 0.8028           
##                  95% CI : (0.6914, 0.8878) 
##     No Information Rate : 0.507            
##     P-Value [Acc > NIR] : 2.446e-07        
##                                            
##                   Kappa : 0.6056           
##                                            
##  Mcnemar's Test P-Value : 1                
##                                            
##             Sensitivity : 0.8056           
##             Specificity : 0.8000           
##          Pos Pred Value : 0.8056           
##          Neg Pred Value : 0.8000           
##              Prevalence : 0.5070           
##          Detection Rate : 0.4085           
##    Detection Prevalence : 0.5070           
##       Balanced Accuracy : 0.8028           
##                                            
##        'Positive' Class : nome             
##  





model_lda_df <- train(Condition ~., data = train_set, method = "lda", metric = "ROC", preProces
s = c("scale", "center"),  
                      trControl = fitControl) 
prediction_lda_df <- predict(model_lda_df, test_set) 
cm_lda_df <- confusionMatrix(prediction_lda_df, test_set$Condition, positive = "nome") 
cm_lda_df 
## Confusion Matrix and Statistics 
##  
##           Reference 
## Prediction me_MBD2 nome 
##    me_MBD2      26   16 
##    nome          9   20 
##                                            
##                Accuracy : 0.6479           
##                  95% CI : (0.5254, 0.7576) 
##     No Information Rate : 0.507            
##     P-Value [Acc > NIR] : 0.01165          
##                                            
##                   Kappa : 0.2976           
##                                            
##  Mcnemar's Test P-Value : 0.23014          
##                                            
##             Sensitivity : 0.5556           
##             Specificity : 0.7429           
##          Pos Pred Value : 0.6897           
##          Neg Pred Value : 0.6190           
##              Prevalence : 0.5070           
##          Detection Rate : 0.2817           
##    Detection Prevalence : 0.4085           
##       Balanced Accuracy : 0.6492           
##                                            
##        'Positive' Class : nome             
## 
################## Logistic regression #################### 
model_logreg_df <- train(Condition ~., data = train_set, method = "glm",  
                         metric = "ROC", preProcess = c("scale", "center"),  
                         trControl = fitControl) 
cm_logreg_df <- confusionMatrix(prediction_logreg_df, test_set$Condition, positive = "nome") 
cm_logreg_df 
## Confusion Matrix and Statistics 
##  
##           Reference 
## Prediction me_MBD2 nome 
##    me_MBD2      26   16 
##    nome          9   20 
##                                            




##                  95% CI : (0.5254, 0.7576) 
##     No Information Rate : 0.507            
##     P-Value [Acc > NIR] : 0.01165          
##                                            
##                   Kappa : 0.2976           
##                                            
##  Mcnemar's Test P-Value : 0.23014          
##                                            
##             Sensitivity : 0.5556           
##             Specificity : 0.7429           
##          Pos Pred Value : 0.6897           
##          Neg Pred Value : 0.6190           
##              Prevalence : 0.5070           
##          Detection Rate : 0.2817           
##    Detection Prevalence : 0.4085           
##       Balanced Accuracy : 0.6492           
##                                            
##        'Positive' Class : nome             
##  
################## K-nearest neighbor ############################# 
model_knn <- train(Condition~., 
                   data = train_set, 
                   method="knn", 
                   metric="ROC", 
                   preProcess = c('center', 'scale'), 
                   tuneLength=10, 
                   trControl=fitControl) 
pred_knn <- predict(model_knn, test_set) 
cm_knn <- confusionMatrix(pred_knn, test_set$Condition, positive = "nome") 
cm_knn 
## Confusion Matrix and Statistics 
##  
##           Reference 
## Prediction me_MBD2 nome 
##    me_MBD2      27   11 
##    nome          8   25 
##                                            
##                Accuracy : 0.7324           
##                  95% CI : (0.6141, 0.8306) 
##     No Information Rate : 0.507            
##     P-Value [Acc > NIR] : 9.002e-05        
##                                            
##                   Kappa : 0.4653           
##                                            
##  Mcnemar's Test P-Value : 0.6464           
##                                            
##             Sensitivity : 0.6944           
##             Specificity : 0.7714           




##          Neg Pred Value : 0.7105           
##              Prevalence : 0.5070           
##          Detection Rate : 0.3521           
##    Detection Prevalence : 0.4648           
##       Balanced Accuracy : 0.7329           
##                                            
##        'Positive' Class : nome             
########################### Model Evaluation ######################## 
model_list <- list(RF=model_rf, LG=model_logreg_df, LDA = model_lda_df, 
                  KNN = model_knn 
resamples <- resamples(model_list) 
bwplot(resamples, metric = "ROC", main = "Evaluating performance of different algorithms") 
 
 
